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Viral diseases take the lives of millions of people each year. The most effective 
methods to prevent viral disease outbreak are viral detection to reduce contact with viral 
pathogens and vaccines to prevent disease. To reduce the costs of the detection of viruses 
and improve vaccine formulation, we explored viral surface properties. The properties we 
have focused on are viral hydrophobicity and surface charge using chemical force 
microscopy (CFM). CFM is a single-particle technique that measures the adhesion force 
of a functionalized atomic force microscopy (AFM) probe, and in this study, a virus 
covalently bound to a surface. The non-enveloped porcine parvovirus (PPV) and 
enveloped bovine viral diarrhea virus (BVDV) were used to demonstrate the use of CFM 
for viral particles with different surface properties.  
The high hydrophobicity of PPV and BVDV by CFM was used for a ligand-free, 
non-specific virus detection method that relies on the interaction of virus with osmolytes. 
It was previously found that the osmolyte mannitol can preferentially aggregate viruses 
while leaving proteins in solution. The virus was incubated with gold nanoparticles 
(AuNPs), and aggregation of the virus-AuNP complex with mannitol was detected by 
dynamic light scattering (DLS).  
The isoelectric point (pI) of PPV and BVDV by CFM was used for a vaccine 
formulation strategy of virus particle encapsulation by polymers that relies on 
electrostatic interactions of the virus with polypeptides. The random screen of different 
ratios of polyelectrolytes to encapsulate viruses could be reduced by knowing the virus 
pIs. An encapsulated non-enveloped PPV is thermally stabilized, demonstrating that this 
method is promising for formulating thermostable vaccines.   
We have developed a unique detection method and can improve vaccine 

















Viruses are nanoscale-sized infectious agents [1], which cause many diseases such 
as influenza, smallpox, acquired immunodeficiency syndrome (AIDS), severe acute 
respiratory syndrome (SARS), and Ebola. In the age of modern medicine, viral diseases 
continue to take the lives of millions of people each year around the world [2], resulting 
in significant human, social, and economic losses. The most effective methods to prevent 
viral disease outbreak are viral detection to reduce contact with viral pathogens and 
vaccines to prevent disease.  
Traditional virus detection methods, such as enzyme-linked immunosorbent assay 
(ELISA) [3], lateral flow immunoassay [4], and polymerase chain reaction (PCR) [5], 
require ligands that bind to either viral capsid proteins or viral nucleic acids. Ligands are 
typically antibodies or oligonucleotides, and are expensive, have limited chemical 
stability, and can only detect one specific type of virus at a time. There are ligand-free 
detection methods, such as transmission electron microscopy (TEM) [6], and in-vitro cell 
culture assays [7], but both are time-consuming, labor-intensive, and expensive. The high 
cost of traditional virus detection methods limits their accessibility in low resources 
countries.  
Low resource countries also have lower vaccination rates due to the need for being 
transported and stored at cold temperatures [8]. If temperatures are not maintained, the 
vaccine may lose its potency and could no longer be effective in fighting disease. This is 
called the cold storage problem [8]. Finding a way to stabilize a virus thermally, so a 
vaccine does not need to be transported and stored in cold temperatures, is important to 
the health and safety of many people.  
To benefit the public health and safety, a ligand-free, general virus detection 
method using gold nanoparticles (AuNPs) aggregation, and the use of polyelectrolyte 
dense phases to stabilize viruses thermally was explored. However, to design a new, 
inexpensive virus detection method and to reduce the need to screen different ratios of 
polyelectrolytes randomly, we have chosen to explore viral surface properties first. 
The properties we have focused on are the hydrophobic and electrostatic surface 
properties of viruses, which determine the viral mobility and colloidal behavior in a 
liquid medium [9-12]. The viral surface characteristics need to be thoroughly understood 
for better manipulating of virus interactions with AuNPs and polyelectrolytes. Common 
methods for characterizing the surface properties of viruses are hydrophobic interaction 
chromatography (HIC) [13-14], aqueous two-phase system (ATPS) cross-partitioning 
[15], zeta potential [16], and isoelectric focusing (IEF) [17]. However, they are bulk 
measurements and limited by the purity of virus samples [18, 19] and solution conditions 
[15, 16, 20]. Moreover, except for IEF, these methods require a large amount of purified 
virus samples, of which the cost is high. Thus, an inexpensive, robust, reliable, and 
single-particle technique chemical force microscopy (CFM) [21] was chosen to 





The dissertation begins with an introduction of this research stated here as chapter 
1. Chapter 2 contains a literature review on why this research is needed and the principal 
background of the research. We discuss the limitations of traditional virus surface 
characterization methods and show the promise of the single-particle method CFM to 
characterize viral surface properties. Also, we discuss the disadvantages of the past and 
current virus detection methods and show the advantage of using AuNPs to detect the 
virus. Towards the end of this chapter, we talk about the cold storage problem of 
conventional formulation and discuss novel vaccine formulation strategies to stabilize 
viral vaccines thermally. 
In Chapter 3, we demonstrate how we developed the single-particle method CFM 
to characterize virus surface characteristics, focusing on the hydrophobicity and surface 
charge, which determine the viral mobility and control the viral colloidal behavior during 
adsorption. CFM allows the characterization of viral capsid surface chemistry in known 
solution conditions with small amounts of virus samples. This single-particle method 
requires the functionalization of an atomic force microscopy (AFM) probe and the 
covalent bonding of the virus to a surface. Conditions were explored during each of these 
processes to understand the key variables for the measurement of virus adhesion to 
functionalized AFM probes. A non-enveloped porcine parvovirus (PPV), and an 
enveloped bovine viral diarrhea virus (BVDV) were used to demonstrate the use of CFM 
for viral particles with different surface properties. CFM with an AFM probe terminated 
with hydrophobic methyl groups was used to study the surface hydrophobicity of a virus. 
An AFM probe terminated with either negatively charged carboxyl acids or with 
positively charged quaternary amines was used to study the surface charge of the virus. 
With the method appearing to be robust, we used CFM for further virus electrostatic 
properties measurement. 
In Chapter 4, we used CFM to determine the isoelectric point (pI) of two viruses 
PPV and BVDV. Traditional determination of virus pI has focused on the bulk 
characterization of a viral solution. However, virus capsids are extremely heterogeneous, 
and a single-particle method may give more information on the range of surface charge 
observed across a population. We have validated the CFM by determining the pI of PPV 
to be 4.8-5.1, which has a known pI value of 5.0 in the literature and to predict the 
unknown pI of BVDV to be 4.3-4.5. Bulk measurements, zeta potential, and aqueous 
two-phase systems (ATPS) cross-partitioning methods were also used to validate the new 
CFM method for virus pI. Most methods were in good agreement. CFM can detect the 
surface charge of viral capsids at a single-particle level and enable the comparison of 
surface charge between different types of viruses. 
In Chapter 5, the biochemical surface properties of viruses were exploited for 
ligand-free, nonspecific virus detection. The detection depends on the interaction of the 
virus with the osmolyte mannitol. Osmolytes are naturally occurring molecules that have 
a high affinity for water. By binding water, the highly hydrophobic virus is partially 
dehydrated, which causes aggregation. It has been found that the osmolyte mannitol can 
preferentially aggregate virus while leaving proteins in solution. This led to the 
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development of a ligand-free detection of virus using AuNP aggregation. A non-
enveloped PPV was incubated with AuNPs, and aggregation of the PPV-AuNP complex 
with mannitol was detected by DLS. The lowest detectable concentration of PPV was 
statistically determined to be 106 MTT50/mL, which is lower than standard antibody 
assays. PPV was also detected when swabbed from a dry surface and in the presence of a 
protein solution matrix. The enveloped BVDV was also detected using the mannitol-
induced aggregation of BVDV-coated AuNPs. The lowest detectable concentration of 
BVDV was statistically determined to be 104 MTT50/mL. This demonstrates that gold 
nanoparticle aggregation can detect viruses without the use of specific ligands. 
 Chapter 6 explores the use of polyelectrolyte dense phases to thermally stabilize 
the virus. We have developed a method of encapsulation of virus particles in polymers 
that relies on the electrostatic interaction of viruses with polypeptides. Encapsulating 
virus particles in polypeptides is a potential solution to the cold storage problem. When 
oppositely charged polypeptides are in solution, the electrostatic interactions of the 
polypeptides create a dense phase liquid called a complex coacervate. Two viruses, PPV 
and BVDV, were explored to form the virus complex coacervates. The amount of 
charged polypeptides corresponded to the difference in the pI of the two viruses. The 
PPV and BVDV coacervates at each maximum extraction condition were used to explore 
the effect of complex coacervates on the stability of viruses against high temperatures. 
The encapsulated non-enveloped PPV is thermally stabilized. Coacervates could help 
prevent the cold storage problem seen not only in developing countries but is also a very 
real problem here in rural parts of America. 
Chapter 7 reviews the major findings from this research and discusses the future 
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2.1 General overview of viral diseases and viruses 
 
2.1.1 Viral diseases outbreak 
 
Viruses are small “obligate parasites”, typically range from 20-400 nm in size [1], 
relying on a living host for production [2]. Viruses are known to cause human disease, 
including influenza, hepatitis, smallpox, measles, severe acute respiratory syndrome 
(SARS), and acquired immune deficiency syndrome (AIDS). Viral diseases can seriously 
or mortally damage human organs, including lungs, liver, intestines, central nervous 
system, and immune system. Viruses are responsible for 10–15% of human cancers [3] 
and are responsible for killing millions of people in the world each year [4]. Viral 
infectious disease outbreak is one of the greatest threats to public health in the twenty-
first century [5]. 
For example, the 2014–2016 Ebola outbreak in West Africa caused more than 
28,616 suspected cases and 11,310 deaths [6]. It was the largest and most severe Ebola 
outbreak ever recorded since the virus was first discovered in 1976 [7]. The second-worst 
ever Ebola outbreak in the Democratic Republic of the Congo (DRC) from August 2018 
is still ongoing [8]. As of September 2019, more than 3,000 people have been infected 
with Ebola, and over 2,000 people have died [8]. Ebola virus disease (EVD) has 
symptoms of fever, body pains, vomiting and diarrhea, and sometimes bleeding inside 
and outside the body, from 2 to 21 days after infection with the Ebola virus [9]. 
Currently, there is no licensed vaccine or cure for EVD. However, an experimental 
recombinant vesicular stomatitis virus–Zaire Ebola virus (rVSV-ZEBOV) vaccine has 
been used to protect over 90,000 people under a compassionate use protocol in ongoing 
DRC Ebola outbreak and showed a high level of protection against EVD (97.5% vaccine 
efficacy) [10]. Also, two investigational treatment monoclonal antibodies, mAb114 and 
REGN-EB3, showed a significant improvement in the survival rate for Ebola patients 
during the ongoing DRC outbreak [11]. The spread of Ebola could also be reduced by 
early virus detection.  
Moreover, the global measles outbreak also hit the U.S. and has become a national 
focus. Measles is caused by a Measles morbillivirus in the paramyxovirus family [12]. It 
is highly contagious and can spread through direct contact with infected people and 
through the air. People infected with the measles can show symptoms of high fever, 
cough, runny nose, red and watery eyes, Koplik spots, and a measles rash [13]. Measles 
can be very dangerous, especially for children under five years old. From January 1 to 
September 26, 2019, a total of 1,243 cases of measles have been confirmed in 31 states of 
the U.S., most of the outbreaks were in New York, Michigan and Washington State in 
unvaccinated communities [14]. The measles outbreak could be prevented with the 
available safe, cost-effective measles, mumps, and rubella (MMR) vaccine [13]. 
According to the World Health Organization (WHO), measles vaccination prevented an 
estimated 21.1 million deaths worldwide from 2000 to 2017 [15]. 
Viral infectious diseases can still cause significant mortality, morbidity, and 
economic burdens for people today. The most effective methods to prevent viral disease 
outbreak are vaccines to prevent disease and to detect viruses to reduce contact with viral 
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pathogens. A full understanding of the viral particles plays a crucial role in the design of 
viral vaccines and virus detection technologies.  
 
2.1.2 Viral structure and families 
 
Virus structures are designed for effective replication within the host organism. 
Viruses contain genetic material (either a DNA or RNA genome) and are surrounded by 
protective protein coats. The viral genome can be single-stranded (ss) or double-stranded 
(ds), linear or circular in shape, and a thousand to a million base pairs in size [1, 2]. The 
protein coat is called a capsid and is encoded by the viral genome [1, 2]. The viral capsid 
is made up of multiple copies of identical protein subunits. There are two major patterns 
of viral capsid: helical symmetry and icosahedral symmetry [1, 2]. Some virus families 
possess an additional lipid bilayer covering, into which viral glycoproteins are inserted, 
known as enveloped viruses [1, 2]. The viral envelopes are derived from host cell 
membranes. Other virus families that do not contain a lipid bilayer carrying viral 
glycoproteins, called non-enveloped or naked viruses [1, 2].  
Both the enveloped and non-enveloped viruses from different viral families can 
cause human infectious disease, as shown in Table 2.1 [16-18].  One basic unit of viral 
taxonomy is the virus family. All viruses in the same family share similar characteristics, 
such as genome type, presence or absence of an envelope, approximate size, etc.  The 
vaccine development against a viral disease is based on the virus properties, but for each 
virus in the same viral family, the vaccine approach could be different due to the distinct 













Table 2.1 Viral families related to human infections [16-18] 
 
Viral family Virus Structure Genome Disease Licensed vaccine 





Bunyaviridae Hantaan virus Enveloped ssRNA Hemorrhagic fever  
Calciviridae Norwalk virus Non-enveloped ssRNA Gastroenteritis  
Coronaviridae SARS coronavirus Enveloped ssRNA SARS  
Filoviridae Ebola virus Enveloped ssRNA EVD  











Hepeviridae Hepatitis E virus (HEV) 
Non-























(HPV) 6, 11, 16, 18, 




genital warts Subunit 
Paramyxoviridae Measles virus; Mumps virus Enveloped ssRNA Measles; Mumps 
Live-
attenuated 















Poxviridae Variola virus Enveloped dsDNA Smallpox Live-attenuated 





Retroviridae HIV type 1 Enveloped ssRNA AIDS  
Rhabdoviridae Rabies virus Enveloped ssRNA Rabies Inactivated 




2.2 Virus characterization 
 
2.2.1 Virus surface properties 
 
Viruses contain a capsid, which is a shell made up of 20 standard amino acids and 
is packed with the viral genome [2]. There are many characteristic features of viruses, 
such as morphology, structure, surface roughness, and mechanical properties such as 
intrinsic elasticity, stiffness, brittleness, and resistance to material fatigue. Two of the 
most important properties are the hydrophobic and electrostatic surface properties of 
viruses, since the viral mobility and colloidal behavior in liquid medium are mainly 
governed by electrostatics and the hydrophobic effects [19-25]. The electrostatic forces 
belong to long-range interactions. The sign and magnitude of the forces are controlled by 
surface charges of viruses and target surfaces, and solution conditions such as pH, ionic 
strengths, etc. Hydrophobic interactions occurred at shorter separation distances and 
could play a major role when electrostatic interactions are the weakest. For example, high 
concentrations of salt solutions could screen virus surface charges. 
In biotechnology manufacture, the processes can be separated into upstream 
processes and downstream processes. The upstream process is the first phase of 
bioprocess, focusing on biological materials inoculated and grown in cell culture to 
generate certain types of biological pharmaceutical products. The downstream process 
focuses on recovering, concentrating, and purifying the upstream bioproducts to meet 
quality requirements. The downstream unit operations such as hydrophobic interaction 
chromatography (HIC), and ion-exchange chromatography (IEC), are commonly used to 
remove virus contaminations in therapeutic products such as antibodies or other 
therapeutic proteins to ensure the safety of these biological pharmaceutical products by 
mammalian cells. Also, these unit operations are commonly used for purifying viral-
based products as vaccines or gene therapy vectors. In either case, the viral surface 
properties, mainly surface hydrophobicity and charge play a crucial role in these highly 
selective, easy to scale-up, and interaction-based chromatography techniques in 
downstream bioprocessing operations [23, 24, 26-31]. To design the optimal parameters, 
such as pH, salt concentrations, and resin charge and hydrophobicity in chromatography 
operations, a detailed understanding of viral electrostatic and hydrophobic surface 
properties will benefit for either viral clearance in therapeutic products or maximum virus 
recovery in vaccine or gene therapy products.  
In addition, with an advanced understanding of viral surface characteristics, the 
interactions of viruses with other molecules like osmolytes or polypeptides could be 
manipulated to target the viral particles specifically, to improve virus detection and 
vaccine formulation. Since virus detections to reduce contact with viral pathogens and 
vaccines to prevent disease are the most effective methods to prevent viral disease 
outbreak, public health could be likely improved with research on viral surface 
properties. The goal of this research is to save lives clinically and to reduce outbreaks of 





One important surface characteristic dominating virus interactions with other 
target substrates is the higher hydrophobicity of viruses as compared to many other 
biomolecules [32, 33]. The hydrophobic effect will minimize the area of contact between 
hydrophobic regions on the viruses and water molecules. The surface hydrophobicity of 
the virus mainly originates from nonpolar surface amino acids, which make up either the 
viral capsid protein or glycoproteins in the viral envelope. Among the 20 standard amino 
acids, aliphatic, and aromatic amino acids contribute to the heterogeneous hydrophobic 
patches on the viral surface [34]. The distribution of hydrophobic and hydrophilic 
residues on the PPV major capsid protein VP2 is shown in Figure 2.1 [32]. The 
landscape of the hydrophobic residues determines the net surface hydrophobicity of the 
virus and governs its adsorption to other hydrophobic surfaces. 
 
 
In a study of MS-2 virus retention by microfiltration (MF) membranes, it was 
found that negatively charged virus can be absorbed to negatively charged polyvinylidene 
fluoride (PVDF) membranes in a 10-20 mM citrate-phosphate buffer at pH 7.0 [19]. It 
indicated that hydrophobic interaction played a major role in the virus-filter adsorption. 
Furthermore, the virus retention almost doubled with the addition of sodium chloride 
(NaCl) and calcium chloride (CaCl2) as compared to the no salt solution [19], likely due 
to increased hydrophobic interactions by salt ions. The salt ions can bind water 
molecules, reduce virus surface solvation, and expose the hydrophobic regions of virus 
and filter to facilitate virus-filter hydrophobic adsorption. If electrostatic interactions 
dominated, then the same charges would repel and impede adsorption, and the addition of 
salt would interrupt electrostatic interactions and reduce virus retention. Also, the 
difference of adhesion of three bacteriophages MS2, PRD1, and ФX174 between a 
positively charged quaternary amine-modified membrane and a negatively charged 
sulfonic acid-modified membrane followed the relative hydrophobicity order ΦX174 < 
MS2 <PRD1 at high ionic strengths 100 mM sodium nitrate (NaNO3) solution, rather 
than surface charge densities order ФX174 <  PRD1 < MS2 [20]. It also indicated that the 
viral surface hydrophobicity dominated the interactions with charged membranes when 
electrostatic interactions are the weakest. Understanding virus surface hydrophobicity 
would provide insight into virus adsorption [25], purification [30], and virus detection 
[35], thus reducing experiments required. 
 
Figure 2.1 Hydrophobic/hydrophilic residues on a PPV surface protein. Reprinted from [32] with 
permission. 
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2.2.1.2 Surface charge and isoelectric point (pI) 
 
Another key surface property that governs colloidal behavior in the virus 
adsorption process is the surface charge, which is pH-dependent in polar media. One such 
measure of the viral surface charge is the isoelectric point (pI), which corresponds to the 
pH where the net charge on the whole viral particle is zero [36]. The surface charge of the 
virus mainly originates from the ionizable polar side chains of its surface amino acids, 
which make up for the viral capsid protein or glycoproteins of the viral envelope. Among 
the 20 standard amino acids, lysine, arginine, and histidine contribute to the protonated 
amine groups on the viral surface, while aspartic acid (or aspartate) and glutamic acid (or 
glutamate) contribute to the deprotonated carboxyl groups on the viral surface [34]. The 
excess of protonated or deprotonated functional groups of the charged amino acids highly 
contributes to the net surface charge of viruses, shown in Figure 2.2 [37]. When 
environmental liquid pH is lower than the viral pI, the protonated functional groups are in 
excess, and the virus surface carries a net positive charge. At environmental liquid pH 
higher than the pI, the deprotonated functional groups are in excess, and the virus surface 
carries a net negative charge. In each case, viruses with the same charges repel each 
other. At the viral pI, the deprotonated carboxyl groups balance out the protonated amino 
groups, and the virus surface is charge neutral. The viral particles tend to form aggregates 
at their pI due to the repulsive interaction between viruses is the smallest [38]. 
 
 
The surface charges of viral capsid proteins at a certain pH based on the 
dissociation constants of charged amino acids can be used for calculation of the virus pI 
using the Henderson-Hasselbalch equation [39]. However, current theoretical calculations 
of virus pI are commonly based on the whole amino acid sequence of the viral surface 
capsid proteins or glycoproteins. However, this approach does not consider protein 
folding. Only the surface amino acids actually contribute to the experimental pI, whereas 
all amino acids, even ones that are buried, contribute to the calculated pI. In addition, 
theoretical calculations do not consider the effects of chemical modifications (e.g., amino 
acids phosphorylated or acetylated) [40] or the effects of other structural components like 
viral enveloped lipid bilayer [41] on the electrostatic surface properties of viruses. 
 
Figure 2.2 Arrangement of functional groups on a viral surface protein. Reprinted [37] from with 
permission. 
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Viruses are rather complex systems, and their surface electrostatic properties need to be 
verified by experimental methods.  
 Knowing the surface charge and pI of a virus is very important, but there are 
limited data on the viral pI values [36]. The pI of a virus can be used to evaluate the 
electrostatic interaction between the virus and solid phase charged groups to predict the 
likelihood of virus attachment to a charged surface [23, 26-28]. The pI can also be used to 
create virus removal filters based on electrostatic adsorption [42, 43] and to eliminate 
empty virus capsids that lack nucleic acids during packaging from full virus particles by 
anion exchange chromatography for gene therapy purification [44]. Moreover, pI can be 
used to design complex coacervates, which are formed due to electrostatic interactions 
[45]. 
The relative contributions of hydrophobic and electrostatic forces to viral mobility 
and colloidal behavior in the liquid medium and their dependences on the viral surface 
properties are poorly understood. Thus, there is a need to explore general methods to 
characterize viral surface characteristics for better manipulation of virus interactions.  
 
2.2.2 Traditional virus surface characterization methods 
 
There is no universal method to quantify the hydrophobicity of viruses. A direct 
comparison of the net surface hydrophobicity of different viruses could hardly be found 
in the literature [32, 33, 46, 47]. In addition, the majority of pIs of viruses measured 
experimentally in the literature are from 3.5-7 [36], viruses with very basic pI do not 
exist; however, the measured pI values of viruses for the same virus species by different 
characterization methods can vary widely. Various characterization methods have been 
employed to determine the surface characteristics of viruses, including HIC, aqueous 
two-phase system (ATPS) cross-partitioning, zeta potential, and isoelectric focusing 
(IEF). 
 
2.2.2.1 Hydrophobic interaction chromatography (HIC) 
 
A HIC method has been established to measure the relative hydrophobicity of 
viral particles. HIC is based on the hydrophobic interactions between the target viral 
particles and hydrophobic ligands on the stationary phase of the chromatography column 
[32, 33]. Kosmotropic salt ions in the Hofmeister series have higher polarity and stronger 
binding to water molecules. As is shown in Figure 2.3, at high salt concentration, 
kosmotropic salt ions can facilitate the hydrophobic interactions between the hydrophobic 
patches on the viral surfaces and hydrophobic ligands on the stationary phase by 
excluding water molecules from the virus and ligand surfaces [48]. As a result, a virus–
hydrophobic ligand complex is formed. The complex will be separated by disrupting the 
hydrophobic interactions that occur when the concentrations of kosmotropic salt in 
solution are lowered. At high concentrations of salt, the kosmotropic ions bind the water 
molecules, reducing viral particle solvation and increasing the hydrophobic interactions 
between biomolecules and chromatography ligands. By lowering the salt concentration, 
water molecules will be released from the kosmotropic ions, and the viral particles will 
be rehydrated and eluted from the hydrophobic bindings. With a linear or step gradient 
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that reduces the salt concentrations, hydrophilic proteins can be eluted first at high salt 
concentrations, while hydrophobic viral particles will be eluted later at lower salt 
concentrations. This simple high-salt HIC method can be performed on either high-




To quantify the relative hydrophobicity, either retention time or elution salt 
concentration can be normalized in a simple 0-1 relative hydrophobicity scale. HIC has 
been used to characterize the surface hydrophobic properties of three different 
bacteriophages and four mammalian viruses [33]. By designating the highest 
concentration of salt eluted protein RNase as reference 0, relative hydrophobicity values 
could be used to indicate and compare the net hydrophobicity of viruses [33, 46]. A HIC 
with a Tosoh Phenyl 750M resin on an FPLC by a step gradient of 0.8 M sodium citrate 
at pH 8.0 was able to rank the relative hydrophobicity of viruses from low to high: 
ΦX174 phage < PP7 phage < Minute virus of mice (MVM) < PR772 phage = Reovirus-3 
< Xenotropic murine leukemia virus (XMuLV) ≤ Pseudorabies virus [33]. In addition, the 
peak spreading in the elution of viruses reflected some heterogeneity in their 
hydrophobicity profiles. The HIC with a Tosoh Phenyl 5PW resin on an HPLC by a step 
gradient of 0.5 M sodium citrate at pH 8.0 was also used to compare the hydrophobicity 
of an infectious MVM and a non-infectious MVM virus-like particle (MVM-VLP), with 
the same control protein RNase as reference 0. The VLP is a non-infectious, multi-
proteins structured molecule that resembles the authentic virus, maintaining the same 
surface characteristics and conformation and can be self-assembled by recombinant 
expression of the viral capsid protein. The relative hydrophobicity values were 0.28 and 
 
Figure 2.3 Hydrophobic interaction chromatography.  
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0.35 for MVM and MVM-VLP, respectively, showing that MVM-VLP is more 
hydrophobic than the MVM [46].  
In addition, an adsorption glass column using Octyl Sepharose-4 fast flow resin in 
an adsorbing solution (10 mM imidazole and 4 M NaCl) at pH 7 was used to characterize 
the viral surface hydrophobicity by eluting the viral particles by decreasing the NaCl 
concentrations [47]. The elution rates of viruses were determined by plotting the 
cumulative eluted percentage of adsorbed viruses as a function of solution ionic strengths 
to compare the hydrophobicity of different viruses [47]. Viruses that eluted the fastest 
had the lowest surface hydrophobicity, while for the viruses that eluted, the slowest was 
the most hydrophobic. The rank of measured viral hydrophobicity from hydrophobicity 
of viruses from low to high are ΦX174 phage < coxsackievirus B4 (CB4) < echovirus 1 
(E1) < CB 5 < E4 < poliovirus 1 (P1) < CB3 < T7 phage < T3 phage < f2 phage < E5 < 
MS2 phage [47].  The same method was also used to characterize the surface 
hydrophobicity of bacteriophages by another research group, showed that MS2 and T4 
are hydrophobic viruses while ФX 174 is more hydrophilic [22], which is consistent with 
the previously published result [47].  
HIC is a simple and reliable method to characterize the hydrophobicity of non-
destructive viral particles, and the eluted fractions allow for distinguishing the infectious 
versus non-infectious viral particles by further virus detection techniques. However, it 
requires the same protein reference or same chromatography column resins to quantify 
the relative hydrophobicity values and to compare the hydrophobicity degree of different 
viruses. Moreover, viruses won’t elute off of HIC sometimes due to the high 
hydrophobicity [32], and chromatography takes a lot of samples. 
 
2.2.2.2 Aqueous two-phase system (ATPS) partitioning method 
 
A biomolecule partitioning method using ATPS can also be used to measure the 
surface hydrophobicity and pI. ATPSs are formed by mixing water-soluble polymers or a 
water-soluble polymer and a salt beyond a critical concentration resulting in two 
immiscible aqueous phases [49]. ATPS polymer-polymer (e.g polyethylene glycol 
(PEG)-dextran) [50] or aqueous polymer-salt (e.g PEG-citrate) [51, 52] can be used to 
preferentially partition biomolecules. This method has been extensively used for 
separation and purification of biomolecules [51-55], but a few studies characterize the 
surface properties of biomolecules [49, 50]. Unlike other methods requiring expensive 
equipment and chemicals and complex procedures, this method is simple and 
inexpensive. The main driving forces for biomolecules interactions between the two 
phases are hydrophobic and electrostatic interactions, so the surface properties could be 
characterized by evaluating the partition behavior [52]. 
An ATPS partitioning method containing PEG-dextran was reported to 
characterize the surface hydrophobicity and isoelectric point of various groups of 
streptococci and staphylococci bacteria [50]. To increase the selectivity of polymers, 
hydrophobic and charged groups were covalently bound to the PEG polymer. The 
relative surface hydrophobicity was determined by comparing the partitioning of bacteria 
in the systems comprising PEG, PEG palmitate (P-PEG), or PEG stearate (St-PEG) [50]. 
Palmitate and stearate addition to PEG differentiated the degree of hydrophobicity of the 
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PEG-rich phase. The higher the surface hydrophobicity of bacteria, the higher the 
hydrophobic affinity of bacteria towards the PEG-rich phase. A relative surface 
hydrophobicity affinity index was determined to be streptococci group A> streptococci 
group C&G > staphylococci [50]. In a similar study, the partitioning of bacteria in the 
system containing positively charged trimethylamino PEG (PEG-TMA) was compared to 
the system containing negatively charged PEG sulfonate (PEG-S) at different pH [50]. 
The study demonstrated that the attractive forces of the bacteria towards the PEG-rich 
phase containing PEG-TMA gradually increased with pH above pI; thus, the partitioning 
increased in the PEG-rich phase. On the contrary, the repulsive forces between bacteria 
and the PEG-rich phase containing PEG-S increased with the pH, thus diminishing the 
partitioning of bacteria in the PEG-rich phase. The pH at which the partitioning trend in 
PEG-TMA intersected with the PEG-S trend was determined to be the pI of bacteria [50]. 
Though this method can hardly compare the relative hydrophobicity defined by 
different ATPS systems, the pI of biomolecules should not be affected by different 
combinations of ATPS composition. Also, a cross-partition using the same PEG-dextran 
system but with two different salt compositions sodium sulfate (Na2SO4) and NaCl was 
used to determine the pI of four different proteins serum albumin, hemoglobin, 
transferrin, papain [56]. The partition coefficient, which was defined as the protein 
absorbance at the top phase to that at the bottom phase, was plotted against different 
solution pH. The cross-point of the two curves of different salt compositions was used to 
determine the pI values of proteins. Proteins which carried a more negative charge had 
higher partition coefficients in Na2SO4 than in NaCl [56]. This ATPS cross-partition 
method showed its promise for determining the pI of viral particles, but it is an indirect 
and not a common method for characterizing viral surface chemistry. The high 
concentrations of salt and polymer in ATPS could produce a big osmotic shock to the 
viral particles that might lead to structural deformations of the viral particles [57]. Thus, 
this method has been used less commonly.  
 
2.2.2.3 Zeta potential 
 
When a charged viral particle is in a polar liquid, an electrical double layer forms 
around the particle. As shown in Figure 2.4 [58], the inner layer is referred to a “Stern 
layer”, which contains a rigid layer of counter-ions attached to the charged particle, and 
the outer layer is referred to as a “diffuse layer”, which is a loose outer layer of free ions 
in liquid attracted to the Stern layer. When the charged viral particle moves in the liquid, 
an effective boundary exists between the ions in the diffuse layer that move together with 
the virus and ions that remain with the bulk liquid, known as the “slipping plane”. Zeta 
potential is the electric potential from the “slipping plane” relative to a point in the bulk 
fluid far away from the particle. 
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Zeta potential, a measure of surface charges of virus particles, can be assessed 
through the electrophoretic mobility of particles, which is defined by the ratio of the drift 
velocity of particles and the applied electric field [59]. Zeta potential is typically 
measured by either microelectrophoresis [60] or electrophoretic light scattering (ELS) 
[61]. Microelectrophoresis involves the placement of a virus suspension in a known ionic 
strength buffer into an electrophoresis cell, which is subjected to an electric field. The 
time it takes for viral particles to move over a given distance in the constant electric field 
is monitored by fluorescent microscopy [60]. The drift velocity could be used to calculate 
the electrophoretic mobility by Equation 2.1 [59]. Although it is a reliable method to 
measure the electrophoretic mobility and can further estimate the zeta potential, it is too 




                                                                                                              (2.1),  
where μe is the electrophoretic mobility, vd  is the drift velocity, and E is the 
electric field strength. 
To overcome these disadvantages, the rapid and simple method of ELS can 
measure the electrophoretic mobility. ELS has a continuous oscillation of the poles of an 
electrical field applied by electrodes to oscillate charged biomolecules. This oscillation 
leads to the scattered light intensity fluctuation proportional to the electrophoretic 
mobility of the particles. The fluctuation of scattered light intensity is detected as a 
frequency shift on the spectrum by a photodetector and further converted into the 
magnitude of the drift velocity of particles. Then electrophoretic mobility could also be 
measured by Equation 2.1. 
Zeta potential could be further calculated from the electrophoretic mobility 
measured either by microelectrophoresis or ELS by the Henry equation [62], as shown in 
Equation 2.2. 
 




                                                                                                        (2.2), 
Where z is the zeta potential, η is the viscosity of the medium, μe is the 
electrophoretic mobility, ε is the dielectric constant of the medium, and f(k∙α)=1.5 known 
as the Smoluchowski approximation [63], valid for large macromolecules, like viral 
particles, in polar media, when the ratio of particle radius (α) to thickness of double 
electric layer (1/k) is very large.  
Both electrophoretic mobility (μe) and zeta potential as a function of pH can be 
used to characterize the viral surface charge and determine the pI of the virus at which 
either the μe or zeta potential is zero [22, 61, 64, 65]. The characterized electrostatic 
properties of viruses are shown in Table 2.2.  
The μe can be used to characterize the viral surface charge and estimate the pI of 
the virus, and it is affected by solution ionic strengths [20]. To compare the absolute 
value of the μe, the surface charges of viruses from low density to high density are 
ФX174 <  PRD1 < MS2 [20]. They all carried a negative charge at the neutral pH. The pI 
values of an MS2 bacteriophage was further determined to be ~3.5 [65]. The absolute 
value of the μe decreased when increasing the salt concentration at a fixed pH [65]. It was 
due to the salt screening effect of particle charges by more ions present in the solution. 
The μe measurement should be conducted in a rather low ionic strength of buffer 
solutions to maximize the electrical double layer. Besides, the μe profiles as a function of 
solution ionic strengths for MS2 phage and its VLPs are different when determined by 
different virus purification methods [66]. The residual impurities existed in the tested 
virus solutions can either become the charged target for measurement, or the impurities 
can bind to viral particles surface. Furthermore, different virus propagation methods have 
been shown to affect the μe of MS2 phage [64]. Negative μe over the entire pH range 
resulted in no measured pI on agar propagation [64]. It might due to the purification 
incompletely eliminated the agar impurities like agaropectin. 
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ФX174 phage μe -1.6 to -1 (10-8 m2V-1s-1) 1-100 mM sodium nitrate 
(NaNO3) solutions at pH 
7 
[20] PRD1 phage μe -1.8 to -1 (10-8 m2V-1s-1) 
MS2 phage μe -3.5 to -1 (10-8 m2V-1s-1) 
MS2 phage pI ~3.5 1-100 mM NaNO3 solutions at various pH [65] 





1-100 mM NaNO3 
solutions at pH 7, 
different virus 
purification methods  




Negative μe, pI 
N/A (agar) 
1 mM NaCl solution at 
various pH, different 
virus propagation 
methods (broth or agar) 
[64] 
Zeta potential 
Norovirus GI.1 VLP pI 4.25 
20 mM citrate phosphate 
buffer at various pH [61] 
Norovirus GII.4 
VLP pI 4.16 
Feline calicivirus 
VLP pI 3.9 
T4 phage pI 2 (7.7 mM KCl solution) 0.002, 2.6, and 7.7 mM 
potassium chloride (KCl) 
solutions at various pH 
[22] 
ΦX 174 phage 





Tomato Bushy Stunt 
Virus (TBSV) pI 4.1 
Agarose gel-based strip [67] TBSV (CP-6XD) pI 3.2 TBSV (CP-4XCys) pI 5.0 
TBSV (CP-4XHis) pI 8.2 
TBSV (CP-Au) pI 8.5 
Full rat parvovirus pI 5.8-6.2 
Agarose gel-based strip [44] Empty rat 
parvovirus pI 6.3 
Norovirus 
Funabashi VLP pI 5.9 
Solution-based capillary [68] 
Norovirus Norwalk 
VLP pI 5.9 
Norovirus Seto VLP pI 6.0 
Norovirus Hawaii 
VLP pI 6.0 
Norovirus Kashiwa 
VLP pI 5.5 
Norovirus Narita 
VLP pI 6.9 
Chromatofocusing MVM pI 5.99 [46] 
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copolymer resin grafted 
with carboxylic acid with 
an HPLC 
φX174 phage pI 6.7-7.0 
Nonporous EVB-DVB 
copolymer resin grafted 
with tertiary amine 
[69] 
 
Zeta potential has also been shown to estimate the pI values of viruses. The 
measured pI values of norovirus and feline calicivirus VLPs match with the aggregation 
behavior near their pIs detected by DLS [61]. However, zeta potential measurements can 
also be affected by the solution ionic strengths. Zeta potential as a function of pH curves 
for T4 and ΦX 174 bacteriophage varied at different ionic strengths of solutions [22]. 
Both μe and zeta potential characterize the viral electrostatic properties. However, 
the measured results could be affected by the ionic strengths of solutions [22, 65], 
different virus propagation [64], and purification methods [64, 66]. The μe and zeta 
potential measured by either microelectrophoresis or ELS also require a large amount of 
highly purified and concentrated virus solutions, which are typically very expensive. 
 
2.2.2.4 Isoelectric focusing (IEF) 
 
To overcome the limitations of μe and zeta potential, a small-scale of 
electrophoretic technique, isoelectric focusing (IEF), has also commonly been used to 
determine the viral pI. IEF is an electrophoretic technique based on the separation of 
zwitterionic molecules, such as viral particles and proteins, according to their pIs [70]. A 
virus sample is introduced into an immobilized pH gradient under the influence of an 
electric field. The pH gradient increases from the anode (positively charged electrode) to 
cathode (negatively charged electrode). The viral particle will carry either a positive 
charge if in a pH region below its pI or a negative charge if in a pH region above its pI 
and can migrate according to their surface charge towards the oppositely charged 
electrode in the stable pH gradient. The overall charge of the viral particle will decrease 
until it reaches the pH position that corresponds to its pI when it carries a net zero charge. 
Since viral particles will not be electrically attracted to either electrode, the migration 
stops, and the viral particles are focused into narrow bands, indicating their pI values 
[71]. The bands can be visualized by silver staining. IEF can be performed in a variety of 
formats, gel-based strip IEF and solution-based capillary IEF are the most commonly 
used to determine the pI of a virus [67, 68, 70]. The pI of viruses determined by IEF can 
be found in Table 2.4.  
An agarose gel-based strip IEF was used to predict the movement of wild type 
TBSV and its derivatives in host plants by measuring corresponding viral pI values [67]. 
The same gel system was used to determine the pI of full and empty rat parvovirus 
particles, and the difference of pI was further used to purify full viral particles from its 
empty particles by a weak DEAE anion exchange chromatography [44]. In addition, a 
capillary IEF was used to determine the pIs of noroviruses VLPs to be 5.5-6.9, which can 
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be further used for virus detection with whole column imaging techniques [68]. However, 
the detected pIs are not consistent with the pIs of norovirus VLPs by zeta potential, which 
is 4.16-4.25 [61]. It might be due to the IEF measure both the internal and external amino 
acids, while the zeta potential only measured the external surface charge. 
IEF has been shown to be a simple and inexpensive method to determine the virus 
pI and need only a small amount of virus samples. However, this method typically 
requires long and complicated experimental steps and has difficulty characterizing more 
hydrophobic viruses due to low solubility inhibiting their migration [67, 68, 72]. 
To overcome the difficulty of characterizing hydrophobic viruses, an IEF on the 
ion-exchange column technique known as chromatofocusing has been developed to 
determine the pI of viruses. The results can be found in Table 2.2. Instead of using the 
applied electric field, chromatofocusing uses a retained, self-generated pH gradient by 
running buffers with chromatography. The chromatographic technique, 
chromatofocusing, can be used to determine the pI of virus based on elution pH and 
retention time [69]. The pH at which viruses eluted from the column at several runs of 
ionic strengths was used to calculate the true pI of the virus [69] by an established 
multiple charge state (MCS) mathematical model [69, 73]. Chromatofocusing using a 
weak cation-exchange determined the pI of an MVM and an MVM-VLP [46]. In 
addition, chromatofocusing using a weak anion-exchange column estimated the pI of a 
bacteriophage φX174 [69].  
HIC, ATPS cross-partitioning, zeta potential, and IEF are used for characterizing 
the surface properties of viruses. However, they are bulk measurements and limited by 
the purity of the virus samples [64, 66] and solution conditions [22, 50, 61]. Impurities 
either from virus propagation or purification in virus solutions can affect the surface 
characterization by two possible approaches. First, the measured result could depend on 
the impurities rather than the viral particles if the virus concentrations are too low while 
impurities are in relatively high concentration [36]. Second, the measured result could be 
the alternated viral surface properties if impurities are in low concentration but can bind 
to or shield the viral surface [36]. In addition, except for IEF, these methods require a 
large volume of purified virus samples, of which the cost is high. IEF does not need a 
high volume of virus samples, but it has difficulty characterizing more hydrophobic 
viruses with low solubility. Besides, silver staining or a fluorescent label needs to add to 
the high concentration of the virus sample. Moreover, all of these methods cannot 
distinguish individual viral particles with different properties from the average viral 
particle population. Thus, there is a need to explore an inexpensive, robust, reliable, and 
single-particle technique to characterize viral surface properties.  
 
2.2.3 Novel surface characterization: chemical force microscopy (CFM) 
 
A novel surface characterization method, chemical force microscopy (CFM) [74], 
which uses an atomic force microscope (AFM), can be used for single-particle viral 
surface characteristics. AFM is an imaging tool with a sub-nanometer resolution, which 
uses a probe to scan a sample surface to get the surface topography. The AFM probe is a 
microcantilever with a very tiny tip mounted at one end.  Functionalization of the AFM 
probe tip with well-defined functional groups enables AFM to measure molecular 
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interactions between a modified AFM tip and a sample, as CFM. CFM can provide 
information on the chemical natures of the measured samples. 
CFM has many advantages for the virus surface characterization over traditional 
surface characterization methods. One significant advantage of CFM over other 
microscopic methods, such as electron microscopy and scanning tunnel microscopy, is 
that the study can be performed in physiological aqueous solutions without disturbing the 
natural state of the virus [75], avoiding complex samples preparations like staining [76] 
and coating with conductive material [77], as required for electron microscopy. In 
addition, the CFM can precisely target the virus particles over other impurities [78], 
which lays the foundation for a single-particle measurement. Moreover, CFM requires 
low amounts of biological samples [79], which can overcome the disadvantages of bulk 
characterization methods, which consume large amounts of purified viruses. Other 
advantages of CFM include high spatial resolution of a few nanometers [80], sensitive 
force resolving capacity of a few piconewtons [81], and simultaneous force probing and 
biochemical sites locating features [82].  
 
2.2.3.1 Fundamental principles of atomic force microscope (AFM) 
 
An AFM consists of a mounted cantilever with a tiny tip at its free end, a laser 
beam from a diode directed to the back of the mounted cantilever, a quadrant photodiode 
detector measuring the reflected beam, a piezoelectric translator sample stage, an 
electronic feedback loop by a controller, and a computer with software processing the 
signals to images or force curves, as shown in Figure 2.5 [83]. An AFM operates by 
scanning an AFM tip over a sample and measuring the deflection of the cantilever due to 
the tip interacting with the samples [84]. A sample is fixed on a flat piezoelectric 
translator stage which controls the sample movement along with horizontal (x-y) and 
vertical (z) directions during scanning [84, 85]. A laser beam impinges on the backside of 
the cantilever and is reflected to a photodiode detector [84, 85]. The detector amplifies 
the defection of the cantilever. The z displacement at each scanned (x,y) point is recorded 
and plotted, yielding a three-dimensional topographic image [84, 85].  
To obtain topographic images, the AFM can operate in two basic modes, contact 
and tapping mode [80, 84]. In contact mode, an AFM cantilever is brought into gentle 
contact with the sample surface. The normal force between the tip and sample is 
dependent on the tip-sample distance and keeps constant during the image scanning [84]. 
When an AFM tip passes over a point (x,y), which has an increased height, the tip-sample 
distance is reduced, and so the tip-sample force is increased. The increased force will 
result in an upward deflection of AFM cantilever and is detected by the photodiode 
detector. It will trigger the feedback system to restore the pre-set force by controlling the 
piezoelectric stage to move the sample away from the probe along the z-direction. The z 
displacement equals the height of that point (x,y), and the height of each point on the 
sample within a scanned area will be determined to form a topographic image. The 
imaging mode is very simple and favorite for a flat rigid surface in liquid, but not ideal 
for soft biological samples, like viruses, due to relative high lateral forces that would 
easily damage the samples [80].  
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To reduce the dragging forces due to the lateral sample movement and minimize 
the biological sample damage, the alternative tapping mode is more appropriate for 
imaging viruses. Instead of continuously touching the sample surface, the AFM 
cantilever oscillates near its resonance frequency across the samples. The amplitude of 
the oscillation is set to be constant [84]. When a tip scans a point (x,y), which has an 
increased height, the amplitude will decrease, and the feedback loop will restore the pre-
set amplitude by moving the piezoelectric sample stage to record the height [80]. 
In AFM topographic images, height information can reflect the true size of the 
sample, but not a lateral dimension. When a tip scans a sample, and only one side of the 
tip touches the sample, the cantilever begins to deflect before the tip apex actually reach 
the sample. Similarly, the other side of the tip still contacts the sample, and the cantilever 
bends even after the tip apex has passed the sample. As is shown in Figure 2.6A [80], the 
measured lateral dimension is larger than the actual lateral size of the sample. Thus, the 
sharper the tip, the greater lateral resolution could be achieved. Besides, an AFM 
cantilever with low stiffness might be ideal in contact mode to minimize the damage for 
the samples, while a cantilever with high spring constant is preferred in tapping mode to 
reduce the instabilities and noise.  
 
 
Figure 2.5 Components of a typical atomic force microscope. Reprinted from [83] with permission. 
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As an imaging tool, AFM has been extensively used to study the morphologies of 
biomolecules ranging from the sub-nanometer-scaled proteins [86] to micron-sized living 
cells in liquid close to its physiological conditions [87]. One major use of AFM is to 
visualize single viruses and their structural components [80] and dynamic structural 
changes [88]. As shown in Figure 2.6B [88],  an intact icosahedral symmetric viral 
capsid structure of adenovirus and the details of repeating protein subunits (capsomers) 
on the virus could be seen in the left, while in the right, the disruption of adenovirus 
capsid and release of the viral genome due to stress is observed by the real-time AFM 
topographic images. The images of structure changes could help further identify the 
mechanical properties of viruses.  
 
2.2.3.2 Force measurement (approach curve vs. withdraw curve) 
 
AFM is not only a high-resolution image tool to provide virus structure 
information, but also an excellent characterization method for mechanical properties and 
surface chemistry of viruses due to its force measurements functions. The interactions 
between the tip and sample can be measured by the deflection of the AFM cantilever as a 
function of sample z displacement during the AFM tip approach and withdrawal cycle 
[89]. A typical force curve is shown in Figure 2.7A [90]. Approach and withdraw curves 
can be roughly divided into four regions [90]. Region I, when an AFM tip is far from a 
sample, no interactive force can be observed between the tip and the sample. With closer 
distances (region II), the AFM probe will be pulled into contact with the sample by van 
der Waals attraction forces. The jump-to-contact occurs when the gradient of the 
interactive force exceeds the spring constant of the cantilever. After contact with the 
sample (region III), the AFM cantilever will have a positive deflection due to the 
repulsive interaction between the tip and sample. This is the region on the approach curve 
where the elastic properties of the sample can be measured. The tip will approach the 
 
Figure 2.6 AFM imaging. (A) Schematic illustration of the lateral dimension of scanned samples affected 
by the shape and size of AFM tip, and (B) adenovirus before and after repeated loading of 100 pN force 61 
times, reprinted from [88] with permission. 
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sample until a pre-set force threshold is reached. Afterward, the AFM tip will change 
direction and move away from the sample, and the AFM cantilever will have a negative 
deflection due to adhesion. Region IV, when the cantilever restoring force exceeds the 
adhesion between the AFM tip and sample, jump-off-contact occurs. If the AFM tip has 
been modified with chemical functional groups, then the chemical interaction formed 
during contact with the sample will bend the cantilever during withdraw more than its 
initial deflection during the approach. The finite force required to pull the AFM probe off 
the surface of the specimen is the interested adhesive force by CFM. Region IV on the 
withdraw curve is where the surface chemistry of the sample can be measured. After 
jump-off the sample, the tip returns to the initial zero force region I.  
 
 
The forces between the AFM tip and samples can be measured by the deflection 
of the AFM cantilever during the sample approach and withdrawal [89]. The deflection 
can be converted into force using Hooke’s law, shown in Equation 2.3 [91].  
𝐹𝐹 = −𝑘𝑘𝑐𝑐𝑑𝑑                                                                                                          (2.3), 
Where F is the force, kc is the spring constant of AFM cantilever, and d is the 
cantilever deflection. 
 
Figure 2.7 AFM force curves. (A) Approach and withdraw curves four regions, zero force region I, non-
contact approach region II, contact region III, and non-contact withdraw region IV, and (B) conversion of 
F-Z curve to F-D curve. Reprinted from [90] with permission. 
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The AFM directly measures the cantilever deflection as a function of sample z-
piezo displacement, and the actual tip-sample distance or separation is given by 
Equation 2.4 [91].  
𝐷𝐷 = 𝑍𝑍 − 𝑑𝑑                                                                                                         (2.4), 
Where D is the actual tip-sample distance or separation, Z is the distance between 
the sample surface and the rest position of the cantilever.  
Therefore, a raw force-z displacement curve will be converted to a force-distance 
(F-D) curve, as shown in Figure 2.7B [90]. Commercial AFM cantilever spring constants 
can range from 0.01 to 100 N/m, enabling the force sensitivity down to 10 pN [90]. 
The majority of force studies on viruses are performed by nanoindentation [78, 
92-94] using the approach curve. Nanoindentation is achieved by pushing the viral 
particles, so the cantilever will bend and result in an approach curve, to study the 
mechanical response of viral particles. After tip contact with the viral particle, the particle 
will progressively indent by increasing the z-displacement, resulting in a repulsive force 
bending the cantilever, and an almost linear approach curve on the soft viral surface. The 
approach curve reflects the stiffness and intrinsic elasticity of the viral particle [83]. 
When the indentation depth exceeds its elastic limit, the viral particle will break and 
result in an irregular approach curve with an upward slope. The rupture force of viral 
particles could be determined to indicate structural strengths, as opposed to brittleness 
[83]. In addition, the resistance of viral particles to material fatigue could be determined 
by the number of indentations withstanding the controlled low-force approach before 
structure damages occur [83]. 
The withdraw curve during the force measurements on virus particles can provide 
information on virus surface properties using CFM. In theory, CFM can measure 
molecular interactions from strong covalent bonds (~100 nN) to weak van der Waals 
force [74] (~1 pN), which is a suitable option for measurement of the hydrophobic or 
electrostatic interactions between virus particles and modified AFM tips with 
corresponding chemistries. CFM enables one to characterize virus surface properties at a 
single-particle level with less consumption of samples [79].  
By modifying the AFM tip with a chemical functional group, CFM has been 
reported to study the surface charges of a single S. cerevisiae cell with a carboxyl acid 
(COOH) functionalized AFM probe [95]. The surface charges of the microbial cell are 
explored by the adhesion force at different solution pH from 3 to 10, as shown in Figure 
2.8A [95]. Different force curves observed with the same chemical group functionalized 
probe and cell surface at different pH liquid environments could be due to a change of 
ionization state of the carboxyl groups modified AFM probe and single S. cerevisiae cell 
surface. No adhesion observed at pH greater than 6 is likely due to the electrostatic 
repulsion between the negatively charged carboxyl terminated probe and the negatively 
charged single S. cerevisiae cell. Whereas, the adhesion force observed at pH less than 5 
is likely because of the positively charged cell surface attracting the negatively charged 
COO- terminated probe. In addition, CFM has been reported to study the surface 
hydrophobicity on microbial pathogen Aspergillus fumigatus with a hydrophobic methyl 
(CH3) group modified AFM probe, as shown in Figure 2.8B [82]. A CFM adhesion map 
was recorded simultaneously with the topographic image, which allows accurately 
locating the hydrophobic R region and hydrophilic P region on the pathogen surface. The 
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difference of surface hydrophobicity between the R and P region was also confirmed with 
the F-D curve, showing the R region had strong adhesion with the hydrophobic CH3 
probe, while no adhesion for P region. 
 
 
Alternatively, the AFM probe could be modified with target biomolecules to 
interact with a chemical functional group modified substrate. CFM has been reported to 
explore the surface charge and to measure the pI values of various proteins bovine serum 
albumin (BSA), fibrinogen, myoglobin, and ribonuclease A to be 4.5-5.0, 5.5-6.0, 6.5-
7.0, and 9.5-10, respectively [79]. In this research, they modify the AFM with each 
protein and use the modified probe to pull forces on two positively charged substrate at 
various solution pH. The inflection point on the curve of adhesion forces as a function of 
 
Figure 2.8 CFM characterization of surface properties (A) Characterizing S. cerevisiae cell surface charges 
recorded in 1 mM KNO3 solutions of varying pH between the surface of yeast cell and a carboxyl group 
modified probe. Reprinted from [95] with permission. (B) Characterizing Aspergillus fumigatus surface 
hydrophobic and hydrophilic regions recorded in acetate buffer between the surface of pathogen and a 
methyl group modified probe. Reprinted from [82] with permission. 
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solution pH was used to denote the pI of the corresponding protein. Besides, a fungal 
pathogen cell modified AFM probe has been used to explore the surface hydrophobicity 
of different fungus. An AFM probe either modified with a wild-type Candida glabrata or 
a mutant strain with epa6 surface protein deletion to pull force on a hydrophobic CH3 
group modified substrate in solution [96]. From the adhesion force histograms from 
recording 100-400 F-D curves, they found 30-50 nN for the wild-type strain, almost zero 
adhesion for the mutant strain, and concluded that strong hydrophobicity of wild-type 
Candida glabrata cells was mainly due to its surface epa6 proteins [96]. 
CFM is suitable to study the surface chemical interactions of soft biological 
molecules, showing its potential for application in viral particles. Virus particles are easy 
to find in the AFM but hard to measure if they are on the tip. Therefore, CFM with the 
AFM probe terminated with a chemical functional group and viral particles on a surface 
was used in my research on characterizing virus surface properties. In this approach, 
CFM can detect the surface chemistry of viral capsids at a single particle level. This way 
has the potential to determine the heterogeneity of a virus population and the effect of 
virus purification on that population. 
 More details of the CFM method, including AFM probe modifications, sample 
immobilization, and measurements of virus surface properties, can be found in Chapter 
3. Virus surface properties can be used to manipulate viruses and play a key role in virus 
interactions with other targets, but there is very limited information in the literature on 
viral surface properties. With a thorough understanding of virus surface chemistry 
characterized by the single-particle technique CFM, virus detection, and thermal stability 




2.3 Virus detection 
 
2.3.1 Past and current virus detection methods 
 
2.3.1.1 Transmission electron microscopy (TEM) 
 
Transmission electron microscopy (TEM) can visualize a 2-dimensional internal 
and external viral structure. It was a predominant method for virus detection due to its 
magnifying power (5,000,000×) [97] to reveal structures inside viruses for identification. 
The virus sample preparation typically required a staining procedure with heavy metals 
salts (such as uranyl acetate or phosphotungstic acid) [76] to increase the contrast of viral 
particles against its background.  
The use of TEM for viral detections contributed to the discovery of many types of 
viruses such as adenovirus, enterovirus, paramyxovirus, and reovirus isolated from cell 
cultures inoculated with clinical viral samples [98]. In addition, the TEM works as a 
characterization tool to confirm the presence of viruses visually since it can reveal 
internal virus morphological information, such as the presence or absence of an envelope, 
nuclear acid, spike, capsid symmetry type, size, and shape.  An example of TEM to 
identify empty adeno-associated virus (AAV) capsids, which lack genome during 
packaging, from full AAV capsid, is shown in Figure 2.9 [99]. Full AAV particles are 
impermeable to the heavy salt uranyl acetate, as shown in Figure 2.9A, while empty 
AAV particles lack DNA exhibiting a ring-like morphology, as shown in Figure 2.9B. 
AAV particles are observed as 25 nm spheres by TEM.  
 
 
Currently, TEM has rarely been used as a direct virus detection tool in clinical 
diagnosis due to its poor detection sensitivity, typically required a high concentration of 
particles, with a minimum of 106 particles/mL [76]. Besides, it is impossible for the 
screening of a lot of samples as in a viral disease outbreak, due to the high cost of TEM 
maintenance and the sample preparation and virus location on the TEM grids is time-
consuming. Also, it cannot identify the viral particle as infectious or not, though it can 
identify the presence of nuclear acid. Therefore, the use of TEM for direct virus detection 
has gradually declined since the 1990s [100] due to two major developments: the 
 
Figure 2.9 TEM images of uranyl acetate negative stained AAV2. (A) Full AAV particle, and (B) empty 
AAV particle. Reprinted from [99] with permission. 
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invention of immunoassays, such as enzyme-linked immunosorbent assay (ELISA) and 
the discovery of molecular detection techniques such as polymerase chain reaction 
(PCR). Meanwhile, to differentiate between infectious and noninfectious virus particles 




Currently, immunoassays remain the standard method to detect the presence and 
concentration of virus particles, which rely on the principle of an antibody to recognize 
and bind a specific viral antigen. An antigen is any substance, such as viruses or bacteria 
that can stimulate an immune response. An antibody is a large, Y-shaped protein 
immunoglobulin that is produced by human B lymphocytes to help eliminate an antigen 
found in the body [101]. Antibodies produced immediately after viral invasion can also 
be an indicator in viral disease diagnosis; thus, immunoassays can either detect the 
presence of specific viral antigen or the corresponding antibody produced by the immune 
system. Immunoassays use detectable labels, typically chemically-linked or conjugated to 
antibodies or antigens to detect the presence of corresponding antigens or antibodies. The 
detectable labels could be radioactive isotopes [102], fluorescent substances [101], 
luminescent molecules [103], or enzymes that produce a color change [104]. Thus, 
immunoassays have developed into a variety of formats. 
Enzyme-linked immunosorbent assay (ELISA) is the most widely used 
immunoassay for virus detection. ELISA is based on an enzyme-labeled antibody capable 
of detecting a viral antigen fixed to a solid plate surface. The virus is detected by 
measuring the product of a substrate and the conjugated enzyme (such as horseradish 
peroxidase or alkaline phosphatase), change the color of a substrate as the typical 
emission signal [104]. ELISA can be performed in a variety of ways; one common 
approach is an indirect sandwich ELISA, as shown in Figure 2.10A. The quantity of 
bounded viral particles is proportional to the intensity of colorimetric change. ELISA is 
also a very sensitive virus detection method but requires numerous washing steps and 
costly assumption of antibodies, and has a risk of the false-positive result by the cross-
reactivity of the used antibodies. 
Lateral flow immunoassay is a one-step modified enzyme immunoassay for the 
rapid, simple, low-cost detection for the presence or absence of a target analyte in a liquid 
sample matrix. It is based on an antibody binding the antigen specifically in the sample 
and is shown in Figure 2.10B [105]. It is similar to ELISA except the line is visualized 
with colloidal gold and not an enzyme, and the capture antibodies are immobilized in the 
test and control lines as the antigen sample flow through the system. The antigen-
antibody complex will be captured at the test line by the primary antibody. Also, the 
excessed labeled antibody will be captured at the control line by the secondary antibody. 
The excess liquid sample will move to the absorption pad, which maintains the flow rate 
of the sample over the membrane and stops the backflow. The intensity of color at the 
test line reflects the amount of target antigen and can be seen by the naked eyes or 
measured with an optical reader. The color at the control line indicates that a strip 
functions properly as a valid test. The most typical application is for medical diagnostics 
as a point-of-care device, such as a rapid strep test of bacterial throat infection, and a 
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home pregnancy test. The lateral flow immunoassay with gold nanoparticles as a direct 
coloring or fluorescent signal makes this assay easy and quick to perform, but it has a low 
sensitivity and accuracy, allowing for false positive/negative results. 
 
 
As immunoassays mainly rely on labeled antibodies to recognize the viral antigen 
for virus detection, and this method required numerous washing steps and costly 
antibodies. In some circumstances, the antibodies might have cross-reactivity resulting in 
false-positive/negative results and low assay sensitivity. To overcome these drawbacks, 
 
Figure 2.10 Immunoassays. (A) Indirect sandwich ELISA: 1) a capture antibody coated on the bottom of a 
plate well; 2) any viral antigen present in the analyte binds to capture antibody; 3) detection antibody is 
added, and binds to virus; 4) enzyme-labeled secondary antibody is added and binds to detection antibody; 
5) substrate is added, results in a detectable color change converted by the enzyme. (B) Europium 
nanoparticles labeled monoclonal antibodies conjugate-linked fluorescent immunochromatography strip 
test for influenza A virus (H1N1). Reprinted from [105] with permission. 
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measuring the nucleic acids instead of the outer capsid proteins is another way to detect 
viruses. 
 
2.3.1.3 Polymerase chain reaction 
 
 Polymerase chain reaction (PCR) is a more sensitive and rapid specific virus 
molecular detection technique, compared with immunoassays. The PCR technique is used 
to amplify viral DNA sequences from clinical samples. The amplification is done in 
cycles using four nucleotides, a thermostable DNA polymerase (e.g., Taq polymerase and 
Pfu polymerase), and primers [106]. Four basic nucleotides are the basic unit of DNA 
molecules. DNA primers are short nucleotide sequences functioning as a starting point 
for DNA synthesis. DNA polymerase is an enzyme that synthesizes DNA from 
nucleotides. A typical PCR cycle includes thermal denature of the target DNA sample, 




The PCR cycler is performed by an automated thermal cycler machine and results 
in an exponential amplification of the target DNA sample by repeating the cycles. This 
cycle is repeated approximately 25–35 times, depending on the input DNA. The 
amplified product can then be stained with a chemical dye such as ethidium bromide or 
contains the pre-labeled DNA primers with fluorescent dyes (fluorophores), and is 
analyzed by standard agarose or polyacrylamide gel electrophoresis [106]. The standard 
PCR can only detect specific DNA, and it typically takes several days to get the analyzed 
result by gel electrophoresis. It is a qualitative method to detect the presence or absence 
of the virus.  
To overcome the limitations of standard PCR techniques, many variants have 
been developed. The two most important developments are reverse transcription-PCR 
 
Figure 2.11 Overview of a Polymerase Chain Reaction Cycle. Reprinted from [107] with permission. 
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(RT-PCR) and real-time PCR (quantitative PCR, qPCR). RT-PCR allows the detection 
and amplification of viral RNA sequences. The RNA is reverse transcribed into 
complementary DNA (cDNA), which is then amplified by the standard PCR procedure. 
Typically, it can serve as the first step in qPCR. qPCR, in contrast to conventional PCR, 
analyzes the result at its end, quantifies DNA throughout the reactions in a quick time (1-
4 hours). qPCR uses fluorescence to measure the real-time accumulation of amplified 
DNA. The amplified DNA is typically hydrated with a TaqMan probe, of which one end 
is a fluorescent reporter, and the other end is a quencher, then releases the fluorescent 
reporter away from the quencher [108]. Thus, the amount of fluorescence released during 
amplification is directly proportional to the amount of amplified DNA and can be 
measured in real-time. It also quantifies RNA as RT-qPCR. 
The (RT-)qPCR is a very sensitive technique that allows the rapid detection of 
viral nucleic acid and is considered a reference method for detecting donated blood for 
transfusion-transmitted viruses ( HIV-1 and HCV) [109]. However, it requires the known 
sequence information of virus to design virus-specific primer and is effective for low 
target numbers. 
Next-Generation Sequencing (NGS) can allow the detecting of novel viruses 
without knowing genome sequence information. It can detect a broad range of viruses, 
has a higher sample throughput, needs a shorter turnaround time, and is very effective in 
the tracking of viral disease outbreak such as influenza [110] and Ebola [111]. The data 
processing of NGS requires specialized personnel and expensive equipment and is 
complex. However, the price is reduced every year.  
 
2.3.1.4 In vitro cell culture assays 
 
In-vitro cell culture assays can detect a broad range of viruses and are very 
sensitive for detecting infectious viral particles. There are several cell-based infectivity 
assays that have been extensively used for measuring the concentration of infectious virus 
by inoculating the virus samples with indicator cells. 
Plaque assay is a reliable method to determine the titers of many different viruses 
[112]. Virus samples are serially diluted, and aliquots of each dilution are used to infect 
monolayer of susceptible cells grown on a nutrient semi-solid medium such as agar gel or 
carboxymethyl cellulose. An infectious virus infects a cell, replicates, then causes cell 
lysis, which releases virions to infect adjacent cells. The gel restricts the spread of the 
infectious virions. Eventually, one infectious virus particle produces a circular area of 
infected cells called a plaque, which can be observed by a light microscope or even by 
the naked eye if large enough. The living cells are often stained by a dye crystal violet to 
increase the contrast between the plaque and background, showing clear plaques on a 
dark background, as shown in Figure 2.12A [113]. The formation of plaque typically 
requires 5-14 days. Results of plaque assays are generally counted manually and reported 
as a plaque-forming unit (PFU) per unit volume (mL). To perform the plaque assay, the 
viruses must cause host cell lysis and need to be diluted so that the plaques can be 
individually seen. Therefore, many dilutions of virus samples have to be initially guessed 




As some viruses cannot form plaques, a 50% tissue culture infectious dose 
(TCID50) infectivity assay was developed as an alternative virus titration method. TCID50 
infectivity assay can detect the presence of an infectious virus in a sample based on the 
observation of cell morphology change, such as cell monolayer destruction, swelling and 
clumping, focal degeneration, rounding of the infected cell, cell fusion forming syncytia, 
and the appearance of nuclear or cytoplasmic inclusion bodies [114]. These 
morphological changes in host cells caused by viral infection are called the cytopathic 
effect (CPE). A CPE of cell destruction is shown in Figure 2.12B. Like the plaque assay, 
serial dilutions of the virus is used to infect monolayer of host cells. Typically after 7-14 
days of post-inoculation, the infected cells are observed under a light microscope and 
scored manually as CPE positive or negative. The scored results are used to 
 
Figure 2.12 In vitro cell culture assays. (A) Plaque formation of adenoviruses serotype 41 with crystal 
violet stain, reprinted from [113] with permission, (B) CPE effect of PK-13 cells infected by PPV, and (C) 
MTT assay of PK-13 cells infected by PPV, courtesy of Pratik U. Joshi, Michigan Technological 
University, Houghton, MI 
36 
mathematically calculate a virus titer as TCID50 per unit volume (mL), which denotes 
CPE occurring in 50% of the inoculated cells [115]. 
Both the plaque assay and TCID50 infectivity assay need staff with extensive 
training and experienced eyes; also, the result readouts are low-throughput. An MTT 
assay was developed to be a more efficient and objective virus titration method. The 
MTT assay is a colorimetric virus titration assay based on the determination of cell 
viability rather than cell cytopathology. Like the plaque and TCID50 infectivity assay, 
virus samples are serially diluted and added into the indicator cell monolayers. After 5-10 
days of incubation of the indicator cells with the virus, a tetrazolium MTT salt is added to 
the infected cells. The reduction of the yellow MTT agent by mitochondrial reductase 
within the metabolically viable cells forms insoluble purple formazan crystals [116]. The 
crystals are solubilized later to form a purple-colored solution. The color intensity, which 
is proportional to the number of alive cells remaining, can be read by a 
spectrophotometer. For the high dilution of virus, where no cells survive, it will show the 
original yellow color of the MTT agent. Figure 2.12C shows the MTT result of PPV 
infected porcine kidney-13 (PK-13) cells in a 96-well plate. The virus dilution that kills 
50% of the control host cells is determined to be the virus titer MTT50 per unit volume 
(mL) [117]. 
In-vitro cell culture assays have been a “golden standard” for virus detection in 
the laboratory for decades, and it is a sensitive method to detect very low amounts of 
infectious virus particles due to the virus propagation in the infected host cells. It can also 
be used for screening of large numbers of virus samples. However, these assays typically 
require a long post-inoculation time 1-2 weeks for the detection of CPE or cell viability. 
Furthermore, false-positive results may occur since some cells could have morphological 
changes due to chemical components in the tested virus samples. 
In all, past and current virus methods have many drawbacks, such as low 
throughput, intensive labor, special and expensive equipment, chemicals, and 
consumables requirements. Therefore, nanotechnology is being developed to overcome 
the limitations of current methods for wider application of virus detection to benefit 
public health.  
 
2.3.2 Gold nanoparticles (AuNPs) in virus detection 
 
2.3.2.1 AuNPs properties 
 
The unique optical properties of gold nanoparticles (AuNPs) originate from their 
surface plasmon resonance (SPR) that is affected by both the particle size and the inter-
particle distance. The electric field of the penetrated incident light can cause the free 
surface conduction AuNPs electrons to polarize and oscillate, and resonance is achieved 
only when their frequency is approximately the same [118]. The resulted plasmon 
oscillation is distributed over the whole AuNPs volume, so the SPR of AuNPs is called 
localized surface plasmon resonance (LSPR) [118]. The LSPR wavelength of AuNPs is 
dependent on the size of individual AuNPs and the inter-particle separations of the 
AuNPs. The intensity of the light that is passing through the AuNPs can be measured by 
ultraviolet-visible (UV-Vis) absorption spectroscopy. A red-shift and peak broadening of 
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the UV-Vis absorption spectrum occurs with AuNPs aggregates. It may also involve a 
color change from red to dark blue or gray based on the gold nanoparticle aggregation 
extent and concentration. In addition to their LSPR absorption, light scattering is another 
key optical property of AuNPs. The scattered light intensity from AuNPs as a function of 
time can be measured by dynamic light scattering (DLS) to determine the hydrodynamic 
size of AuNPs. The typical characterization of AuNPs aggregation by UV-Vis, DLS, and 
TEM is shown in Figure 2.13 [119]. 
 
 
2.3.2.2 Detection of specific viruses using AuNPs 
 
Recent studies have tried to harness the unique properties of AuNPs to develop 
various rapid, sensitive, simple virus detection methods. A summary of recent studies of 
detection of human viruses using AuNPs is found in Table 2.3. The AuNPs detection 
signals commonly are measured by UV-Vis absorption spectroscopy, DLS, surface-
enhanced Raman spectroscopy (SERS), color change, and enhanced or quenched 
fluorescent emission. Both the nucleic acids and capsid proteins of the virus can be used 
as biochemical detection targets. The design and principle of the detection methods could 
be dramatically different, but the similarity is that these AuNPs detection methods 
typically involve using antibodies for capturing virus capsid proteins or using 
complementary oligonucleotides for detecting virus nucleic acids. Once the virus is 
captured, nanoparticle aggregation is induced to identify the difference between a sample 
with and without virus. The antibodies and oligonucleotides are very expensive, have 
limited chemical stability, and can only detect one specific type of virus at a time.  
 
Figure 2.13 Characterization of isolated AuNPs (A) UV-Vis absorption spectrum, (B) DLS particle size, 
(C) TEM image, compared with (D) UV-Vis absorption spectrum, (E) DLS particle size, (F) TEM image of 
aggregated AuNPs in 100 mM NaCl. The insets show the real color of isolated and aggregated AuNPs. 
Reprinted from [119] with permission. 
38 
Thus, a ligand-free, general AuNPs virus detection is preferred. Two examples of 
ligand-free detection have been shown for the Influenza B virus [120] and HPV-16 L1 
VLP [121] and can be found in Table 2.3. For Influenza B, the detection is based on the 
specific binding capacity of sialic acid to the enveloped protein hemagglutinin; for the 
HPV-16 L1 VLP, the detection is based on the presence of the virus that inhibits the 
AuNPs aggregated by salt. Other biomolecules like proteins could also prevent the salt 
induced-aggregation if the concentration is high enough [119]. However, neither of the 
above mechanism could be developed for a general virus detection method.  The most 
common principle for the virus detection summarized in Table 2.3 is colorimetric UV-
Vis. However, this type of detection is not sensitive to lower degrees of aggregation and 
not suitable for the analysis of colored samples. Light scattering-based assays typically 
have a better limit of detection than UV-Vis; examples include HBV surface antigen 
[122, 123] and HIV-1 U5 cDNA [124]. In addition, the smaller the AuNPs size, the better 
limit of detection that could be achieved. Based on review of current AuNPs aggregation 
methods for virus detection, a small sized gold sphere by DLS could be promising for 
exploring the ligand-free general virus detection method. 
Virus particles can aggregate in a variety of solution conditions through the 
manipulation of pH and salt concentration. Viruses tend to form aggregates close to their 
pI, where the net charge of the virus surface is neutral, and the repulsive electrostatic 
forces on the virus surfaces are the lowest. MS2, ΦX174, and PRD1 bacteriophage 
particles formed aggregates when the pH was lowered from 7 to near their pI of 4 [20]. 
Viruses show different degrees of aggregation depending on salt types and concentration. 
A NaCl solution ranging from 0.5-4 M reversibly aggregated the hepatitis B surface 
antigen (HBsAg) virus-like particles (VLPs) into oligomeric particles, while 1-2 M 
ammonium sulfate irreversibly aggregated the VLPs [125]. 
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Osmolytes can also aggregate the virus. Osmolytes are natural, organic 
compounds that are found in many organisms to maintain constant cell volume in a harsh 
environment, like extreme pH, high concentration of salt, and high pressure, by balancing 
the hydrostatic pressure between internal and external cellular spaces [138]. Osmolytes, 
based on their effects on protein stability, can be categorized into two groups, protecting 
and denaturing osmolytes. Protecting osmolytes, such as polyols, amino acids, sugars, 
and methylamines, can stabilize proteins by attaching to the water contents and 
rearranging the water molecules around the protein backbones [139]. Denaturing 
osmolytes, like urea, have the opposite effect: they can unfold the proteins by attaching to 
the protein backbones by hydrogen bonds [140]. Protecting osmolytes interact 
unfavorably with the protein backbone, resulting in preferential depletion from the 
protein surface [141]. Denaturing osmolytes interact favorably with the protein backbone 
and often unfold proteins [141]. 
It has been discovered that protecting osmolytes, including the amino acid 
(glycine) and sugar (mannitol), can flocculate both enveloped Sindbis virus (SINV) and 
non-enveloped PPV [142, 143], and resulted in 80% removal with a 0.2 μm filter. The 
proteins, BSA and lysozyme, were not flocculated and resulted in a less than 5% removal 
[142, 143]. This difference indicated that the osmolyte flocculation effect is specific to 
viruses, not tested proteins. The specificity is likely related to the high hydrophobicity of 
viruses as compared to the proteins [32].  
Protecting osmolytes stabilize proteins due to unfavorable interaction with the 
protein backbone, causing an osmophobic effect [144, 145]. Osmolytes have a high 
affinity for water, thus can remove water molecules near hydrophobic residues on the 
protein surface [146]. To compensate for this change in free energy [141], the protein 
tends to fold, which results in a more compact shape to enhance protein stability [147]. 
Viruses tend to aggregate in this same dehydration by osmolytes due to two major 
differences between viruses and proteins: first, viral surfaces have more hydrophobic 
residues than proteins [32, 33], causing more water molecules to be removed from the 
viral surface. Second, viruses have a rigid shape and cannot collapse to account for the 
dehydrated surface. Viruses tend to attract each other and form aggregations. The 
osmolyte effect on virus and protein stability is shown in Figure 2.14 [148]. Thus, 
protecting osmolytes can be used as virus flocculants [142, 143]. The flocculation can 
also be used for virus purification [148]. Osmolyte mannitol has been used as a flocculant 
for PPV and SINV and can purify the flocculated viruses from protein contaminants after 
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microfiltration. A 58-96% virus recovery and an 80% of contaminated protein removal 
could be achieved [148].  
 
 
Osmolytes have shown preferential flocculation of both enveloped and non-
enveloped viruses in virus removal and purification. We propose using the osmolytes as 
preferential viral flocculants in the ligand-free virus detection method. We want to use 
the preferential flocculation of osmolytes coupled with the AuNPs detection by 
measuring the aggregation (Chapter 5). The proposed method would be accomplished by 
coating the viral particles around AuNPs and then inducing the aggregation with 
osmolytes. Protein coated AuNPs that do not aggregate in osmolyte solutions would be 
used as a negative control for virus detection. This method would allow for the detection 
of viral particles without the need for expensive antibodies or oligonucleotides. It would 
also not be virus-specific. This method could be a potential quick, sensitive, inexpensive, 




Figure 2.14 Virus and protein stability with osmolyte. Reprinted from [148] with permission. 
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2.4 Virus thermal stability 
 
2.4.1 Viral based vaccines 
 
According to the WHO, vaccines are one of the most effective methods to prevent 
viral disease outbreaks. Since the first smallpox vaccine was created using a cowpox 
lesion fluid by Edward Jenner in 1796 [149], 81 vaccines have been licensed by the Food 
and Drug Administration (FDA) in the US to prevent against infectious diseases 
effectively [150]. Vaccines have been used to protect against more than 25 chronic or 
life-threatening diseases [151], such as measles, polio, hepatitis, influenza, smallpox, 
rabies, and cervical cancer. Currently, vaccines save about 3 million lives worldwide 
each year [152]. However, about 1.5 million people, primarily children, die due to 
vaccine-preventable diseases yearly [153], according to the Global Alliance for Vaccines 
and Immunizations (GAVI). A major portion of the problem results from the thermal 
instability of many currently used vaccines [154]. This triggered researchers to improve 
viral thermal stability.  
 There are three major types of viral-based vaccines licensed for human use, live 
attenuated, inactivated, and subunit vaccines [155, 156]. Live-attenuated vaccines are 
usually produced by extended passage of a disease-causing (wild) virus in non-human 
cell culture to weaken the wild virus [2, 157, 158]. The attenuated virus can still replicate 
and stimulate high immunity, but it loses the ability to cause disease. Live attenuated 
viral vaccines can cause strong and long-lasting immune response since the similarity to 
natural infection. Thus, this type of vaccine typically requires just one dose and can give 
people lifetime protection. Examples include MMR, smallpox, varicella (chickenpox), 
and yellow fever vaccines [157]. Inactivated vaccines are typically treated by chemical or 
heat inactivation to stop virus replication [2, 157, 158]. The inactivated virus cannot 
replicate, but can still produce immunogenicity, though not as strong as the live 
attenuated virus. This type of vaccine usually requires multiple doses and can protect 
people against the corresponding viral diseases for a limited time. It may require a 
booster shot to maintain ongoing immunity. Examples include hepatitis A, rabies, and 
polio vaccines [157]. Subunit vaccines use a component of the virus, such as a surface 
polysaccharide, capsid protein, or nucleic acid, to stimulate immune response [2, 157, 
158]. Like the inactivated vaccine, this type of vaccine also require booster shots to 
obtain ongoing protection against diseases. Examples include hepatitis B, and HPV [157]. 
The immune response caused by these three types of vaccines from strong to weak in 
order as live attenuated > inactivated > subunit vaccines. However, the stability of these 
three types of vaccines is in reverse order.  
 
2.4.2 Cold chain and cold storage problem 
 
In order for viral vaccines to be effective, they must be transported and stored in a 
“cold chain” [159]. A cold chain is a system of transporting and storing vaccines at the 
recommended temperature, typically 2-8 °C, from the manufacturer until the point of use 
[159, 160]. Figure 2.15A [161] shows a typical cold chain from vaccine manufacturer 
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through different storage and transportation mechanisms until vaccine administration. If 
temperatures are not maintained during this supply chain, i.e., if a vaccine is exposed to 
excessive heat or cold, the vaccine may lose its potency and could no longer be effective 
in fighting disease. This is called the cold storage problem [161].  
 
 
A vaccine vial monitor (VVM), which is a temperature monitoring device, 
typically accompanies vaccines throughout the transportation and storage of the vaccine. 
As shown in Figure 2.15B [162], a VVM is a chemical indicator label on the vaccine 
container and records its cumulative heat exposure by a gradual color change. The 
 
Figure 2.15 Cold chain. (A) A typical flow of cold chain, reprinted from [161] with permission. (B) A 
vaccine vial monitor (VWM) to indicate the cumulative heat exposure of vaccine, reprinted from [162] 
with permission. 
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vaccine needs to be discarded if the color or inner square is the same color or darker than 
the color of the outside circle, which indicates that the vaccine is exposed to excessive 
heat and, therefore, likely to be damaged. According to the WHO, about 50% of the 
vaccines produced are discarded due to poor thermal stability each year [163]. The 
unreliable cold chain system is one of the major causes of poor immunization coverage in 
developing countries [160, 161], which could increase the likelihood of a viral infectious 
disease outbreak. Key issues that limit the cold chain reliability in low resources 
countries are insufficient cold chain capacity, inadequate temperature monitoring and 
control, and lack of up-to-date cold chain equipment [160].  
The unreliable cold chain can expose the vaccines to high temperatures. High 
temperatures can damage vaccines in a variety of ways, accelerating unwanted reactions, 
such as hydrolysis, deamination, and breakage of non-covalent bonds, causing proteins to 
denature or degrade, dissociating polysaccharides or reducing the infectivity of virus in 
the live attenuated vaccines [154, 164]. All vaccines will lose potency over time, and the 
rate of potency loss depends on temperature and exposure time. Heat damage is 
cumulative, so higher temperature and longer exposure time lead to faster vaccine 
thermal degradation [164]. Therefore, developing robust, thermostable viral vaccines that 
are less dependent on the cold chain is urgent and important for universal access to 
immunization.  
 
2.4.3 Conventional vaccine formulation to stabilize viral vaccines 
 
Vaccines are formulated to generate a strong protective immune response to the 
targeted antigen and typically comprise three key components, antigen, adjuvant, and 
excipients [165, 166]. The antigenic component in a viral vaccine is the viral component 
that causes an immune response. The adjuvant is an agent that can be added to some 
vaccines to enhance the immunogenicity of the antigens in vivo and is typically used with 
less immunogenic antigens, like subunit and inactivated vaccines. Typically, aluminum 
hydroxide and aluminum phosphate are commonly used adjuvants in licensed vaccines 
[165]. Aluminum salts function by adsorption and slow release of antigen components at 
the injection site for the immune response. Excipients, the third component of a vaccine, 
are typically inert agents added to a vaccine for a specific purpose such as preservation, 
pH control, and stabilization; examples include preservatives, buffers, and stabilizers 
[166]. Preservatives prevent bacteria, and fungi growth; commonly used preservatives are 
2-phenoxyethanol, phenol, and thiomersal [166]. Buffers are used to control the pH of the 
formulated vaccine within the physiological range. Stabilizers are used in the formulation 
to improve vaccine stability during transportation and storage. Examples include sugars 
such as sucrose, lactose, and trehalose, amino acids such as glycine or monosodium 
glutamate, and proteins such as human serum albumin or gelatin.  
The mechanisms why stabilizer can improve antigen stability is still unclear. But 
major discussions on these bulk agents can create a crowding environment by either form 
a hydrogen bond between the sugar and the viral surface, non-specific interactions 
between the proteins and viral surface. The crowding environment has limited space for 
unfolded proteins and large aggregation. Thus, the crowding effect disfavors viral surface 
proteins unfolding and denaturation, facilitate heat-induced unfolded viral capsid proteins 
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refolding back to the native state [167], and inhibit viruses forming insoluble aggregates 
[168]. 
The formulation and thermal stability of commonly used FDA licensed viral 
vaccines are summarized in Table 2.4 [164, 169, 170]. Inactivated and subunit vaccines 
typically require adjuvants to boost immune response but are rather stable when exposed 
to high temperatures. Live attenuated viral vaccines stimulate a stronger immune 
response than other types of vaccines and, therefore, do not contain adjuvants. However, 
they are more sensitive to temperature changes, and tight temperature control is required 
for them to remain immunogenic [168]. There is a need to develop versatile methods to 
thermally stabilize the live attenuated vaccines.  
A conventional formulation strategy to improve the thermal stability of live-
attenuated vaccines is to lyophilize the vaccines in excipients for long-term storage [170], 
as shown in Table 2.4. Lyophilization, or freeze-drying, involves controlled removal of 
bulk water and desorption of bound water, under decreased pressure and low temperature. 
The lyophilized vaccine product will typically have a low residual moisture content of 
<3% [171]. The lyophilized vaccine can be stored long-term and can be reconstituted 
immediately by mixing the dried vaccine powder with a buffer before use. The drying 
process typically requires cryoprotectants as well as stabilizers in the formulation to 
protect the vaccines from dehydration and ice-crystal formation. Sugars can form glass 
rather than crystals due to high glass-transition temperatures and can form hydrogen 
bonds to the dried virus surface as water substitutes [172]. Different excipients need to 
select for different live attenuated vaccine formulations and require a large number of 
screen experiments. The dried formulation has improved thermal stability, but most of the 




Table 2.4 FDA-approved viral vaccines types, formulation, and thermal stability [164, 169, 170] 
 
Vaccine type Vaccine Formulation Stability at 2-8°C 25° 37°C ≥45°C 
Live attenuated 
vaccine 
MMR Lyophilized, no adjuvant 2 years >1 month >1 week unstable 
Yellow fever Lyophilized, no adjuvant 2 years >1 month >2 weeks unstable 
Varicella Lyophilized, no adjuvant 2 years 6 h (27°C) unstable unstable 
Rotavirus Liquid, no adjuvant 2 years 48 h unstable unstable 








months N/A 3 months N/A 
Rabies Lyophilized, no adjuvant 3 years N/A 3 months N/A 






Hepatitis B Liquid, aluminum adjuvant 4 years N/A 1 month 1 week 
HPV Liquid, aluminum adjuvant 3 years 2 years 
1.5 
months 14 days 
 
 
2.4.4 Novel formulations to enhance the thermal stability of virus by 
complex coacervation  
 
To develop robust, thermostable viral vaccines that are less dependent on the cold 
chain, a new formulation strategy for stabilizing viral vaccines thermally is proposed by 
using the complex coacervation to encapsulate the viral particles. Complex coacervation 
[173-175] is an associative liquid-liquid phase separation phenomena based on 
electrostatic interactions of two or more oppositely charged polymers, and entropy gains 
for releasing of small, bound, counter-ions from the polyelectrolyte salts into solution 
[168, 176, 177]. Oppositely charged polymers such as proteins, polypeptides, 
polynucleotides, and polysaccharides can be used to form complex coacervation. When 
oppositely charged polyelectrolytes interact in a solvent to reach net charge neutrality, 
two equilibrium phases can be formed. The polymer-rich dense phase is called the 
complex coacervate phase [173-175], and the polymer-poor dilute phase is called the 
supernatant, as shown in Figure 2.16A [178, 179]. Coacervates are formed by mixing 
clear, homogenous solutions of oppositely charged polymers until a turbid solution 
containing fine coacervate droplets is formed, causing a microphase separation [174, 
175].  The droplets coalesce together over time or can be accelerated by centrifugation to 
form a dense bulk coacervate phase, causing a macrophase separation [174, 178]. Optical 
microscopic images of the coacervate droplets formed initially and in their coalesced 
form (after centrifugation) are shown in the insets circled images in Figure 2.16A. 
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The phase behavior of complex coacervation has been reported to be weakly 
affected by temperature [178, 180], showing the promise for application in high 
temperature. However, the phase behavior of complex coacervation is strongly dependent 
on the polyelectrolyte mixing ratio (stoichiometry), polyelectrolyte concentration, ionic 
strength (salt concentration), and solution pH. This phase behavior is depicted by the salt 
concentration vs. polymer concentration phase diagram, which separates the one-phase 
region from the two-phase region, as shown in Figure 2.16B [173]. At low salt and 
polymer concentrations, liquid-liquid phase separation as complex coacervation occurs 
underneath the binodal curves. The single-phase solution region is above the binodal 
curves. The different binodal curves represent how the immiscible region changes with 
different polymer chain lengths, and increasing polymer chain length can expand the two-
phase region, as indicated by the arrow. Polymers with higher charge density can also 
increase the two-phase region [177, 181]. The critical point is the highest point of the 
binodal curve, which indicates that the existence of a limit of ionic strength when 
coacervation occurs for a given polymer system [173, 181]. The equilibrium 
concentration for a coexisting coacervate and supernatant phase is defined by the tie line, 
shown as the dashed line. 
Complex coacervation has been used in a variety of areas, such as drug delivery 
[182, 183], gene therapy [184-186], and biomimic adhesives [187, 188]. One of the most 
important applications is as a method for encapsulation of biomolecules [45, 174, 186, 
189-191], such as proteins, which can be achieved by using the proteins as a component 
of the complex coacervate matrix. Direct encapsulation of proteins by a binary protein-
polyelectrolyte system [192] is sometimes limited by the polyampholyte nature of 
proteins, which bear both cationic and anionic groups. A two-component protein with 
oppositely charged polyelectrolyte can hardly form complex coacervates at physiological 
conditions due to the low charge density of the protein [193-195]. To overcome the 
limitations of the binary system, either the surface amino acids need to be modified to 
increase the protein charge density [193-195], or a tertiary system of complex coacervate 
is used to effectively encapsulate proteins [45, 190, 191, 196]. The advantage of using 
complex coacervation to encapsulate proteins is that the process allows for the 
encapsulation in aqueous physiological solution rather than harsh organic solvents.  
Precipitation [197] or emulsion [198] requires organic solvents to encapsulate proteins by 
poly (lactic-co-glycolic) acid (PLGA), and the process may denature the protein of 
interest [199]. Also, the complex coacervation in aqueous solution does not need extra 




A tertiary system of complex coacervate is typically used to encapsulate proteins 
effectively. Tertiary systems of coacervation will form an intermediate complex between 
the protein and oppositely charged polyelectrolyte. While some charges on the 
polyelectrolyte are neutralized by the charge on the protein, the overall charge of the 
intermediate complex is dominated by the polyelectrolyte. The coacervation is induced 
by adding a second, oppositely charged polyelectrolyte, which interacts directly with the 
intermediate complex by electrostatic attraction. The driving force for the coacervation is 
relying on the association of two opposite charged polyelectrolyte due to electrostatic 
attraction and the entropy gain from bound counterion release, which causes phase 
separation [168, 176, 177]. As shown in Figure 2.16C [190], a tertiary complex 
coacervate was formed to encapsulate BSA at neutral pH. BSA has a pI 4.5-5.0 [79], so it 
has a net negative surface charge at pH 7. The net negative BSA and polycation poly(L-
lysine) (PLy) formed an intermediate complex first, and the intermediate further 
 
Figure 2.16 Complex coacervation. (A) Scheme of complex coacervation of cationic polymer chitosan and 
anionic polymer hyaluronic acid (HA) in 0.1 M sodium acetate solution. Reprinted from [178] and [179] 
with permission.  (B) Schematic representation of a typical phase diagram to define the phase boundaries as 
a function of salt concentration vs. polymer concentration for a given stoichiometry, pH, and temperature. 
Different colors represent different polymer chain lengths. Reprinted from [173] with permission. (C) BSA 
encapsulation via complex coacervation. Reprinted from [190] with permission. 
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interacted with a polyanion poly (D/L-glutamic acid) (PGlu) to form the final complex 
coacervate. This encapsulation of BSA with oppositely charged polypeptides showed 
better encapsulation efficiency near neutral pH compared with acidic pH, and it showed 
better stability at a higher degree of polymerization (the number of monomeric units in a 
polymer x=400) compared with x=100 [45, 190]. This system maintained the structural 
stability of the encapsulated BSA [190]. It showed promise for encapsulating our studied 
viruses since the pI of PPV and BVDV were similar to BSA, and encapsulation of viruses 
was desired at a neutral pH and in an organic-free aqueous solution. In all, the 
synthesized polypeptides are easily tunable for different degree of polymerization [177] 
and biocompatible with cells [190], and the coacervation did not affect the structural 
stability of the encapsulated proteins [168, 189-191, 201].  
Complex coacervation not only maintained the structure stability of encapsulated 
proteins, but it also showed enhanced stability of proteins against harsh conditions [191], 
like denaturant urea environment, extreme pH, and high temperature. Encapsulated 
proteins (BSA, carbonic anhydrase, and α-chymotrypsin) within 
poly(diallyldimethylammonium) and poly(acrylate) complex coacervates showed 
enhanced stability against urea-induced protein unfolding [167]. The coacervate droplets 
bound the protein conformers that were partially unfolded by urea and reduced the 
misfolding and aggregates [167]. An encapsulated BSA within poly(acrylic acid) (PAA) 
and poly(allylamine hydrochloride) (PAH) complex coacervates showed a reduced 10% 
protein unfolded fraction compared with 50% for free BSA, at the extreme pHs of 3 and 
12 [191]. The reasons for why complex coacervates can protect proteins against extreme 
pH is likely due to extra hydrogen or hydroxide ions diffusing into the coacervate will 
first encounter polyelectrolytes and BSA molecules closest to the phase boundary 
between supernatant and coacervate. The polyelectrolytes on the phase boundary could 
shield the proteins further within the complex coacervate, and the small confined weak 
polyelectrolyte environment can act as a sort of buffer to maintain a stable pH 
environment within the coacervates. Moreover, the tertiary system of complex 
coacervates BSA-PAH-PAA showed protection of BSA against heat to a small degree, 
with a 45% unfolded fraction compared with 55% for free BSA at 70 °C [191]. The peak 
denaturation temperature of an encapsulated canola protein isolate (CPI) with chitosan 
(CS) complex coacervate was 92.3°C, higher than the 77°C for free CPI, indicating that 
the encapsulated CPI is more thermostable [202]. An encapsulated lysozyme by 
hyaluronic acid (HA) complex coacervates showed a high protein recovery at room 
temperature for 12-weeks’storage compared to free lysozyme compared at the same 
condition, indicated improved stability [168].  
There are several possible mechanisms for a protein’s enhanced thermal stability 
when encapsulated in a complex coacervate. The improved thermal stability of proteins 
in the coacervate phase could be attributed to the crowding environment, which disfavors 
proteins unfolding and denaturation, facilitate heat-induced unfolded proteins refolding 
back to the native state [167], and inhibit proteins forming insoluble aggregates [168]. 
The small, dense, compact, polymer-rich coacervate phase can provide entropic and 
enthalpic stabilization [168, 202]. The main driving force for protein unfolding is 
believed to be the high conformational entropy of the denatured state [203]. The flexible, 
unfolded state of a protein has a much greater conformational freedom than the compact, 
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folded state. The limited volume of the crowded environment would minimize the 
degrees of conformational freedom in the unfolded state, and hence improve the 
stabilization of the native state of protein due to an entropic stabilization [203, 204]. 
Also, unfolded proteins have larger hydration radii and occupy more volume compared to 
the folded state, and the excluded volume effect from the crowded environment lacks the 
space available for the extended denatured proteins, thus favoring any process like 
protein folding in which the volume decreases [203-205]. In addition, the denatured 
enthalpy of protein in polyelectrolyte complex has been shown to be much higher than 
free proteins [202], indicating that complex coacervation could impart thermal stability to 
proteins. Furthermore, complex coacervate microdroplets can be considered as a 
membrane-free, artificial cellular platform for proteins, thus serving as a type of protocell 
[206], which allows spatial compartmentalization for biomacromolecules without the use 
of membrane (vesicle) formation [207-209]. Thus, the coacervate stabilizes proteins by 
mimicking the proteins inside of a membrane-free cell, which is a highly crowded 
environment due to the presence of macromolecules, such as proteins, nucleic acids, 
ribosomes and carbohydrates [206]. In reality, protein folded inside cells, thus the 
intracellular environment mediated by the coacervates favors to fold protein in its 
compact native state and keep the stability of proteins. Besides, A water content of 68-83 
wt% [178, 210] was reported for BSA- poly(diallyldimethylammonium chloride), PLys-
PGlu, PLys-poly(L-aspartic acid), poly(L-histidine)-PGlu, poly (L-ornithine)-PGlu 
complex coacervates systems; the high amounts of water content trapped by coacervate 
dense phase can also protect the proteins against dehydration by heat evaporation.  
The finding on encapsulated proteins by complex coacervation with improved 
thermal stability showed the promise for encapsulating viral particles and thermally 
stabilizing viruses via coacervation. We have developed a method to encapsulate viral 
particles in polymers that relies on the electrostatic interaction of viruses with 
polypeptides. Encapsulating viral particles via complex coacervation is a potential 
solution to the cold storage problem. The partitioning of viral particles into the dense 
phase and the effect of complex coacervates on the stability of viruses against high 
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3 Virus surface chemistry 
characterization1 
  
                                                 




Virus surface chemistry, primarily the hydrophobicity and surface charge of the 
virus, determines its mobility and governs its colloidal behavior in virus adsorption 
processes. Both the hydrophobicity and surface charge of the virus can dominate virus 
removal performance in different solution environments [1-3]. Hydrophobic interaction 
chromatography (HIC) has been used to purify viral particles [4, 5] and as a measure of 
viral particle hydrophobicity [6, 7]. Viruses are well known to adhere to charged surfaces 
[2, 8] and charge-charge interaction is often used to remove viruses. However, each of 
these methods requires large amounts of virus for detection by infectivity assays or 
nucleic acid amplification by polymerase chain reaction. A method to develop virus 
purification and removal techniques is needed that requires less virus, therefore reducing 
time and resources. We propose that knowledge of virus surface chemistry measured in a 
small volume could fulfill this need.  
There is limited information on the surface chemistry of virus [6, 9]. Current 
methods have been used to characterize the virus surface chemistry, including HIC [10], 
virus adsorption to known chemical surfaces [11, 12], zeta potential [13], and isoelectric 
focusing [14]. The disadvantages of these methods are that many require large amounts 
of virus, and they are bulk measurements. Bulk measurements can be affected by 
purification methods [15], solution conditions [16], and cannot account for heterogeneity 
in the virus population [17]. In addition, the cost of production and purification of a large 
quantity of virus is high. Hence, there is a need for methods that can accurately target 
single virus particles and simultaneously measure the surface chemistry of the virus with 
trace amounts of samples.   
A novel surface characterization method, chemical force microscopy (CFM) [18], 
which uses chemical interactions between a functionalized atomic force microscopy 
(AFM) tip and a sample, is leading to a renewed look at single particle virus surface 
chemistry. CFM is a versatile method for monitoring the topography of the sample and 
measuring the interaction forces between a functionalized AFM tip and a sample [19]. 
The chemical interaction is measured by the deflection of the AFM cantilever during the 
AFM tip approach and withdrawal [20]. The deflection can be converted into the force 
needed to pull the functionalized AFM tip from the sample using the spring constant of 
the cantilever and Hooke’s law [21]. The AFM probe pull-off force during withdrawal 
from the sample can be quantified as a measurement of adhesion force [18] and can be 
used to compare the surface chemistry of samples [22]. 
CFM is a sensitive and reliable tool to evaluate the surface chemistry of soft 
biological material. CFM has been reported to map the hydrophobic interactions of the 
microbial pathogen Aspergillus fumigatus with a hydrophobic (methyl-functionalized) 
AFM tip [23], and measure the hydrophobic forces between a fibronectin-modified AFM 
tip and a methyl acetate-modified substrate [24]. For surface charge measurements by 
CFM, it has been reported that carboxyl acid-modified AFM probes have been used to 
determine the surface charge of a single S. cerevisiae cell surface at various pH [25]. 
Protein surface charge at various pH has been explored by measuring the adhesion forces 
between four target proteins (bovine serum albumin, myoglobin, fibrinogen, and 
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ribonuclease A) that were covalently immobilized onto an AFM probe and a charged 
substrate [26].  
CFM is suitable to probe the surface chemistry of nanometer-sized virus particles. 
One advantage of CFM is that the virus can be studied in a physiological environment 
without disturbing the natural state of the virus [27]. CFM can measure chemical 
interactions ranging from strong covalent bonds (~100 nN) to weak van der Waals forces 
(~1 pN ) [18], making it a suitable tool for measurement of hydrophobic interactions and 
surface charge of virus particles. 
To develop CFM as a way to measure virus surface chemistry, we first 
demonstrated that covalently binding virus to a surface could keep the natural size and 
shape of the virus without deformation or disassembly, as compared to a physical 
adsorption method. Then, AFM probe functionalization was explored and the optimal 
coating concentration and time for each interested chemistry were determined. Finally, 
the successfully functionalized AFM probes were used for virus surface chemistry study. 
CFM with a methyl-terminated probe was used to study the surface hydrophobicity of a 
virus. CFM with a charged probe was used to study the surface charge of a virus. With a 
thorough understanding of virus surface chemistry, future virus purification and removal 
techniques could be significantly improved to specifically absorb viral particles.  
 
 




Potassium phosphate monobasic (molecular biology grade, ≥99.0%), sodium 
phosphate monobasic monohydrate (ACS grade, 98.0-102.0%), and sodium chloride 
(ACS grade, ≥99.0%) were a gift from Millipore Sigma (Burlington, MA). Sodium 
phosphate dibasic heptahydrate (ACS grade, 98.0-102.0%), 12-mercaptododecanoic acid 
(HS (CH2)11COOH, 96%), 1-dodecanethiol (HS(CH2)11CH3, ≥ 98%), 11-
mercaptoundecyl)-N,N,N-trimethylammonium bromide (HS(CH2)11N(CH3)3Br), and 
primary amine (NH2) functionalized silica nanoparticles (nanoparticles <30 nm (DLS)) 
were purchased from Sigma-Aldrich (St. Louis, MO). N-hydroxysulfosuccinimide (NHS) 
and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) were 
purchased from Thermo Fisher Scientific (Grand Island, NY). All aqueous solutions or 
buffers were prepared using purified water with a resistivity of ≥18 MΩ·cm from a 
Nanopure filtration system (Thermo Scientific, Waltham, MA) and filtered with a 0.2 µm 
bottle top filter (VWR, Radnor, PA) or a 0.2 µm syringe filter (VWR) prior to use. A 
standard phosphate buffered saline (PBS) (pH 7.2) was prepared by dissolving 0.21 g 
potassium phosphate monobasic, 0.726 g sodium phosphate dibasic heptahydrate, and 9 g 
sodium chloride into 1000 mL Nanopure water. A 20 mM phosphate buffer (PB) solution 
(pH 7.0) was prepared by dissolving 1.0763 g sodium phosphate monobasic monohydrate 
and 3.2705 g sodium phosphate dibasic heptahydrate into 1000 mL of Nanopure water. 
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3.2.2 Virus purification 
 
Porcine parvovirus (PPV) strain NADL-2, was a gift from Dr. Ruben Carbonell 
(North Carolina State University, Raleigh, NC). Bovine viral diarrhea virus (BVDV) 
strain NADL was purchased from USDA APHIS. For purification of both PPV and 
BVDV, the virus was first dialyzed using a Biotech Cellulose Ester 1,000 kDa dialysis 
tubing (Rancho Dominguez, CA) at 4°C for two days with two buffer exchanges to 
remove small sized protein contaminants. The exchanged buffer was either PBS (for 
virus hydrophobicity study) or 20 mM PB (for virus surface charge study). The dialyzed 
virus was further purified with a Bio-Rad Econo-Pac 10DG desalting column (Hercules, 
CA). The concentrations of purified virus solutions were determined from titrations to be 
1×108 MTT50/mL for PPV and 1×107 MTT50/mL for BVDV using an MTT assay [28, 29]. 
 
3.2.3 Virus samples and control surfaces preparation 
 
A glass slide with an area of 2.54 cm2 was coated with 5 nm of chromium with a 
Perkin-Elmer Randex Sputtering System (Model 2400, Waltham, MA). The chromium-
coated slide was further coated with a 30 nm gold layer using the sputter. All of the 
deposition steps were performed under a 5 × 10-6 Torr vacuum. The bifunctional linkers 
were attached to the gold-coated slide by immersing the slide in 14 mL of a mixed 
solution containing a total of 2 mM of HS(CH2)11COOH and HS(CH2)11CH3 in ethanol 
for 12 hours. Then the slide was rinsed with ethanol and air dried in a chemical hood. The 
ratio of carboxylic acid and methyl capped thiols was 1:1, unless stated otherwise. The 
functionalized surface was equilibrated with 14 mL Nanopure water for 15 minutes to 
remove any free bifunctional linkers from the surface. The surface was further treated 
with a total of 0.5 mL of an equal volume mixture of 0.1 M NHS and 0.4 M EDC in 
Nanopure water [30, 31] for 30 minutes and equilibrated with PBS (pH 7.2) for 2 
minutes. This step was to activate the carboxylic acid groups to NHS esters. After 
activation, 0.5 mL of virus surrogate NH2-functionalized silica nanoparticles or purified 
PPV or BVDV was applied to the surface for 30 minutes. Finally, the surface was washed 
with Nanopure water three times to remove any unattached virus or silica particles. The 
virus or silica nanoparticles functionalized surfaces were stored in either a 14 mL of PBS 
or 14 mL of 20 mM PB (pH 7.0) at 4°C, depending on if hydrophobic or charge 
interactions were to be measured, respectively. The control surfaces were prepared in the 
same manner except one pure thiol compound was used. 
 
3.2.4 AFM probe modification  
 
For hydrophobicity measurements, gold-coated Bruker AC-40 AFM probes 
(spring constant ~0.1 N/m, tip radius ~10 nm) were immersed in a 14 mL ethanol 
containing 4 mM of HS(CH2)11CH3 for 24 hours, rinsed with ethanol, and air-dried in a 
chemical hood. For surface charge measurement, negatively-charged AFM probes were 
prepared by immersing the AC-40 AFM probes in the same manner in HS 
(CH2)11COOH. Similarly, positively charged AFM probes were modified by incubating 
the NT-MDT GSG10/Au AFM probes (spring constant ~0.11 N/m, tip radius ~ 35 nm) in 
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a 14 mL ethanol-containing 10 mM solution of HS(CH2)11N(CH3)3Br for 48 hours, rinsed 
with ethanol, and air-dried in a chemical hood. 
 
3.2.5 AFM imaging, force measurement and analysis 
 
All AFM experiments were carried out at room temperature (~20°C), using a 
Bruker Dimension ICON Atomic Force Microscope with ScanAsyst (Santa Barbara, 
CA). The AFM topographic images were obtained using ScanAsyst in liquid (in imaging 
tapping mode) at a scanning rate of ~1 Hz and 512 × 512 pixels over scan areas of 500 × 
500 nm, with a Bruker ScanAsyst-Fluid+ silicon nitride AFM probe (spring constant ~0.7 
N/m, tip radius ~2 nm) or a NT-MDT GSG30 AFM probe (spring constant ~0.6 N/m, tip 
radius ~6 nm). All topographic images were obtained in PBS pH 7.2.  
AFM force measurements were performed in PeakForce QNM (tapping mode) or 
contact mode in liquid. As the AFM probe spring constant can change during the 
chemical modification, it was calibrated before the force measurement experiment by 
measuring the thermal noise of the free cantilever in liquid [32]. We recorded five 
consecutive F-D curves for a single viral particle and then would move to another viral 
particle to record another set of curves. Over 500 F-D curves were recorded with at least 
three separate combinations of probe/virus samples. All F-D curve measurements 
between modified probes and viral particle surfaces were collected in liquid conditions 
with PBS (for hydrophobicity measurement) at pH 7.2 or in 20 mM PB at pH 7.0 (for 
surface charge measurement). The control experiments were carried out under the same 
conditions. Data analysis was performed with the Bruker Nanoscope Analysis software, 
and all the figures were drawn with Excel unless stated otherwise. 
 
3.3 Results and discussion 
 
To characterize virus surface chemistry by the single particle CFM method, the 
key steps were the functionalization of AFM probes with the chemical functional group 
of interest and immobilization of virus particles on a surface, as shown in Figure 3.1. We 
used standard methods to functionalize the gold-coated AFM tips. However, virus AFM 
experiments are commonly done by adsorption of the virus to a surface, and 
characterization is by nanoindentation [33-35]. The goal of nanoindentation is to measure 
the force needed to break open a virus capsid by pushing on it. However, in our work, we 
are pulling on the virus rather than pushing on it. By covalently bonding the virus to the 
surface, we would be assured that the AFM force experiment was measuring chemical 
interaction between the virus and the AFM probe, and not the virus and the solid surface.      
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3.3.1 Virus and virus surrogate immobilization 
 
There are various methods to immobilize viruses on a surface, including physical 
adsorption [36], antibody capture [37, 38], and covalent attachment [39]. Physical 
adsorption by deposition of virus particles on a solid surface is simple, but the capsid 
proteins might deform during adsorption [36]. It is not clear if the deformation can 
change the exposed virus surface proteins and therefore change the virus surface 
properties. It was also a concern that the virus may have a stronger bond to the AFM 
probe than the surface. This would result in misleading results because we would not 
clearly know which bond rupture force we were measuring. The antibody capture and 
covalent binding methods provide strong bonds between the virus and the surface. The 
density of both the capture antibodies and covalent linkers will determine the number of 
 
Figure 3.1 Overview of AFM probe surface modification and virus attachment on a gold surface. (A) AFM 
probes were functionalized with either a hydrophobic methyl group, a negatively charged carboxyl acid 
group, or a positively charged quaternary amine group. (B) Virus particles were immobilized with 
NHS/EDC chemistry. (Virus image was created in BioRender) 
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virus particles immobilized on a surface. The antibody binding method is virus-specific, 
but it is expensive and the antibodies could be denatured in some of the conditions 
explored during CFM. Thus, the method of covalently binding the virus to the surface 
was chosen.  
To covalently bond the virus to the surface, a bifunctional linker that contained a 
thiol functional group was chemisorbed onto the gold surface [40]. The linker contained a 
carbon chain that self-assembled onto the gold-coated slide (Figure 3.1B). The functional 
group was always a carboxylic acid (COOH) was chosen because it covalently attaches to 
lysines on the virus surface using EDC and NHS chemistry [30, 31]. The surface was a 
mixture of COOH-capped and CH3-capped compounds to control the density of the 
COOH bifunctional linker.  
To test the covalent immobilization chemistry, NH2-functionalized silica 
nanoparticles were used as a virus surrogate and attached to the COOH functional the 
surface. The natural particle size of 10-15 nm was detected for NH2-functionalized silica 
nanoparticle topographic images, as shown in Figure 3.2A-C, confirming the utility of 
the immobilization chemistry. To determine the optimal density of particles attached to 
the surface, various ratios of COOH-capped and CH3-capped thiol linkers at 9:1, 1:1, and 
1:9 were tested. A ratio of 9:1 COOH/CH3 caused a high density of nanoparticles and 
resulted in aggregated nanoparticles that could not be individually distinguished, as 
shown in Figure3.2A. The best concentration was 50 w/w% COOH-capped and 50 
w/w% of CH3-capped compounds, shown in Figure 3.2B, and this condition was used for 
further experiments. At a ratio of 1:9, too few nanoparticles attached to the surface, as 
shown in Figure 3.2C, making locating the virus difficult. Control surfaces were 
measured to determine the roughness of the surface at different stages of 
functionalization. Figure 3.2D shows that the hydrophobic functional group SAM-CH3 
modified surface had a surface roughness of ~1 nm. This is the same roughness as was 
found for the bare gold surface control in Figure 3.2E and the NHS-EDC modified 




The successful immobilization of virus particles was demonstrated using PPV and 
BVDV through topographic images and corresponding height analysis, as shown in 
Figure 3.3A and 3.3B. The PPV had a measured size of 24 nm, which falls into the 
 
Figure 3.2 Topographic images and corresponding height analysis of virus surrogate NH2-functionalized 
silica NPs with different ratios of COOH and CH3–capped thiol linkers and controls. Silica NPs were 
imaged after immobilization with (A) 9:1, (B) 1:1, and (C) 1:9 COOH to CH3 ratios. Control surfaces were 
(D) methyl-modified surface, (E) bare gold surface, and (F) NHS-EDC surface. 
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reported size range of PPV of 18 - 26 nm [41]. PPV immobilized with an antibody 
capture method had a height of ~18 nm [42] in AFM topographic images, smaller than 
the size of PPV measured in our method. In addition, Figure 3.3B shows that BVDV has 
a size of 40-60 nm, which is consistent with the reported size of BVDV reported [43]. 
The height analysis results also indicate that our covalent virus immobilizing method can 
keep a natural form of the virus without deformation or disassembly. We also used 
physical adsorption to immobilize virus particles by depositing the virus particles onto 
the gold surface without covalently binding, as shown in Figure 3.3C and 3.3D. The 
measured sizes for both PPV and BVDV were smaller than the literature reported sizes, 
indicating that deformation of the virus particles occurred, and further confirmed the 
advantage of covalent immobilization of virus.  
 
 
3.3.2 AFM probe modification 
 
There are many ways to modify an AFM probe with a chemical functional group, 
including silanization [44, 45], esterification [46, 47] and thiol attachment [23, 25]. The 
chemical groups of interest that functionalize the AFM probes determines what viral 
surface chemistry can be explored. Commercially available AFM tips are typically made 
of silicon nitride, which can form a silanol (Si-OH) surface layer on the AFM tip in air. 
Common methods for functionalization of AFM tips are silanization between the silanol 
groups on the AFM probe and a silane coupling agent such as R-(CH2) n-Si-(OC2H5)3 [44, 
45] (R represents any interested chemical group), and esterification between the silanol 
groups on the AFM probe and a hydroxyl terminated agent R-(CH2)n-OH [46]. AFM tip 
silanization typically occurred in the vapor phase and required heat treatment of the 
silanized tip at ~110°C for ~10 min [44, 45]. Direct AFM tip esterification typically 
required a heating treatment over 100°C for several hours to functionalize the AFM probe 
[46, 47]. Another option is to coat the AFM tip with gold and adsorb an alkanethiol agent 
R-(CH2)n-SH onto the AFM tip [23, 25]. One key advantage of thiol attachment 
chemistry over the previous mentioned covalent binding chemistry for AFM probe 
 
Figure 3.3 Topographic images and corresponding height analysis of virus. (A) PPV covalently bound to 
gold, (B) BVDV covalently bound to gold, (C) PPV deposited on gold, and (D) BVDV deposited on gold. 
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functionalization is that the tip modification can be performed at room temperature with a 
low concentration (~1 mM) of alkanethiol agent [23, 25]. Another advantage is that 
commercially available alkanethiol agents are terminated in a variety of chemistries. The 
disadvantage of the thiol method is that the adsorption takes longer than the higher 
temperature methods. We chose to use the thiol attachment method, for the AFM probe 
modification in our study, shown in Figure 3.1A.  
 






12 hours 24 hours 24 hours 48 hours 
1 mM 0 pN 
N/A N/A 
N/A 2 mM 0 pN 
4 mM 
N/A 
1734 pN 0 pN 
10 mM N/A N/A 165 pN 
N/A: condition not tested. 
All mean forces >0 were calculated based on the adhesion forces from 500 recorded F-D curves with at 
least three separate combinations of probe/control samples. Null adhesion force was based on 50 F-D 
curves with one combination of probe/control sample. 
 
To measure small molecular binding interactions, a very soft, gold-coated Bruker 
AC-40 AFM probe (spring constant ~0.1 N/m, tip radius ~ 10 nm) was used. To 
functionalize the tip with a methyl functional group (CH3), a coating condition of 1 mM 
of HS(CH2)11CH3 in ethanol for 12 hours[23] was used. To confirm the probe 
functionalization, the force between the coated probe and a CH3 modified control surface 
in PBS at pH 7.2 was measured. However, no adhesion force could be detected, as shown 
in Table 3.1.  The coating concentration was increased to 2 mM for 12 hours, and still, 
no adhesion force was measured. Next, the coating concentration was increased to 4 mM 
and coating time to 24 hours. These changes resulted in strong adhesion forces with a 
mean value of 1734 pN, shown in Table 3.1 and Figure 3.4A. Over 500 force-distance 
curves were collected to create the histogram in Figure 3.4A showing the range of 
interactions with multiple virus particles. The possible reason why the literature reported 
coating condition did not work in our experiment might be due to the tiny AFM tips used 
in our experiment as compared to the larger tip area used in the previous work [23]. The 
small available area for coating limited the efficiency of methyl group binding.  
To confirm the probe modification for the viral surface charge study, the 
negatively charged carboxyl (COO-)-terminated probe at coating condition with 4 mM of 
74 
HS(CH2)11COOH in ethanol for 24 hours was tested with positively charged silica 
nanoparticles in PB at pH 7.0. Strong adhesion forces with a mean value of 210 pN were 
measured, as shown in Figure 3.4B. No adhesion forces could be detected on the 
negatively charged COO- modified control surface at pH 7.0 (data not shown). This was 
the only coating condition tested for this condition. 
 
 
The positively charged quaternary amine (NR4+)-terminated probe was with a 
negatively charged COO- modified control surface in PB at pH 7.0. To functionalize with 
the positively charged NR4+, the same coating condition with 4 mM for 24 hours were 
used with the gold-coated Bruker AC-40 AFM probe. No adhesion forces could be 
detected, as seen in Table 3.1. The probe coating might have been hindered by the small 
available areas of AC-40 probe, so another soft NT-MDT GSG10/Au AFM probe (spring 
constant ~0.11 N/m, tip radius ~ 35 nm) was coated following the same coating 
concentration with an HS(CH2)11N(CH3)3Br in ethanol. On average, 1 out of 10 probes 
tested were successfully coated with the quaternary amine. To improve the binding 
efficiency, a coating condition of 10 mM for 48 hours was tested to coat the GSG10/Au 
probe. Strong adhesion forces could also be seen in Figure 3.4C, with a mean force of 
165 pN. No adhesion forces could be detected on the positively charged silica 
nanoparticles control surface (data not shown). It is likely that a high coating 
 
Figure 3.4 Probe functionalization confirmation. Adhesion histograms and representative force-distance 
curves (retraction only) of positive control surface with a CH3-terminated, COOH-terminated, or a NR4+-
terminated probe. (A) CH3-terminated probe with a CH3-modified surface, (B) COO--terminated probe with 
a primary amine-modified silica NPs, and (C) NR4+-terminated probe with a COOH-modified surface. (A) 
Measured in PBS buffer at pH 7.2, and (B&C) measured in 20 mM phosphate buffers at pH 7.0. Multiple 
(n= 500) F-D curves were recorded over 500 nm × 500 nm areas. 
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concentration and long coating time were needed due to the repulsion of the positively 
charged quaternary amine.  
 
3.3.3 Virus surface probing by CFM 
 
A virus surface is heterogeneous, containing hydrophobic and charged patches. 
On the virus surface, the ratio of aliphatic amino acids such as valine, leucine, isoleucine, 
and methionine to aromatic amino acids such as phenylalanine, tyrosine, and tryptophan 
determine the net hydrophobicity of the virus [48]. Also, the ratio of protonated 
positively charged groups contributed by lysine, arginine, and histidine to deprotonated 
negatively charged groups contributed by aspartic acid (or aspartate) and glutamic acid 
(or glutamate) determine the net surface charge of the virus [49]. Though several methods 
have been established to evaluate the surface charge virus such as zeta potential [13], 
chromatofocusing [50], chromatography [6, 51], and isoelectric focusing [14], there 
seems to be no universal hydrophobicity measurement for the virus, making it difficult to 
compare among published results. The CFM is capable of detecting the surface chemistry 
of viral capsids at a single particle level with a trace amount of samples ~1500 μL, and 
could be established as a baseline comparison of the surface chemistry between different 
types of viruses.  
Viruses have a higher hydrophobicity as compared to many proteins [6, 51]. Viral 
surface hydrophobicity plays a crucial role in virus removal [1, 52] and purification [53, 
54]. CFM was able to quantify hydrophobic interactions between a CH3-modified AFM 
probe and an immobilized viral particle. This enabled the direct comparison of 
hydrophobicity between different viruses. For the hydrophobicity study, CFM force 
measurements were performed in PBS buffer at pH 7.2.  
 
Table 3.2 Model virus properties. 
 









enveloped Parvoviridae ssDNA 18-26 ~5.0 
B-19 human 





Enveloped Flaviviridae ssRNA 40-60 ̶ Hepatitis C [41, 43] 
 
Non-enveloped PPV and enveloped BVDV were selected to explore virus surface 
chemistry with CFM. Some of their properties can be found in Table 3.2. The adhesion 
of PPV and BVDV to a hydrophobic probe are shown in the top graphs of Figure 3.5. In 
Figure 3.5, all the histograms were summarized and the mean forces were calculated 
based on the adhesion forces from 500 recorded F-D curves with at least three separate 
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combinations of probe/virus samples. The results are found in Table 3.3. PPV showed a 
higher adhesion force than BVDV, indicating that PPV is more hydrophobic than BVDV. 
One possible reason may be that the enveloped BVDV contains glycolipids with 
hydrophilic heads [56]. Thus, PPV might prefer to adsorb to more hydrophobic surfaces 
than BVDV. If PPV and BVDV are model viruses used in virus clearance studies, with 
an understanding of the viral surface hydrophobicity, we can better design a process that 
will retain multiple viruses in different pools than the protein product. 
 
 





CH3 272 pN 118 pN 
COO- 0 pN 0 pN 
NR4+ 570 pN 304 pN 
 
Most viruses carry a negative charge under physiological conditions due to the 
viral isoelectric point (pI) typically being below pH 7 [9]. Viral surface charge plays a 
key role in controlling virus adsorption and aggregation. AFM probes terminated with 
negatively charged COO- groups and positively charged NR4+ groups were used to 
 
Figure 3.5 Adhesion histograms and representative force-distance curves (retraction only) of virus with a 
CH3-terminated, COO--terminated, or a NR4+-terminated probe, recorded in PBS at pH 7.2 (for 
hydrophobicity measurement) or 20 mM phosphate buffers at pH 7.0 (for surface charge measurement). 
Multiple (n= 500) F-D curves were recorded over 500 nm × 500 nm areas. (Virus images were created in 
BioRender) 
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measure the surface charge of PPV and BVDV. To explore the electrostatic interactions 
of viral surface, viruses were studied in a low ionic strength buffer since high salt 
concentration will shield electrostatic interactions. The electrostatic attractions between 
the surface of viruses and charged chemical modified AFM probes were measured at pH 
7.0.  
The middle graphs in Figure 3.5 show PPV adhesion to a negatively charged 
COO- probe. Almost no adhesion was observed at pH 7.0. In the complementary 
experiment with the positively charged NR4+ modified AFM probe, strong adhesion was 
observed for PPV at pH 7.0 (the bottom of Figure 3.5 and Table 3.3). Similar force 
measurements were performed for the enveloped virus BVDV, as shown in Figure 3.5. 
Similar adhesion phenomena were observed for probing the surface charge of BVDV. 
However, the mean electrostatic force collected for BVDV was smaller than PPV. More 




Our covalent virus immobilization method can retain a natural form of the virus 
without deformation or disassembly. Our AFM probe functionalizing method of thiol 
attachment to gold-coated probes can be achieved at room temperature and allows the 
attachment of many chemical functional groups of interest. With the immobilized virus 
and functionalized AFM tips, we have studied viral surface chemistry with trace amounts 
of sample using CFM. We determined that PPV is more hydrophobic than BVDV using a 
methyl-terminated AFM probe. When charged groups were put on the AFM probes, the 
surface charge of the virus could be measured. Both PPV and BVDV carry a negative 
charge at neutral pH. 
The CFM can detect the surface chemistry of viral capsids at a single particle level 
and enable the comparison of the surface chemistry between different types of viruses. 
Another appealing advantage of CFM to determine the virus surface chemistry over other 
methods is the amount of virus used in this study is very low, reducing the high cost of 
producing biological samples. With a thorough understanding of virus surface chemistry, 
future virus purification and removal techniques could be significantly improved to 
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The characterization of virus particles traditionally takes place at the molecular 
level using genetic manipulation of viral capsid proteins to understand individual amino 
acid interaction [1, 2] or in bulk by characterization of viral solutions [3, 4]. However, 
there is an intermediate scale at the single-particle level [5, 6] that is missing. Measuring 
the variability in a viral population at the single-particle level could help explain or more 
accurately measure infectious to noninfectious particle ratios [7], thus improving our 
understanding of the virus infection cycle. Single-particle methods could also provide 
insight into the ratio of empty to full capsids in gene therapy manufacturing [8], thus 
providing a quick quantitation of the quality of a gene therapy preparation for human use.  
In addition, the virus surface charge can be used to evaluate the adhesion forces between 
the virus and a target substrate to predict the likelihood of virus attachment to a charged 
surface [9]. The surface charge can be used to design virus removal filters based on 
electrostatic adsorption [10, 11] and to eliminate empty virus capsids that lack nucleic 
acids during packaging from full virus particles by anion exchange chromatography for 
gene therapy purification [12]. 
One important surface characteristic is the virus surface charge, most often 
characterized by the isoelectric point (pI). The pI corresponds to the pH where the net 
charge on the virus particle is zero [13]. Although the net surface charge is zero, due to 
the large size of viruses, there are many charged patches distributed on the viral surface at 
the pI. The excess of protonated or deprotonated functional groups of the charged amino 
acids highly contributes to the net surface charge of viruses. The surface charges of viral 
capsid proteins at a certain pH based on the dissociation constants of charged residues 
can be used for calculation of the virus pI using the Henderson-Hasselbalch equation 
[14]. Like any other charged particle, when a charged virus particle is in liquid, an 
electrical double layer will form around the virus particle comprising of a Stern layer, 
which is a rigid layer of counter-ions first attached to the charged particle, and a diffuse 
layer, which is a loose outer layer of free ions in liquid attracted to the Stern layer [15]. 
The surface charge of the virus particle measured here is the charge at the slipping plane, 
which is the outer edge of the diffuse layer of the virus particle. Thus, the surface charge 
of the virus particle is a function of pH and ionic strength of the fluid. 
Various characterization methods have been employed to determine the pI of 
virus particles. Zeta potential, as a measure of surface charges of virus particles at the 
slipping plane, requires a high concentration of purified virus particles and is affected by 
the ionic strength of solutions and different virus purification methods [4, 16]. Isoelectric 
focusing is an electrophoretic technique based on the separation of virus particles, 
according to their pI [17]. Isoelectric focusing typically requires long and complicated 
experimental steps, and it is limited by the low solubility of virus particles [17, 18]. 
Cross-partitioning can be measured using an aqueous two-phase system (ATPS) [19, 20]. 
An ATPS cross-partitioning method containing charged poly(ethylene glycol) (PEG) was 
used to measure the pI of various groups of Streptococci and Staphylococci bacteria [19], 
and it has the potential to measure the pI of virus particles. However, zeta potential, 
isoelectric focusing, and cross-partitioning methods are limited by the purity of virus 
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samples [21] and solution conditions [4, 16, 19]. Both zeta potential and cross-
partitioning methods require a large number of purified virus samples. An inexpensive, 
robust, and reliable single-particle method to characterize the virus surface charge is 
needed. 
A novel surface characterization method known as chemical force microscopy 
(CFM) [22], which uses an atomic force microscope (AFM), has the potential to measure 
single virus particle surface chemistry. CFM measures the chemical interactions between 
a functionalized AFM tip and a sample. CFM has been reported to explore the surface 
charge of a single Saccharomyces cerevisiae cell [23] and to measure the pI values of 
various proteins: bovine serum albumin, myoglobin, fibrinogen, and ribonuclease with 
trace amounts of protein samples [24]. CFM has also become popular to measure the 
interactions between biomolecules, such as specific antibody-antigen interaction [25], 
protein-protein interaction [26], and ligand-receptor interaction [27]. One significant 
advantage of CFM over other microscopy methods for virus surface characterization is 
that the measurement can be performed in physiological aqueous solutions without 
disturbing the natural state of the virus [28]. In addition, CFM uses a small amount of 
biological samples [24], which can overcome the disadvantage of bulk characterization 
methods that can consume a large number of purified virus samples. CFM is therefore 
less expensive and is not reliant on the purification method since contaminant proteins 
will not interfere with the measurement. 
In this research, we used modified AFM probes functionalized with either a 
positive or negative charge to determine the viral pI using CFM. We validated the CFM 
by comparing the pI of non-enveloped porcine parvovirus (PPV) with its known pI value. 
CFM also determined the pI of enveloped bovine viral diarrhea virus (BVDV), which 
does not have a literature-reported pI value. The bulk measurements of zeta potential and 
ATPS were used as a comparison of the virus pI. Most of the bulk measurements were in 
good agreement with the pI values determined by CFM, but it required significantly more 
viral samples to complete. We also compared our experimental data to computationally 
calculated virus electrostatic surface property data. The CFM can detect the surface 
charge of viral capsids at a single-particle level, and it can enable the comparison of the 
surface charge between different types of viruses or subpopulations of different virus 
samples. With a thorough understanding of the virus surface charge, the understanding of 











4.2 Experimental section 
 
4.2.1 Materials.  
 
Sodium phosphate monobasic monohydrate (ACS grade, 98.0-102.0%), 
poly(ethylene glycol) (PEG, average MW: 12 kDa), and sodium chloride (ACS grade, ≥ 
99.0%) were a gift from MilliporeSigma (Burlington, MA). Sodium phosphate dibasic 
heptahydrate (ACS grade, 98.0-102.0%), citric acid monohydrate (ACS grade, ≥99.0%), 
sodium citrate tribasic dihydrate (ACS grade, ≥ 99.0%), 12-mercaptododecanoic acid 
(HS (CH2)11COOH, 96%), 1-dodecanethiol (HS(CH2)11CH3, ≥ 98%), 11-
mercaptoundecyl-N,N,N-trimethylammonium bromide (HS(CH2)11N(CH3)3Br), primary 
amine (NH2)-functionalized silica nanoparticles (nanoparticles <30 nm (DLS)), and 
sodium hydroxide (NaOH, ACS grade, ≥ 97.0%) were purchased from Sigma-Aldrich 
(St. Louis, MO). N-hydroxysulfosuccinimide (NHS) and 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride (EDC) were purchased from Thermo 
Fisher Scientific (Waltham, MA). Phosphate-buffered saline (PBS) (pH 7.2) was 
purchased from Life Technologies (Grand Island, NY). Thiazolyl blue tetrazolium 
bromide (MTT) (98%) was purchased from Alfa Aesar (Haverhill, MA). Sodium dodecyl 
sulfate (SDS) was purchased from VWR (Radnor, PA). Hydrochloric acid (HCl, ACS 
grade, 36.5-38.0%) was purchased from Fisher Scientific (Pittsburgh, PA). All aqueous 
solutions or buffers were prepared using purified water with a resistivity of ≥18 MΩ·cm 
from a Nanopure filtration system (Thermo Scientific) and filtered with a 0.2 µm bottle 
top filter or a 0.2 µm syringe filter (VWR) prior to use.  
 
4.2.2 Buffers.  
 
Citrate buffer (CB) solutions with different pH (3.0–6.0) were prepared by mixing 
different volume percentages of 20 mM stock solution of citric acid and sodium citrate 
tribasic. Phosphate buffer (PB) solution at pH 7.0 was prepared by mixing 20 mM stock 
solution of sodium phosphate monobasic and sodium phosphate dibasic. The final pH 
was adjusted with 1 M NaOH or HCl, as needed, and it was measured with a Fisherbrand 
Accumet AE150 benchtop pH meter (Hampton, NH) with a 3-in-1 single-junction gel 
pH/ATC probe (cat. 13-620-AE6) calibrated using the manufacturer’s instructions.  
 
4.2.3 Virus production, purification, and titration.  
 
Porcine kidney cells (PK-13, CRL-6489) were purchased from ATCC. Porcine 
parvovirus (PPV) strain NADL-2 was a gift from Dr. Ruben Carbonell (North Carolina 
State University, Raleigh, NC). PPV was propagated in PK-13 cells, as described 
previously [29], and stored at −80ºC. Bovine turbinate cells (BT-1, CRL-1390) were 
purchased from ATCC, and bovine viral diarrhea virus (BVDV) strain NADL was 
purchased from USDA APHIS. BVDV was propagated by infecting 80% confluent flasks 
of BT-1 cells with 105 MTT50/mL of the virus in PBS and collecting the virus released 
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into the media after 72 h. The BVDV had 10 v/v% glycerol added before storing it at 
−80ºC.  
For purification of PPV or BVDV [30], the virus was first dialyzed using a 
Biotech Cellulose Ester 1,000 kDa dialysis tubing (Rancho Dominguez, CA) at 4°C for 2 
days with two buffer exchanges of 20 mM PB. The dialyzed virus was further purified 
with a BioRad Econo-Pac 10DG desalting column (Hercules, CA).  
Both types of viruses were titrated with a cell viable MTT assay [29]. Briefly, 
either 8 x 104 cells/mL PK-13 cells (to titrate PPV) [31] or 2.5 x105 cells/mL BT-1 cells 
(to titrate BVDV) [32] were seeded into a 96-well plate in a volume of 100 µl/well. After 
a 24 h incubation, 25 µl/well of the virus sample was added to the corresponding host 
cells in quadruplicate, and it was serially diluted across the plate. After 6 days, 10 
μL/well of 5 mg/mL MTT salt in PBS (pH 7.2) was added to the plate. After 4 h, this was 
followed by the addition of 100 μL/well of the solubilizing agent, consisting of 10 w/v% 
SDS in 0.01 M HCl (pH 2.5). Plates were read for absorbance at 550 nm on a Synergy 
Mx monochromator-based multimode microplate reader (Winooski, VT) 12-20 h after 
the solubilizing agent addition. The virus dilution that killed 50% of the cells is stated as 
the virus titer MTT50. The concentrations of purified virus solutions were determined by 
the MTT assay to be 1×108 MTT50/mL for PPV and 1×107 MTT50/mL for BVDV. 
 
4.2.4 Virus samples and control surfaces preparation. 
 
A diced glass slide (1 in. × 1 in. × 1 mm) was coated with a 5 nm thick chromium 
layer followed by a 30 nm gold layer using a Perkin-Elmer Randex sputtering system 
(Model 2400, Waltham, MA). The gold-coated slide was soaked in a glass Petri dish 
containing 14 mL of a 1:1 solution of 2 mM solution of HS(CH2)11COOH and 
HS(CH2)11CH3 in ethanol for 12 h, rinsed with ethanol, and then air-dried in a chemical 
hood. The surface was then equilibrated with 14 mL of Nanopure water for 15 min. A 
total of 0.5 mL of an equal volume mixture of 0.1 M NHS and 0.4 M EDC was added to 
the surface for 30 min, and it was then washed and incubated with PBS (pH 7.2) for 2 
min. A 0.5 mL of purified PPV or BVDV or positively charged control NH2-
functionalized silica nanoparticles was applied to the surface for 30 min. Finally, the 
surface was rinsed three times with Nanopure water and soaked in 14 mL of 20 mM CB 
(pH 3.0-6.0) or PB (pH 7.0) at the desired pH and stored at 4°C. The negatively charged 
control carboxyl acid-modified surface was prepared in the same manner except the 
solution contained pure HS(CH2)11COOH. The controls were used for testing the 
chemistry of virus immobilization and probe functionalization. 
 
4.2.5 AFM probe functionalization.  
 
Negatively charged AFM probes were prepared by incubating the gold-coated 
Bruker AC-40 AFM probe (~0.1 N/m) in a 4 mM solution of HS (CH2)11COOH in 
ethanol for 24 h, rinsed with ethanol, and air-dried in a chemical hood. Similarly, the 
positively charged AFM probe was prepared by immersing the NT-MDT GSG10/Au 
AFM probe (~0.1 N/m) in a 10 mM solution of HS(CH2)11N(CH3)3Br in ethanol for 48 h, 
87 
rinsed with ethanol, and air-dried in a chemical hood. Functionalized probes were used 
immediately after they were prepared. 
 
4.2.6 AFM imaging, force measurement, and analysis. 
 
All AFM experiments were performed at room temperature on a Bruker 
Dimension ICON AFM with the ScanAsyst system (Santa Barbara, CA). AFM 
topographic images were obtained using tapping mode in PBS with a Bruker ScanAsyst 
Fluid+ silicon nitride AFM probe or a NT-MDT GSG30 AFM probe. AFM force 
measurements were made in peak force tapping mode or contact mode. The spring 
constant of the modified AFM probe was calibrated before the force measurement by 
using the thermal noise method [33]. More than 500 force-distance (F-D) curves were 
collected with at least three separate combinations of probe/virus samples. All F-D curve 
measurements between modified probes and viral surfaces were performed in either 20 
mM CB solutions at the desired pH or in a 20 mM PB at pH 7.0. The control experiments 
were carried out in 20 mM PB at pH 7.0. Data analysis was performed with the Bruker 
Nanoscope Analysis software. To determine the pI of the virus, the mean adhesion force 
from 500 F-D curves was plotted as a function of pH and fit to a sigmoidal curve [34] 





                                                                                                     (4.1) 
where Y is the adhesion force, x is the pH, and x0 is the pI. yf is the maximum adhesion 
force, and the rate constant for the change of the mean adhesion force is given by 1/τ. 
 
4.2.7 Zeta potential measurement.  
 
Purified PPV or BVDV was diluted 1:10 in either 20 mM CB at the desired pH or 
20 mM PB solutions at pH 7.0. The zeta potential was measured with a Malvern 
Zetasizer Nano ZS (Worcestershire, U.K.). Measurements were performed at 25°C using 
a capillary zeta cell (750 μL) with an equilibration time of 2 min. Three measurements of 
10-100 runs were carried out using the automatic option.  
 
4.2.8 ATPS measurement.  
 
A stock solution of 33 w/w% PEG 12 kDa and 30 w/w% citrate at pH 4.5-6.5 was 
used to prepare the ATPS. The total system size was 1 g, at a final concentration of 15 
w/w% PEG, 14 w/w% citrate, and 0.1 g of purified PPV, at various pH values [35]. The 
systems were mixed with a vortex and subjected to 12,300 ×g for phase separation in an 
ST16R centrifuge (Thermo Scientific) at 21°C for 5 min. The top (PEG-rich) and bottom 
(citrate-rich) phases were collected for further virus titration. The partition coefficient (K) 
was calculated as, 
𝐾𝐾 =  𝑉𝑉P ∗ 𝑇𝑇P
𝑉𝑉C ∗ 𝑇𝑇C   
                                                                                                        (4.2) 
where V is the volume of the PEG-rich phase (P) or citrate-rich phase (C) and T is the 
titer of PPV in either phase expressed as MTT50/mL. 
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4.2.9 Theoretical calculation of virus surface potential and pI.  
 
The pI of the virus by an amino acid sequence was calculated by an online protein 
isoelectric point calculator (http://isoelectric.ovh.org) [36], using the theoretical average 
value from 16 methods. The amino acid sequence was from the UniProt Knowledgebase 
(UniProtKB) [37]. 
The surface potential of the virus was calculated from the protein crystal structure 
using the protein contact potential in PyMOL [38]. Each protein crystal structure was 
from the Protein Data Bank (PDB) based on its corresponding ID. The electrostatic 
potential map of the virus surface based on its overall surface charge distribution was also 
created in PyMOL, and it was applied on the protein surface by calculating the 
electrostatic potential in a vacuum and using the protein contact potential [38]. 
 
4.3 Results and discussion 
 
4.3.1 Surface and probe preparations.  
 
The first step was to prepare the surface and AFM probes needed for CFM 
measurements. Probe modifications using gold-coated AFM tips are common [23, 39], 
and the modifications used are shown in Figure 4.1A. However, a new method to attach 
the virus was needed. One of the common characterizations of the virus with an AFM is 
nanoindentation [5, 40, 41]. Nanoindentation is typically conducted by depositing the 
virus on a gold surface and pushing on the virus. We were concerned that if we deposited 
the virus on gold and then pulled on it, we would not be confident if the bond that broke 
during the measurement was the tip-virus interaction or the gold-virus interaction. 
Therefore, we decided to covalently bond the virus to the surface, as shown in Figure 
4.1B. We created a mixed surface with terminated carboxylic acid and methyl groups, 
and we used NHS/EDC chemistry to covalently bond the virus to the carboxylic acid 
groups [42, 43]. The mixed surface was designed to increase the spacing of the viral 






Non-enveloped PPV and enveloped BVDV were successfully immobilized to the 
surface. Topographic images and corresponding height analysis, as shown in Figure 4.2, 
confirmed that the virus immobilization method retained a natural form of the virus 
without deformation or disassembly. It is common to use height as a confirmation of no 
modification or deformation of the viral particles [44, 45]. A total of 18 viral particles 
from three purified batches for PPV and BVDV were measured with topographic images. 
PPV had an average height of 23 ± 3 nm, and BVDV had an average height of 46 ± 8 nm. 
Confirmation of the viral envelope prior to attachment and zeta potential measurements 
was confirmed by the ability of BVDV to infect cell culture and by transmission electron 
microscopy (TEM) images (SI Figure A.1.1). 
The quality of the topographic images was limited. It is possible that the length of 
the bifunctional linker used to immobilize the virus particles created a soft surface that 
resulted in the blurred edges in the virus particle images. To obtain higher-quality 
topographic images for PPV and BVDV in liquid, the virus particles were deposited onto 
a gold surface without covalent bonding, as shown in SI Figure A.1.2A&B. The blurred 
fringes of virus particles were greatly reduced in these improved conditions. A total of 
nine viral particles from two purified batches for PPV and BVDV were measured. PPV 
had an average height of 18 ± 3 nm, and BVDV had an average height of 30 ± 2 nm. 
Viruses on gold had a smaller size than those covalently attached to the surface. This 




Figure 4.1 Overview of AFM probe functionalization and virus immobilization on a gold surface. (A) 
AFM probes were functionalized with either a negatively charged carboxyl acid group or a positively 
charged quaternary amine group and (B) virus particles were immobilized with NHS/EDC chemistry. 
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Controls were conducted to confirm that the virus immobilization method was 
required. Figure 4.2C shows that positively charged primary amine-functionalized silica 
nanoparticles were successfully immobilized with the NHS/EDC method, and the size of 
15 ± 4 nm was measured with the AFM for 18 particles from three different 
immobilization trials. The size was the same as given by the manufacturer. In addition, 
we found that the negatively charged SAM-COOH-modified surface had a surface 
roughness of 3 nm, as shown in Figure 4.2D. This is the same roughness as was found 
for the bare gold surface with the NHS/EDC control (SI Figure A.1.2C). The need for 
the NHS/EDC addition is shown in SI Figures A.1.2D&E, where very little PPV and no 
BVDV could be found when the NHS/EDC step was removed from the protocol. 
Probe functionalization was confirmed by verifying the charge on the probe. The 
negatively charged carboxyl-terminated probe (COO-) interacted with the positively 
charged silica nanoparticles at pH 7.0 (SI Figure A.1.3A). No adhesion forces could be 
detected on the negatively charged COO--modified control surface at pH 7.0 (data not 
shown). For the positively charged quaternary amine-terminated probe (NR4+), strong 
adhesion was found when interacting with the negatively charged COO- control surface at 
pH 7.0 (SI Figure A.1.3B). No adhesion forces could be detected between the positively 




Figure 4.2 Topographic image and corresponding height analysis of viruses and controls. (A) PPV, (B) 
BVDV, (C) NH2-functionalized silica NPs, and (D) carboxylic acid-modified surface. 
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4.3.2 Virus pI using CFM.  
 
Most viruses carry a negative charge under physiological pH due to the pI of the 
virus typically being below 7 [13]. As a proof of concept that CFM can measure the pI of 
viral capsids, the non-enveloped virus, PPV, and the enveloped virus, BVDV, were 
selected to explore the virus surface charge. Some of their physical properties can be 
found in Table 4.1. PPV has a literature-reported pI of 5.0, measured by isoelectric 
focusing [18]. No pI information could be found for BVDV.  
 
 
Table 4.1 Model virus properties. 
 









enveloped Parvoviridae ssDNA 18-26 ~5.0 
B-19 human 





Enveloped Flaviviridae ssRNA 40-60 ̶ Hepatitis C [47, 48] 
 
 
AFM probes terminated with either COO- or NR4+ were used to measure the 
surface charge of each virus. To provide maximum electrostatic interactions while still 
maintaining pH control, low ionic strength buffers at 20 mM concentration were used. 
Figure 4.3A shows the adhesion of PPV to the negatively charged COO--modified AFM 
probe as a function of pH. One representative F-D curve (retraction only) is shown for 
each pH, and they changed shape across different pHs. The overall histogram shape also 
changed as a function of pH. The strongest adhesion forces were observed at pH 3.0, 
compared with almost no adhesion being observed at pH 6.0.  
In a similar experiment with the positively charged NR4+-modified AFM probe, 
the opposite adhesion trend was observed (Figure 4.3B). The strongest adhesion force 
was present at pH 6.0, and the adhesion force decreased with a decrease in pH. The 






The adhesion force data for PPV as a function of pH are summarized in Figure 
4.4A and 4.4B. All of the adhesion forces are the mean values, which were calculated 
from 500 recorded F-D curves with at least three separate combinations of probe/virus 
samples at each pH. To determine the pI of PPV, the experimental data were fitted to a 
sigmoidal curve described by Eq. 4.1, and the pI was determined to be the inflection 
point of the fitted curve. The inflection point was chosen because other measurements of 
pI for biological molecules, with respect to pH, often show an inflection point at the pI. 
This includes zeta potential curves [4, 49], ATPS [20], and CFM for proteins [24]. The 
inflection point for PPV was found at 5.1 for the COO- probe. Similarly, the inflection 
point for the NR4+-modified probe was 4.8. Therefore, the pI of PPV is 4.8-5.1, as 
determined by CFM. This is similar to the literature-reported pI of 5.0 for PPV [18].  
Bulk methods were also used as a comparison to the CFM results. The zeta 
potential for PPV shifted from negative to positive at pH 4.0, as shown in Figure 4.4C, 
thus giving a pI of 4.0. The pI value of PPV was also estimated by a nontraditional bulk 
method, ATPS cross-partitioning [20]. The partitioning of PPV in a PEG-citrate system 
was measured at different pH values. The virus particles remained in the citrate-rich 
phase, comprising of negatively charged citrate ions when the virus had a positive charge. 
Moreover, the virus particles repelled the negatively charged citrate ions when the virus 
became negatively charged, and therefore partitioned to the PEG-rich phase. The pI of 
PPV was estimated as 5.4 by ATPS cross-partitioning. Figure 4.4D shows that the viral 
particles mostly partitioned to the citrate-rich phase at a pH < 5.4. At a pH > 5.4, the 
majority of the virus could be found in the PEG-rich phase. However, the cross-
partitioning of the virus particles is not purely dependent on the charge repulsion from the 
 
Figure 4.3 Adhesion histograms and representative F-D curves (retraction part) of PPV with a COO--
terminated probe (A) or a NR4+-terminated probe (B), recorded in 20 mM citrate or phosphate buffers of 
varying pH. Multiple (n= 500) F-D curves were recorded over 500 nm × 500 nm areas. 
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citrate-rich phase. The net partitioning in either phase is driven by a synergistic effect of 
charge repulsion from the citrate-rich phase and hydrophobic interaction from the PEG-
rich phase [35, 50].  
 
 
The pI values estimated by the two bulk methods for PPV both have a larger shift 
from the literature-reported pI value 5.0 by isoelectric focusing [18], as compared to 
CFM. Zeta potential and cross-partitioning methods are bulk measurements. Zeta 
potential has been shown to be limited by the purity of virus samples [21]. Contaminating 
proteins present in the virus solutions can affect the measured pI result. For cross-
partitioning measurements, there are several driving forces that dictate the partitioning of 
biomolecules [35, 51, 52]. The measurement is not purely a measurement of charge. 
However, the single-particle CFM precisely targets individual virus particles, and it is not 
affected by contaminant proteins. In addition, the amount of the virus used in CFM is as 
low as that used in isoelectric focusing. However, isoelectric focusing is limited by the 
low solubility of virus particles [17, 18], making it difficult to obtain measurements for a 
variety of viral species.  Herein, we have demonstrated that the CFM method is a reliable 
method to measure the pI of PPV since the pI determined by CFM is correlated with the 
pI values of PPV by other characterization measurements.  
Similar force measurement experiments were performed for the enveloped 
BVDV. The BVDV data can be found in SI Figure A.1.4. Similar adhesion trends were 
observed for BVDV as was found for PPV. The pI value of BVDV is estimated to be 4.3-
4.5 by CFM, and it is shown in Figure 4.5A&B. The pI by CFM was in good agreement 
with the pI value determined by zeta potential at pH 4.2 (Figure 4.5). The zeta potential 
correlated better to the CFM results for BVDV than PPV might be due to less 
 
Figure 4.4 PPV pI determination using a variety of methods. (A) CFM with the COO- probe, (B) CFM 
with the NR4+ probe, (C) zeta potential, and (D) ATPS. The CFM data were fit to a sigmoidal curve. Error 
bars are the standard deviation of three separate experiments. *p<0.01 using Student’s t-test. 
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contaminated proteins existed in purified BVDV samples, but we did not test the 
contaminated protein levels in either virus preparation. The infectivity of both viruses 
was confirmed prior to zeta potential measurements, confirming the structural integrity of 
each virus and the presence of an envelope for BVDV. 
 
 
The ATPS cross-partitioning method was unable to evaluate the pI value of 
BVDV. ATPS contains high concentrations of salt and polymer, likely producing a high 
osmotic shock to the viral particles that could cause structural deformations of the BVDV 
envelope [53]. This was measured by a large reduction in the BVDV viral infectivity 
after contact with the ATPS solutions. Enveloped viruses are more susceptible to 
structural damage by osmotic stress as compared to non-enveloped viruses. Hence, the 
ATPS cross-partitioning method is not applicable to all types of viruses. 
 
 
4.3.3 Comparison to theoretically calculated virus pI and surface potential. 
 
Two methods were used to calculate the electrostatic surface properties of model 
viruses. The first method used the entire amino acid sequence to predict the pI of the 
virus by the Henderson-Hasselbalch equation [14]. This is a common method to calculate 
protein pI [36, 54, 55]. However, it does not take into account protein folding. Only the 
surface amino acids actually contribute to the experimental pI, whereas all amino acids, 
even ones that are buried, contribute to the calculated pI. For the second method used, 
only the surface amino acids for one viral surface protein were calculated to determine 
the electrostatic surface property of the virus [38]. A similar method was used to 
determine the hydrophobicity of a virus, as compared to proteins [56]. The electrostatic 
surface potentials of the viruses tested here are based on the surface maps shown in SI 
Figure A.1.5. The electrostatic surface property did not directly report a pI, but it can be 
used to compare the general trends of the experimental pI by CFM, the calculated pI 
based on the entire amino acid sequence, and the surface potential of only the surface 




Figure 4.5 BVDV pI determination using two methods. (A) CFM with the COO- probe, (B) CFM with the 
NR4+ probe, and (C) zeta potential. The CFM data were fit to a sigmoidal curve. Error bars are the standard 
deviation of three separate experiments. *p<0.01 and +p<0.05 using Student’s t-test. 
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Table 4.2 Computational electrostatic surface properties of the model virus vs. CFM-determined pI. 
 
































^Calculations based on entire amino acid sequence [256] 
+ Calculations based on surface amino acids [258] 
*This work 
 
The sequence of the VP2 capsid protein in PPV was used to calculate the 
theoretical pI and the electrostatic potential, and the results are shown in Table 4.2. PPV 
has an icosahedral capsid containing viral proteins (VP) 1, 2, and 3 [57]. VP2 is the major 
coat protein, and composes 80% of the viral capsid [57]. Virus-like particles 
spontaneously form when only VP2 is expressed. Therefore, the crystal structure of VP2 
was used in this work.  
For enveloped viruses, the pI is affected by both the lipid and glycoprotein 
content in the envelope. In our current calculations, we are disregarding the contribution 
of the lipid bilayer. Three structural glycoproteins are embedded into the BVDV 
envelope, Erns, E1, and E2 [59]. E2 is the major envelope protein located on the outer 
surface of the BVDV, and it plays a key role in virus attachment and entry to host cells 
[60]. Thus, E2 was used for the BVDV computational electrostatic surface property 
calculations. 
In the case of PPV and BVDV, the calculation of the pI for both viruses shifted to 
a higher pH as compared to the experimental CFM values, as shown in Table 4.2. It is 
possible that the nucleic acids inside the virus capsid could reduce the pI [49, 61]. 
However, the general trends are not the same for the experimental and calculated pIs, as 
BVDV has a higher calculated pI than PPV. When the surface charge is calculated by the 
electrostatic surface potential, the trend holds the same as the calculated pI, where BVDV 
has a higher pI than PPV. However, this simple calculation does not take into account 
chemical modifications (e.g., amino acids phosphorylated or acetylated) that are often 
observed [62]. For the enveloped virus, the level of cholesterol affects the surface charge. 
It has been shown that increasing the level of cholesterol in a lipid bilayer reduces Na+ 
binding to lipid head groups, thus reducing the surface charge of the membrane [63]. This 
may explain why enveloped BVDV, which is cholesterol-rich [59], has lower adhesion 
forces measured by CFM than that of non-enveloped PPV at pH 3 by the COO- probe and 
at pH 7 by the NR4+  probe (comparing Figures 4.4 & 4.5). The pI values calculated by 
theoretical methods do not correlate well with the pI values determined experimentally, 
which is mainly due to that the electrostatic surface properties of viruses are not purely 
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determined by the surface capsid proteins. Virus particles are much more complex 
systems, and the theoretical calculations do not take into account the effects of the amino 
acids and the virus envelope. For these reasons, we need to determine the pI values of 
viruses by the experimental CFM method. 
CFM can detect the electrostatic surface properties of viral capsids at a single-
particle level. Another benefit of using CFM to determine the virus pI is the amount of 
the virus used in this study is as low as ~150 μL at a titer of 108 MTT50/mL. As is known, 
virus samples can be expensive. CFM allows the study of virus surface charge with small 
amounts of samples, as has been demonstrated as an advantage of CFM for proteins [24]. 
This single-particle technique could improve our understanding of the virus infection 
cycle, quantify the quality of a gene therapy preparation for human use, and improve 




We have used functionalized AFM tips to study viral electrostatic surface 
properties with small amounts of sample. We chose to covalently attach the virus to a 
gold surface to guarantee that the bond that is broken during CFM is the virus-tip 
interaction and not the virus-surface interaction. This attachment method maintained a 
natural virus state without deformation or disassembly. The adhesion force as a function 
of pH was a good fit for a sigmoidal curve, which allowed the determination of the 
inflection point as the pI of the virus. CFM determined the pI of PPV to be 4.8-5.1 and 
BVDV to be 4.3-4.5. PPV had a literature-reported pI of 5.0, and BVDV did not have a 
literature-reported pI. The pI values determined by CFM are in good agreement with 
most of the pI values determined by the bulk measurements of zeta potential and ATPS.  
CFM can detect the surface charge of viral capsids at a single-particle level, and it 
can enable the comparison of the surface charge between different types of viruses. Virus 
particles are much more complex systems than surface capsid proteins, and the 
theoretical calculations done here did not provide an accurate measure of the virus 
surface pI due to effects not taken into account, like amino acid modifications and the 
viral envelope. Therefore, we need to determine the pI of viruses experimentally. With a 
thorough understanding of virus surface chemistry, future technologies in areas of 
biosensing, vaccines, gene therapy, and targeted drug delivery could be significantly 
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The novel properties of gold nanoparticles (AuNPs) can be harnessed to create 
specialized sensors for biomolecules.1-3 One class of biomolecule that has shown great 
promise for AuNPs detection are viral particles.4-6 Viruses are unique colloids that consist 
of a protein capsid shell that encapsulate nucleic acids and may be surrounded by a lipid 
bilayer. Most commonly, the capsid proteins or nucleic acids are the biochemical targets 
for direct virus detection.7-10 Virus can be detected with lateral flow assays, in which the 
AuNPs function as direct coloring,11-12 or through the aggregation of the AuNPs.3, 10, 13-14 
While these are promising methods for disease detection of specific viral infections, there 
is a need to detect the presence of infectious virus particles without being virus specific. 
In one case, blood transfusions in Africa are commonly tested for only three different 
viruses, HIV, hepatitis B and hepatitis C,15 whereas in the US, blood donations are tested 
for at least seven different viruses.16 A general virus detection method could alleviate the 
need for low resource countries to test for specific viruses in blood donations. The goal is 
not a disease diagnosis, but the general safety of the blood supply. 
Another application could be the evaluation of the cleanliness of a surface. One 
example would be the elimination of norovirus after a cruise ship outbreak. According to 
the Centers for Disease Control and Prevention (CDC), norovirus causes about 20 million 
people in the US to have acute gastroenteritis each year17 and the virus can be transmitted 
through contact with contaminated food, water or surfaces. A rapid and inexpensive virus 
detection method could alleviate many of these transmissions through the testing of 
surface cleanliness. 
AuNPs are widely used as a colorimetric detection mechanism due to their unique 
surface plasmon resonance (SPR) property. A strong optical absorbance peak of AuNPs 
is dependent on the size of AuNPs and also highly sensitive to inter-particle separations. 
Aggregation of AuNPs results in a red-shift and peak broadening of the ultraviolet-visible 
(UV-Vis) absorption spectrum and an obvious color change from red to dark blue or 
gray.18-19 However, this type of detection is not sensitive to lower degrees of aggregation 
and not suitable for the analysis of colored samples. To overcome the limitations of 
colorimetric assays by UV-Vis detection,20-21 the light scattering properties of AuNPs 
have been used for biomolecule detections.6, 14, 22 Light scattering-based assays have a 
lower limit of detection, up to four orders of magnitude, as compared to UV-Vis 
spectrophotometric-based AuNPs aggregation detection.23 Light scattering methods may 
be required to detect pathogens, which can be infectious at very low concentrations. 
There have been assays developed for the detection of proteins using AuNP 
aggregation. Proteins non-specifically adsorb to AuNPs, creating a protein corona24-25 
through a combination of hydrophobic interactions,26 electrostatic interactions,27 and co-
ordinate binding between the thiol or amino groups of proteins and the AuNPs.28-29 A 
protein concentration assay has been developed by determining the amount of protein 
needed to create a protein corona around an AuNP that will protect the nanoparticle from 
salt-induced aggregation.30 This demonstrates the application of a non-specific 
biomolecule concentration assay using AuNPs aggregation. 
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AuNPs can be easily conjugated with biomolecules, making them a good 
candidate for specific virus detection using antibodies or oligonucleotides. AuNPs 
conjugated with an antibody can sensitively detect the presence of the H3N2 influenza A 
virus with a detection limit of 7.8 hemagglutination units.13 Hepatitis C virus (HCV) 
specific oligonucleotide-functionalized AuNPs were used to quantify HCV RNA in 
clinical samples by AuNPs aggregation with a limit of detection of 4.57 international 
units (IU)/μL.10 However, these systems require an antibody or oligonucleotide that is 
specific to the virus of interest for detection. But what if we need to know if any virus is 
present? To develop a non-specific viral particle assay based on AuNPs aggregation, 
methods to aggregate generic viral particles need to be explored.  
Virus particles can aggregate in a variety of solution conditions through 
manipulation of pH, salt concentration, and osmolyte concentration. Viruses tend to form 
aggregates close to their isoelectric point (pI), where the net charge of the virus surface is 
neutral and the repulsive electrostatic forces on the virus surfaces are the lowest.31 MS2, 
ΦX174, and PRD1 bacteriophage particles formed aggregates when the pH was lowered 
from 7 to near their pI of 4.32 Viruses show different degrees of aggregation depending on 
salt types and concentration. A sodium chloride solution ranging from 0.5-4 M reversibly 
aggregated the hepatitis B surface antigen (HBsAg) virus-like particles (VLPs) into 
oligomeric particles, while 1-2 M ammonium sulfate irreversibly aggregated the VLPs.33  
Osmolytes have been shown to preferentially aggregate both the non-enveloped 
porcine parvovirus (PPV) and enveloped Sindbis virus (SINV) while not aggregating 
bovine serum albumin (BSA) or lysozyme.34-36 The hypothesis of why this aggregation 
occurs is based on the differences between virus and protein surface chemistry. Most 
osmolytes protect proteins from high osmotic stress, resulting in enhanced protein 
stability.37 Osmolytes have a high affinity for water and a low affinity for the protein 
backbone.38-39 Therefore, osmolytes are able to remove water molecules near 
hydrophobic residues on the protein surface.40 To compensate for this change in free 
energy, the protein rearranges into a more compact structure.37 Viruses tend to aggregate 
in this same situation due to two major differences between viruses and proteins: viruses 
have been shown to be more hydrophobic than proteins,41-42 allowing more surface area 
to be dehydrated, and viruses are more rigid than proteins and cannot collapse to 
compensate for the free energy change. In response to the change in free energy, viruses 
aggregate. 
In this study, PPV and bovine viral diarrhea virus (BVDV) were detected by 
comparing the aggregation of virus-coated AuNPs in mannitol solutions and sodium 
chloride solutions to BSA and thyroglobulin-coated AuNPs. PPV and BVDV were 
chosen to demonstrate the robustness of this general virus particle detection assay, as 
PPV is a small non-enveloped virus while BVDV is a larger, enveloped virus. Results 
indicate that virus and protein-coated nanoparticles can be distinguished by a difference 
in aggregate size measured by dynamic light scattering (DLS). Two proof-of-concept 
tests were conducted to determine if PPV could be detected in simulated applications. 
PPV was dried on a surface and then recovered by rubbing the area with a wet cotton 
swab. The reconstituted PPV was quantitatively measured with the developed AuNPs 
aggregation assay. PPV could also be quantitatively detected in different concentrations 
of BSA solution matrix, demonstrating the possible application in testing blood 
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donations. These results indicate that ligand-free AuNPs aggregation may be a promising 
detection method for the presence of viral particles. This nonspecific virus detection 
method is promising for determining the presence of viruses in a blood transfusion 
sample or on a contaminated surface.  
 
 
5.2 Experimental section 
 
5.2.1 Materials  
 
Bovine serum albumin (BSA) (≥98%) and thyroglobulin from porcine thyroid 
gland were purchased from Sigma-Aldrich (St. Louis, MO).  For synthesis of AuNPs, 
gold (III) chloride trihydrate (HAuCl4·3H2O) (≥99.9%) and trisodium citrate (ACS grade, 
≥99.0%) were purchased from Sigma-Aldrich. Potassium phosphate monobasic 
(molecular biology grade, ≥99.0%), sodium phosphate monobasic monohydrate (ACS 
grade, 98.0-102.0%), and sodium chloride (ACS grade, ≥99.0%) were a gift from 
Millipore Sigma (Burlington, MA). Sodium phosphate dibasic heptahydrate (ACS grade, 
98.0-102.0%), D-mannitol (≥ 98%), and glutaraldehyde solution (Grade I, 70% in H2O) 
were purchased from Sigma-Aldrich. Phosphate buffered saline (PBS) (pH = 7.2) was 
purchased from Life Technologies (Grand Island, NY). Thiazolyl blue tetrazolium 
bromide (MTT) (98%) was purchased from Alfa Aesar (Haverhill, MA). All aqueous 
solutions or buffers were prepared using purified water with a resistivity of ≥18 MΩ·cm 
from a Nanopure filtration system (Thermo Scientific, Waltham, MA) and filtered with a 
0.2 µm bottle top filter (VWR, Radnor, PA) or a 0.2 µm syringe filter (VWR) prior to 
use. 
 
5.2.2 Virus titration and purification  
 
Porcine kidney cells (PK-13, CRL-6489) and bovine turbinate cells (BT-1, CRL-
1390) were purchased from ATCC. Porcine parvovirus (PPV) strain NADL-2 was a gift 
from Dr. Ruben Carbonell (North Carolina State University, Raleigh, NC). Bovine viral 
diarrhea virus (BVDV) strain NADL was purchased from USDA APHIS. PPV was 
propagated in PK-13 cells and BVDV was propagated in BT-1 cells. Both PPV and 
BVDV were titrated with an MTT assay, as described previously.43-44 The MTT assay is a 
cell viability assay that can be correlated with viral infectivity. For purification of virus, 
PPV or BVDV was first dialyzed using a Biotech Cellulose Ester 1000 kDa dialysis 
tubing (Rancho Dominguez, CA) at 4°C for two days with two buffer exchanges in 4 mM 
phosphate buffer (pH 7.2). The dialyzed virus was then polished with an Econo-Pac 
10DG desalting column (Hercules, CA).  
 
5.2.3 Synthesis and characterization of AuNPs  
 
The citrate-capped AuNPs were synthesized using the previously established 
citrate reduction method.30 Briefly, a trisodium citrate solution was added to boiling 
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hydrochloroauric acid (HAuCl4) solution and kept boiling for 15 minutes. The boiling 
solution color was observed to turn from pale yellow to purple, followed by the formation 
of deep red AuNPs colloids. The AuNP colloidal solution was cooled to room 
temperature for further characterization.  
The synthesized AuNPs were characterized by UV-Vis absorption spectroscopy, 
dynamic light scattering (DLS), and transmission electron microscopy (TEM). The 
AuNPs solution was transferred into one well of a 96-well plate and the UV-Vis 
absorption spectrum was measured from 400 – 900 nm wavelength with a Synergy Mx 
microplate reader (Winooski, VT). The hydrodynamic diameter and zeta potential of 
AuNPs were measured with a Malvern Zetasizer Nano ZS (Worcestershire, United 
Kingdom). The morphology of the AuNPs was characterized with a JEOL JEM-2010 
TEM (Peabody, MA) at 200 kV. The concentration of the AuNPs was determined by the 
molar extinction coefficient, which is related to the particle diameter, using a previously 
established method.45 The synthesized AuNPs were prepared fresh and kept at room 
temperature until use. The AuNPs were washed once by re-suspending the AuNPs pellet 
into nanopure water after pelleting with an ST16R Centrifuge (Thermo Scientific, 
Asheville, NC) at 7,000 × g for 20 minutes and diluted to a final concentration of 3.5 nM 
for subsequent experiments. 
 
5.2.4 Coating and characterization of virus-AuNPs complexes  
 
Different concentrations of purified PPV, BVDV, BSA, or thyroglobulin were 
added to the 3.5 nM AuNPs for a final concentration of 1.75 nM AuNPs. The coated 
AuNPs were vortexed and rotated end-over-end for 20 hours on a Roto-shake Genie 
rocker (Bohemia, NY) at the maximum rotation speed and then centrifuged at 6,000 × g 
for 20 minutes. The coated AuNPs were characterized by UV-Vis spectroscopy and DLS. 
The coated AuNPs were resuspended in a 1 M mannitol or 1 M sodium chloride solution 
and characterized.  
Prior to detection of coated AuNPs with the Malvern Zetasizer, the virus was 
inactivated according to university biosafety protocols. A quantity 7.14 µL of 70% 
glutaraldehyde solution was added to 1 mL of coated AuNPs before and after osmolyte or 
salt treatment to make the final solution concentration of 0.5% glutaraldehyde. Each tube 
was incubated at room temperature for 2 hours and was measured with the Malvern 
Zetasizer. 
To quantify the aggregation of AuNPs, the mean hydrodynamic diameter (DH), 
was measured by DLS. The change in the hydrodynamic diameter after treatment (ΔDH) 
was calculated by Eq. 5.1.  
𝛥𝛥𝐷𝐷𝐻𝐻 = 𝐷𝐷𝐻𝐻  𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑒𝑒𝑐𝑐 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 𝑐𝑐𝜖𝜖𝑐𝑐𝑒𝑒𝑎𝑎 𝑐𝑐𝑎𝑎𝑒𝑒𝑐𝑐𝑐𝑐𝑡𝑡𝑒𝑒𝑡𝑡𝑐𝑐 −𝐷𝐷𝐻𝐻  𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑒𝑒𝑐𝑐 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 𝑏𝑏𝑒𝑒𝜖𝜖𝑐𝑐𝑎𝑎𝑒𝑒 𝑐𝑐𝑎𝑎𝑒𝑒𝑐𝑐𝑐𝑐𝑡𝑡𝑒𝑒𝑡𝑡𝑐𝑐         (5.1) 
A high ΔDH represents a high degree of aggregation of coated AuNPs by either osmolyte 
or salt treatment.  
For TEM characterization, 8 log PPV, 8 log PPV-coated AuNPs, and 8 log PPV-
coated AuNPs after 1 M mannitol aggregation were adsorbed to a plasma etched TEM 
copper grids (Carbon Type-B, 300 mesh) for 2 minutes and were negatively stained with 
106 
2% uranyl acetate (Fisher Scientific) for 2 minutes. The morphology of the virus samples 
was imaged with a JEOL JEM-2010 TEM at 80 kV. 
 
5.2.5 Proof-of-concept tests  
 
To determine the effect of protein interference on the virus detection, 500 μL of 
PPV was spiked into the same volume of solution containing different concentrations of 
BSA in PBS. The diameter was measured by DLS before and after addition of 1 M 
mannitol. 
To simulate testing a surface for virus contamination, a swab test was 
developed.46-47 Five 20 μL droplets of purified PPV in PBS buffer were placed on a 
sterile petri dish and dried in the biosafety cabinet for 1 hour. After the droplets 
evaporated, 100 µL of PBS buffer was pipetted onto the surface. The surface was then 
swabbed with a sterile cotton swab in a horizontal, vertical and diagonal direction, five 
times for each direction. The cotton swab was placed in a tube containing 800 µL PBS 
buffer, incubated for 10 minutes, vortexed for 10 seconds and incubated for an additional 
10 minutes. Liquid retained in the swab was removed by pressing of the cotton against 
the tube wall. The diameter was measured by DLS before and after addition of 1 M 
mannitol. 
 
5.2.6 Statistical analysis  
 
Statistical analysis was performed using R statistical software. A two sample t-test 
assuming equal variances (estimate pooled variance) was employed for comparison of 
virus-coated AuNPs with protein-coated AuNPs to determine an analytical limit of 





















5.3 Results and discussion 
 
5.3.1 Rationale of virus detection method 
 
Traditional virus detection methods require the specific detection of either capsid 
proteins by antiviral antibodies13-14 or viral nucleic acids by complementary 
oligonucleotides.3, 10 While this is a reliable method to detect known viral contaminates, it 
will not detect unknown viral particles. This work is a proof-of-concept study 
demonstrating that the behavior of virus and AuNPs in osmolyte and salt solutions can be 
used for virus detection of general viral contamination, without targeting a specific virus. 
 
 
Earlier work demonstrated that viral particles preferentially flocculate in the 
presence of osmolytes.34-35 As described in the introduction, this is due to the 
hydrophobicity and rigidity of virus particles. Osmolytes dehydrate protein and virus 
surfaces. However, since viruses are more hydrophobic than proteins,41-42 they aggregate 
when there is a loss of their hydrating layer. Thus, viruses aggregate when in the presence 
of high osmolyte concentrations, while proteins do not. This study will apply this 
knowledge to induce the aggregation of virus and detect that aggregation with AuNPs as 
a beacon. A cartoon of AuNPs aggregation to probe the presence of viral particles is 
shown in Figure 5.1. In the presence of osmolytes, virus-coated AuNPs aggregate and a 
measurable size increase is observed. However, the aggregation is not detected when 
protein-coated AuNPs are in the presence of osmolyte solutions. Salts are known to 
induce the aggregation of AuNPs,48-50 since electrolytes can neutralize repulsive forces 
arising from the surface charge of citrate-coated AuNPs, causing the AuNPs to 
 
 
Figure 5.1 The outcome of AuNPs aggregation detection of virus. 













aggregate.51 Minimal aggregation was shown when the osmolytes mannitol and glycine 
contacted uncoated AuNPs (see SI A.2). Viruses on the surface of AuNPs can stabilize 
the nanoparticles from salt-induced aggregation, likely with a similar mechanism that 
protein-coated AuNPs are stabilized from salt-induced aggregation.30 The reaction of the 
coated AuNPs to salt-induced and osmolyte-induced aggregation allowed the virus-
containing samples to be identified from the protein-only samples. 
 
5.3.2 Synthesis and characterization of AuNPs 
 
The characterization of synthesized and coated AuNPs can be found in Figure 
5.2. Synthesized AuNPs formed a red colloidal solution and were monodisperse and 
uniform, as shown in Figure 5.2A. The AuNPs showed a mean zeta potential of -36 ± 3 
mV, indicating the synthesized citrate-capped AuNPs were stable and negatively charged 
(Figure 5.2B).  The isolated AuNPs had an absorbance peak at 519 nm in the UV-Vis 
absorbance spectrum (Figure 5.2C). The PPV-coated AuNPs and the BSA-coated 
AuNPs had a red-shift of 6 nm in the peak wavelength, as compared to bare AuNPs. This 
demonstrated that the AuNPs were coated successfully.52 Coating of AuNPs with PPV or 
BSA also increased the hydrodynamic diameter of the AuNPs, as shown in Figure 5.2D. 
The bare AuNPs had a mean hydrodynamic diameter of 15 ± 0.4 nm. When the AuNPs 
were coated with PPV or BSA, the hydrodynamic diameter increased according to the 
size of the coating molecule, PPV is 18-26 nm53 and BSA is ~6.8 nm54. Both the red-shift 
in the UV-Vis spectrum and the increase in the size indicated the formation of a 
monolayer25 on the AuNPs surface for either protein or virus. 
For biosafety reasons, the PPV had to be inactivated before testing with DLS. It 
was confirmed that the size did not change for the BSA-coated AuNPs before and after 
crosslinking. It was also observed that the size of the coated nanoparticles prior to 
aggregating agent addition was as expected in Figure 5.2D, providing evidence that the 




5.3.3 Concentration dependence 
 
It was difficult to compare the concentration of PPV and BSA. It was determined 
that the best way to compare the virus and protein would be to find a concentration of 
each that covered the same area on the AuNP assuming similar binding affinities. It was 
calculated that 1 nM BSA covered the same area on the AuNPs as 108 MTT50/mL of PPV 
(see SI A.2), which is the highest concentration of PPV that can be obtained from our 
virus propagation method. The calculation assumed that the structure of the virus or BSA 
did not change from the crystal structure size53-54 and that there was a 1:1,000,000 ratio of 
infectious to non-infectious virus particles for the PPV.55 A higher concentration range of 
BSA was also tested because it has been shown that 1 nM BSA is too low a concentration 




Figure 5.2 Characterization of synthesized and coated AuNPs. (A) TEM image of the AuNPs, the inset 





Figure 5.3 Concentration dependence for detection of PPV versus control BSA & thyroglobulin. 
(A&D&G) Size profile of PPV, BSA or thyroglobulin coated AuNPs as a function of concentrations before 
and after 1 M mannitol addition as measured by DLS. (B&E&H) Size profile of PPV, BSA or 
thyroglobulin coated AuNPs as a function of concentrations after 1 M NaCl addition as measured by DLS. 
(C&F&I) Change in AuNPs aggregation size for PPV, BSA or thyroglobulin after 1 M mannitol addition. 
Solid markers represent PPV, open markers represent BSA and thyroglobulin. All data points are the 
average of three separate tests and error bars represent the standard deviation. Concentrations are plotted as 
a log scale. TEM images of (J) 8 log PPV, (K) 8 log PPV-coated AuNPs and (L) 8 log PPV-coated AuNPs 
with 1 M mannitol. *p <0.05 for virus compared to BSA and thyroglobulin controls. 
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The mean hydrodynamic diameter (DH) measured by DLS was used to quantify 
the size of AuNPs before coating, after coating, and after inducing aggregation with 
either mannitol or salt. ΔDH designates the change in the size of coated AuNPs after 
induction of aggregation with either osmolyte or salt (Eq. 5.1). Figure 5.3A shows that 
PPV-coated AuNPs increase in size after 1 M mannitol aggregation. The aggregation of 
PPV-coated AuNPs in mannitol is likely due to the flocculation of PPV caused by 
mannitol.34, 36 Higher concentrations of PPV, starting at 106 MTT50/mL, reduced 
aggregation in NaCl due to the virus protecting the AuNPs from salt-induced 
aggregation, shown in Figure 5.3B. The calculated ΔDH for PPV shows a linear trend 
when plotted against the log of PPV titer when PPV has a concentration greater than 105 
MTT50/mL (Figure 5.3C). The change in DH due to the mannitol-induced aggregation of 
PPV increased from 25 ± 2 nm to 61 ± 16 nm between 104 MTT50/mL and 108 
MTT50/mL. The lowest concentration of PPV that could be detected was estimated to be 
106 MTT50/mL, which is ~1 pM. This lowest detectable concentration is lower than 
standard antibody binding assays that detect virus,58-60 which typically have a nanomolar 
detection limit.61-62 
 The size of BSA-coated AuNPs in mannitol was much smaller than PPV-coated 
AuNPs, as shown in Figure 5.3. This demonstrates that there is a clear difference 
between AuNPs aggregation with mannitol in the presence of PPV versus BSA, 
demonstrating mannitol aggregation as a potential method to detect the virus. BSA-
coated AuNPs showed the same trend as PPV-coated AuNPs, in the presence of salt. 
However, BSA-coated AuNPs is less protected than PPV from 0-1 nM, if we assume 108 
PPV is equal to 1 nM of BSA, as calculated based on the same coverage area in the SI 
A.2. This is likely due to a difference in binding affinity for BSA and PPV. The size 
difference, ΔDH, in BSA-coated AuNPs induced by mannitol as a function of protein 
concentration can be seen in Figure 5.3F. The size increase of BSA-coated AuNPs in 1 
M mannitol had a ΔDH value in the range of 19 ± 1 nm to 33 ± 8 nm for all protein 
concentrations studied. For PPV, the ΔDH reached 61 ± 16 nm for the highest 
concentration studied. This difference is the main basis for determining the detection of 
virus versus proteins.   
Thyroglobulin-coated AuNPs (see SI A.2 for UV-Vis and DLS confirmation of 
coating) were also tested for their ability to aggregate in mannitol and salt. Thyroglobulin 
is a major protein involved with iodine metabolism and is 12 nm63 in size.  The reference 
range for thyroglobulin concentration in serum is about 20 to 25 ng/mL64 (equivalent to 
30-38 nM). All tested concentrations of thyroglobulin-coated AuNPs protected the 
AuNPs from aggregation by NaCl, shown in Figure 5.3H. The size increase of 
thyroglobulin-coated AuNPs in 1 M mannitol had a ΔDH value in the range of 22 ± 1 nm 
to 35 ± 4 nm for all protein concentrations studied (Figure 5.3I). This ΔDH is smaller 
than PPV-coated AuNPs in mannitol. This further demonstrated that there is a clear 
difference between AuNPs aggregation with mannitol when in the presence of PPV 
versus protein controls.  
The aggregation profile of PPV-coated AuNPs compared with protein-coated 
AuNPs by 1 M NaCl is similar to the aggregation profile of human papillomaviruses 
(HPV) type 16 L1 VLPs-coated AuNPs compared with BSA-coated AuNPs induced by 
70 mM NaCl.65 Aggregation of AuNPs-coated VLPs was sharply decreased as VLPs 
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concentration was increased, while BSA-coated AuNPs showed a flat trend for AuNPs 
aggregation by salt.65 While changes in NaCl aggregation of virus-coated AuNPs may 
detect viral particles compared with BSA near 1 μM, our data suggests that mannitol 
aggregation is more quantitative and less susceptible to contaminating proteins in 
solution. 
TEM images of PPV, PPV-coated AuNPs and PPV-coated AuNPs with 1 M 
mannitol are shown in Figure 5.3J-L, respectively. The size of PPV detected in the 
images falls into the reported size range for PPV of 18 - 26 nm.53 Figure 5.3K confirmed 
the successful interaction of PPV with the AuNPs. Figure 5.3L showed aggregation of 
PPV-coated AuNPs in mannitol. This demonstrates that PPV-coated AuNPs aggregate in 
the presence of mannitol. 
UV-Vis absorption spectrum was used as a secondary detection method for 
AuNPs aggregation, however, no significant difference between the red-shift for 
mannitol-induced aggregation for PPV and the red-shift for mannitol-induced 
aggregation for control BSA could be found (see SI). This is possibly due to the lack of 
sensitivity of the UV-Vis absorption spectrum that is needed to identify the small 
differences in aggregation between mannitol-induced aggregates of PPV and AuNPs. 
 
5.3.4 Application: virus detection in protein solution matrix 
 
To determine the interference of proteins on virus detection using the AuNPs 
aggregation method, PPV was spiked into an equal volume of BSA solution with 
different concentrations to keep a constant final virus concentration of 108.3 ± 100.2 
MTT50/mL. Figure 5.4A shows the average size of PPV-coated AuNPs in different 
concentrations of BSA before and after mannitol-induced aggregation. PPV-coated 
AuNPs placed in BSA solutions had a significantly larger size than BSA-coated AuNPs 
alone (Figure 5.4B). The highest BSA concentration of 500 μM was chosen because it is 
the physiological concentration of albumin in serum.66-67 The calculated average 
concentration from the AuNPs standard detection curve for PPV was 108.5 ± 100.7 
MTT50/mL, which is within ± 100.5 (MTT50/mL) (the known MTT error) from the PPV 
titer determined with the MTT assay. This reproducibility across different BSA 
concentrations indicates that AuNP aggregation in mannitol could be a promising 




5.3.5 Application: evaluation of surface contamination 
 
AuNPs aggregation in mannitol was used as a proof-of-concept test to detect viral 
contamination on a surface. PPV was allowed to dry on a petri dish and was then 
collected with a cotton swab, as shown in Figure 5.5A. PPV at a concentration of 106.9 ± 
100.2 MTT50/mL was collected with this swab sampling method, achieving a 60 ± 23% 
virus recovery. Figure 5.5B shows the ΔDH after induction with mannitol. Swabbed PPV 
had a significantly larger aggregation of AuNPs caused by mannitol as compared to BSA. 
To determine the concentration of swabbed PPV using the AuNPs aggregation method, 
the PPV titer was determined from the AuNPs standard curve in Figure 5.3E. The 
calculated titer was within the error of the MTT assay. This reproducibility indicates that 
the comparison of AuNPs aggregation in mannitol can be a promising test for the 








Figure 5.4 Detection of virus in a protein solution matrix. (A) The average size of PPV-coated AuNPs in 
different concentrations of BSA before and after 1 M mannitol addition and measured by DLS. (B) The 
change in the size of PPV-coated AuNPs in different concentrations of BSA after 1 M mannitol addition. 
Solid symbols represent PPV and open symbols represent BSA only. All data points are the average of 
three separate tests and error bars represent the standard deviation. 




























5.3.6 Nonspecific virus detection  
 
To test the non-specificity of the AuNPs aggregation assay, an enveloped virus 
BVDV with a size of 40-60 nm68 was detected by mannitol-induced AuNP aggregation. 
The confirmation of BVDV-coated AuNPs is in the SI. Using the same procedure as PPV 
and the control proteins, the mean DH was used to quantify the size of AuNPs before 
coating, after coating, and after inducing aggregation with either mannitol or salt. Figure 
5.6A shows that BVDV-coated AuNPs increase in size after 1 M mannitol addition. At a 
concentration of 105 BVDV MTT50/mL or higher, the AuNPs were protected from salt-
induced aggregation, as shown in Figure 5.6B. The ΔDH due to the mannitol-induced 
aggregation of BVDV increased from 51 ± 13 nm to 165 ± 31 nm between 104 
MTT50/mL and 107 MTT50/mL, as shown in Figure 5.6C. The lowest detectable 
concentration was estimated to be 104 MTT50/mL for BVDV. BVDV was detectable at a 
lower concentration than PPV. This could be due to the BVDV being an enveloped virus, 
potentially increasing its affinity for AuNPs. Or the size ratio between the virus and the 
AuNP could be important. In this study, only 15 nm AuNPs were used with viruses that 
were ~20 nm (PPV) and between 40-60 nm for BVDV. Future work will explore a larger 






Figure 5.5 Swab sampling to detect contamination of PPV on a surface. (A) The process of swab 
sampling, (B) Size aggregation measured by DLS for swabbed PPV versus control swabbed BSA. Swabbed 
PPV is 106.9 ± 100.2 MTT50/mL as measured by the MTT assay and 107.4 MTT50/mL as measured by the 
PPV-AuNPs aggregation assay in 1 M mannitol. All data points are the average of three separate tests and 



















The aggregation of virus-coated AuNPs in mannitol can be detected by DLS and 
there is a linear increase in aggregate size with an increase in PPV concentration on a 
semi-log plot. This indicates the potential of quantitative detection of virus with this 
described AuNPs aggregation method. The lowest detectable concentration of virus was 
estimated to be 106 MTT50/mL, which is lower than standard antibody assays. The non-
specific nature of this assay was tested by detecting the aggregation of BVDV-coated 
AuNPs in mannitol. The lowest detection concentration for BVDV was estimated to be 
104 MTT50/mL. 
The AuNPs aggregation assay has the ability to determine the presence of virus in 
up to 500 μM of BSA quantitatively, used as a model contaminant in a protein-rich 
biological fluid. Also, PPV was detected quantitatively after it was swabbed from a dried 
sample on a petri dish. The developed ligand-free AuNPs aggregation method can 
determine the presence of virus within 24 hours, which is comparable or faster than 
current virus detection methods. This general virus detection method could be a quick, 
sensitive, inexpensive and portable method for detecting the presence of viral particles in 
low resource countries. Future work includes exploring additional viruses, reducing the 
time for the assay, and determining the ideal AuNP size and shape. The goal is to develop 
this assay into an early screening step for a viral infection in blood samples or cleanliness 
of a surface, which could help to control a viral disease outbreak. 
 
 
Figure 5.6 Concentration dependence for detection of BVDV. (A) Size profile of BVDV coated AuNPs as 
a function of concentrations before and after 1 M mannitol addition as measured by DLS. (B) Size profile 
of BVDV coated AuNPs as a function of concentrations after 1 M NaCl addition as measured by DLS. (C) 
Change in AuNPs aggregation size for BVDV after 1 M mannitol addition. All data points are the average 
of three separate tests and error bars represent the standard deviation. *p <0.05 for virus compared to BSA 
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According to the World Health Organization (WHO), millions of people die from 
vial infectious disease each year [1]. One of the most effective methods to prevent viral 
infection is with vaccines. In order for viral vaccines to be effective, they must be 
transported and stored in a “cold chain” [2]. A cold chain is a system of transporting and 
storing vaccines at the recommended temperature, typically 2-8 °C, from the 
manufacturer until the point of use [2, 3]. If temperatures are not maintained, the vaccine 
may lose its potency and could no longer be effective in fighting disease [4]. 
Approximately half of the vaccines produced are discarded due to poor thermal stability 
each year [5]. The unreliable cold chain system is one of the major causes of poor 
immunization coverage in developing countries [4]. Therefore, developing robust, 
thermostable viral vaccines that are less dependent on the cold chain is urgent and crucial 
for universal access to immunizations. 
There are three major types of viral-based vaccines licensed for human use, live 
attenuated, inactivated, and subunit vaccines [6, 7]. Live-attenuated vaccines are usually 
produced by extended passage of a disease-causing (wild) virus in non-human cell culture 
to weaken the wild virus [8-10]. The attenuated virus can still replicate and stimulate high 
immunity, but it loses the ability to cause disease. Inactivated vaccines are typically treated 
by chemical or heat inactivation to stop virus replication [8-10]. The inactivated virus 
cannot replicate, but can still produce immunogenicity. Subunit vaccines use a component 
of the virus, such as a surface polysaccharide, capsid protein, or nucleic acid, to stimulate 
immune response [8-10]. The immune response caused by these three types of vaccines 
from strong to weak in order as live attenuated > inactivated > subunit vaccines. However, 
the stability of these three types of vaccines is in reverse order. Live attenuated viral 
vaccines are the most sensitive to temperature changes, and tight temperature control is 
required for them to remain immunogenic [6]. There is a need to develop versatile methods 
to thermally stabilize the live attenuated vaccines.  
Various methods have been developed to create thermostable viral vaccines. One 
method to stabilize viral vaccines is to engineer the vaccines to withstand degradation. 
Genetic modification of the fusion protein of a respiratory syncytial virus showed greater 
immunogenicity and enhanced thermal stability than the wild virus at 37°C [11]. Foot-
and-mouth disease virus mutants were engineered to slow the rate of dissociation of the 
virus, thus stabilizing the viral vaccine [12]. However, the method of modifying each 
viral vaccine is labor-intensive and virus-specific. A more standard method to stabilize 
vaccine formulations is to add stabilizing excipients [13-15]. At 37°C for 10 days, an 
adenovirus serotype 5 in the presence of a molar concentration of sucrose solution 
maintained high infectivity, and its vaccine strain in sucrose kept the immunogenicity in 
vivo for viruses [13]. In order to further improve the thermal stability of viruses, vaccines 
are often dried by lyophilization, spray drying, or foam drying [15, 16]. Drying aims to 
slow down the physical and chemical degradation of the vaccine. Lyophilized rotavirus 
vaccines formulated in optimized HEPES buffer, bulking agent polyvinyl pyrrolidone, 
cryoprotectant sucrose, and amino acids L-arginine and glycine, can retain its potency for 
20 months at 37°C and 7 months at 45°C [17].  Two enveloped viruses showed enhanced 
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thermal stability in trehalose, while one non-enveloped virus had improved thermal 
stability in mannitol by spray drying [14]. Small-sized monosaccharide mannitol can 
tightly bind the non-enveloped viral capsid proteins, while polysaccharide trehalose can 
behave as a glassy stabilizing matrix by forming strong hydrogen bonds with the viral 
envelope to maintain the fluidity of the lipid bilayer membrane and prevent crystalline 
formation [14, 18]. The viruses remained hydrated due to water molecules around the 
viruses that were confined by the formation of hydrogen bonds with the excipients [14]. 
Although these methods showed promise for creating thermostable vaccines, their 
applicability is limited by complicated treatment procedures and expensive specialized 
equipment for drying samples. In addition, most vaccine formulations required large 
amounts of trial and error experiments for selections of excipients, since the 
thermodynamic reason for the stabilization is unknown. Therefore, a simple, 
inexpressive, and versatile approach for stabilizing viruses against heat is needed to be 
explored. 
Our proposed formulation strategy for thermally stabilizing viral vaccines is to 
encapsulate the virus. Virus encapsulation by hydrated silica provided a protective layer 
that slowed the infectivity loss of the human-enterovirus type 71 by six-fold at 37°C for 
20 days, or at 40 °C for 36 hours [19]. Our approach has been to use biocompatible 
polypeptides to create a complex coacervate to encapsulate the viral particles. Complex 
coacervation [20-22] is an associative liquid-liquid phase separation phenomena based on 
electrostatic interactions of two or more oppositely charged polymers. Entropic gains for 
releasing of small, bound, counter-ions from the polyelectrolyte salts into solution [23-
25] can also drive the phase separation. When oppositely charged polymers interact in a 
solvent to reach net charge neutrality, two equilibrium phases can be formed: a polymer-
rich dense phase known as a complex coacervate [20-22], and a polymer-poor dilute 
phase known as the supernatant. The phase behavior of complex coacervation has been 
reported strongly dependent on polyelectrolyte mixing ratio (stoichiometry), 
polyelectrolyte concentration, ionic strength (salt concentration), and solution pH, but 
weakly affected by temperature [26, 27].  
Complex coacervation has been used in a variety of areas, such as drug delivery 
[28, 29], gene therapy [30-32], and biomimic adhesives [33, 34]. One of the most 
important application is as a method for encapsulation of proteins [35-38]. A tertiary 
system of two polyelectrolytes and a protein have created complex coacervates that 
successfully encapsulated the protein [35-37, 39]. The encapsulated proteins maintained 
either structure [24, 35, 36, 38, 40] and were also able to enhance the stability of the 
proteins against high temperatures [36]. Protein unfolding occurs when heat increases the 
kinetic energy of the protein and causes the molecules to vibrate until the non-covalent 
bonds holding the structure together are disrupted [41]. A variety of protein systems have 
shown thermal protection against denaturation, including bovine serum albumin (BSA) in 
a poly(allylamine hydrochloride)/poly(acrylic acid) system [36], canola protein isolate 
(CPI) in chitosan (CS) [42] and lysozyme in hyaluronic acid (HA) [24]. The finding on 
encapsulated proteins by complex coacervation with improved thermal stability showed 
the promise for encapsulating viral particles and stabilizing the viruses thermally via 
complex coacervation.  
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In this study, two viruses, non-enveloped porcine parvovirus (PPV) and 
enveloped bovine viral diarrhea virus (BVDV) were explored to form virus complex 
coacervates. The viruses were encapsulated by a positively charged poly(L-lysine) (PLys) 
and negatively charged poly(D,L-glutamic acid) (PGlu)). The formation of virus 
coacervates was explored as a function of charge fractions, which is the ratio of the 
polycation, PLys to the polyanion PGlu, qualitatively and quantitatively. Virus thermal 
stability studies were performed as a proof-of-concept for thermostable vaccines. The 
polypeptide complex coacervates demonstrated effective protection for the non-
enveloped PPV against high temperature, but not for the enveloped BVDV. This method 








Potassium phosphate monobasic (molecular biology grade, ≥99.0%) and sodium 
chloride (NaCl, ACS grade, ≥99.0%) were a gift from Millipore Sigma (Burlington, 
MA). Sodium phosphate dibasic heptahydrate (ACS grade, 98.0-102.0%), sodium 
hydroxide (NaOH, ACS grade, ≥97.0%), sodium dodecyl sulfate (SDS) and dimethyl 
sulfoxide (DMSO, BioReagent, >99.7%) were purchased from Sigma-Aldrich (St. Louis, 
MO). Hydrochloric acid (HCl, ACS grade, 36.5-38.0%) and (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) (HEPES) (≥99.0%) were purchased from Fisher Scientific 
(Pittsburgh, PA). Homopolypeptides poly(D,L-glutamic acid) (PGlu) and poly(L-lysine) 
(PLys) with a degree of polymerization of 400 were purchased from Alamanda Polymers 
(Huntsville, AL). The polypeptides were used as received without further purification. 
Pierce fluorescent dye 5-(and 6)-carboxy-tetramethyl-rhodamine succinimidyl ester 
(NHS-Rhodamine) was purchased from Thermo Fisher Scientific (Waltham, MA). 
Thiazolyl blue tetrazolium bromide (MTT) (98%) was purchased from Alfa Aesar 
(Haverhill, MA). All aqueous solutions and buffers were prepared using purified water 
with a resistivity of ≥18 MΩ·cm from a Nanopure filtration system (Thermo Scientific, 
Waltham, MA) and filtered with a 0.2 µm bottle top filter (VWR, Radnor, PA) or a 0.2 
µm syringe filter (VWR) prior to use. Phosphate buffered saline (PBS) (pH 7.20 ± 0.03) 
was prepared by dissolving 0.21 g potassium phosphate monobasic, 0.726 g sodium 
phosphate dibasic heptahydrate, and 9 g NaCl into 1000 mL Nanopure water. Stock 
solutions of 10 mM polypeptide solutions were prepared on a charged monomer basis 
and adjusted with 1 M HCl and NaOH to the desired pH 8.00 ± 0.03 pH units. 
Zwitterionic buffer solution of 0.4 M HEPES was also adjusted with 1 M HCl and NaOH 
to the desired pH 8.00 ± 0.03 pH units. 
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6.2.2 Virus production, purification and titration 
 
Porcine kidney cells (PK-13, CRL-6489) and bovine turbinate cells (BT-1, CRL-
1390) were purchased from ATCC. Porcine parvovirus (PPV) strain NADL-2, was a gift 
from Dr. Ruben Carbonell (North Carolina State University, Raleigh, NC). Bovine viral 
diarrhea virus (BVDV) strain NADL was purchased from USDA APHIS. PPV was 
propagated in PK-13 cells, and BVDV was propagated in BT-1 cells, as described 
previously [43, 44], and stored at −80ºC until further use. PPV or BVDV were further 
purified with a Biotech Cellulose Ester 1,000 kDa dialysis tubing (Rancho Dominguez, 
CA) and a BioRad Econo-Pac 10DG desalting column (Hercules, CA) in PBS buffer, as 
previously described [45], and stored at 4°C until further use.  
To determine the concentration of the infectious virus, an MTT assay was used. 
Briefly, either 8 x 104 cells/mL PK-13 cells (to titrate PPV) [46] or 2.5 x105 cells/mL BT-
1 cells (to titrate BVDV) [47] were seeded in a 96-well plate in a volume of 100 µL/well. 
After one day incubation, 25 µL/well of virus sample was added to the corresponding 
host cells in quadruplicate and serially diluted across the plate. After 6 days post-
inoculation, 10 μL/well of 5 mg/mL MTT salt in PBS (pH 7.2) was added to the plate. 
After 4 hours, 100 μL/well of solubilizing agent, 10% SDS in 0.01 M HCl (pH 2.5), was 
added to the plate. After 12 to 24 hours, plates were read at 550 nm in a Synergy Mx 
monochromator-based multimode microplate reader (Winooski, VT). The virus dilution 
that killed 50% of the cells is stated as virus titer MTT50 [44]. 
 
6.2.3 Formation of virus complex coacervates 
 
Complex coacervates with encapsulated virus samples were formed by first 
pipetting water, and then HEPES buffer into a 1.7 mL microcentrifuge tube, followed by 
the virus (PPV or BVDV), PLys, and PGlu. The samples were vortexed for 5 seconds 
after the addition of one component to ensure fast and complete mixing. A typical 
experiment varied the ratio of Plys to PGlu but maintained a constant total polymer 
concentration of 7 mM and a constant virus concentration. The final virus concentrations 
were 4-6 log10 (MTT50/mL) for PPV and 4-5 log10 (MTT50/mL) for BVDV. All the virus 
complex coacervates were prepared immediately before use and studied at room 
temperature. Each sample contained a total volume of 240 µL. All experiments were 
performed in triplicate. 
 
6.2.4 Virus complex coacervates characterization and quantification 
 
To qualitatively measure the formation of the virus complex coacervate, turbidity 
was measured by placing 100 µL into a 96-well plate and measuring the absorbance at 
562 nm [37, 48]  on the microplate reader. The measured signal was referenced against a 
control well containing only Nanopure water and HEPES buffer. Samples were then 
examined using an Olympus IX51 microscope with a DP72 camera (Center Valley, PA) 
to confirm the presence or absence of coacervation.  
Viruses were also labeled with a fluorescent dye NHS-Rhodamine that absorbs 
visible green light at a wavelength of 552 nm and emits orange-red visible light at 575nm 
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to confirm the presence of the virus in the coacervate phase. 1 mL of purified virus 
solutions (8 log PPV or 7 log BVDV) were incubated with 10 mg/mL NHS-Rhodamine 
in DMSO solution (2.15 μL for PPV and 6.5 μL for BVDV) for 1 hour at room 
temperature, and excess non-tagged fluorescent dye was removed with a desalting 
column. The fluorescently labeled virus was used immediately to form the virus 
coacervates, as described in Section 2.3. An aliquot of 100 μL of tagged virus 
coacervates was transferred to one well of a 96-well plate and examined with an Olympus 
IX51 microscope. The coacervates droplets were imaged using both brightfield and 
fluorescence modes and analyzed with ImageJ.  
To determine the virus complex coacervate quantitatively, each phase was 
measured with the MTT virus infectivity assay [44]. A total of 240 μL of the complex 
coacervate sample containing the virus in the micro-centrifuge tube was centrifuged 
using an ST16R Centrifuge (Thermo Scientific, Asheville, NC) at 14000 rpm for 20 min 
at 15ºC to phase separate the supernatant and dense coacervate phase. Following 
centrifugation, 220 μL of the supernatant was carefully transferred into a new micro-
centrifuge tube, and the volume of the remaining supernatant was measured via pipetting. 
A volume of 220 µL of 2 M NaCl solution was added to the dense coacervate phase 
(transparent gel) to dismantle the coalesced virus coacervate, followed by vortexing. Both 
the supernatant and dismantled coacervate were further titrated by the MTT assay.  
The partitioning of the virus into the complex coacervate phase was also 
determined. The partition coefficient (K) was calculated by Eq.6.1 [36, 37]. 
𝐾𝐾 = 𝐶𝐶c
𝐶𝐶s
                                                                                                                 (6.1) 
where Cc is the virus concentration in the coacervate phase, and Cs is the virus 
concentration in the supernatant phase. 
 
6.2.5 Virus thermal stability study 
 
A microcentrifuge tube containing either the PPV dense coacervate phase or 
purified PPV was capped and wrapped in paraffin film and put in a digital dry bath (USA 
Scientific, Ocala, FL) at 60ºC. The BVDV complex coacervate and purified BVDV were 
put in the dry bath at 40ºC. At each time point, a 1~2 µL dense virus coacervate sample 
was removed from the heating block and dismantled in 220 µL of 2 M NaCl solution. 
One purified virus sample was also removed from the heat at the same time. Both the 
dismantled virus coacervate and purified virus sample were evaluated with the MTT 
assay to determine the remaining infectious virus concentrations. 
A log reduction value (LRV) of the virus was calculated by Eq. 6.2. 
𝐿𝐿𝐿𝐿𝐿𝐿 = −log10 (
𝐶𝐶f
𝐶𝐶i
)                                                                                             (6.2) 






6.3 Results and Discussion 
6.3.1 Virus coacervates characterization 
 
We examined the complex coacervation of two viruses, non-enveloped PPV and 
enveloped BVDV. Some of the physical properties of the studied viruses are shown in 
Table 6.1. PPV has an isoelectric point (pI) of 4.8-5.1, and BVDV has a pI of 4.3-4.5 
[43]. The pI corresponded to the pH where the net surface charge of the viral particle is 
zero [49]. The virus carries a net negative charge if the solution pH is higher than the 
viral pI, and a net positive charge if the solution pH is lower than the viral pI [49]. Thus, 
both the viruses carried a net negative charge at the solution condition (HEPES, pH 8.0) 
we studied. We used oppositely charged polypeptides PLys and PGlu to encapsulate 
viruses to form a tertiary system of complex coacervate. Previous work showed that BSA 
encapsulated within these two oppositely charged polypeptides achieved the highest 
encapsulation efficiency and the optimum partition of BSA into the coacervate phase at 
pH 8.0 at 0 mM NaCl concentration [35, 37].  In addition, the complex coacervation did 
not affect the structural stability of the encapsulated proteins [35, 37]. Thus, these two 
polypeptides in salt-free HEPES buffer at pH 8.0 were chosen for forming virus complex 
coacervates. Charged viruses can be encapsulated via the electrostatic interaction of 
charged polypeptides, as shown in Scheme 6.1. The negatively charged virus and the 
polycation, PLys, were mixed first to form an intermediate complex. The polyanion, 
PGlu, was then added to form a stable virus complex coacervate system. 
 
Table 6.1 Model virus properties. 
 






















Scheme 6.1 Encapsulate virus via electrostatic association of charged polypeptides. 
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To characterize the encapsulation of viruses, optical micrographs of virus 
encapsulation within coacervate droplets were taken and are shown in Figure 6.1. PPV 
and BVDV were both fluorescently labeled and used to form the complex coacervates. 
The co-localization of the orange-red fluorescence from the viruses within the 




6.3.2 Encapsulation of virus as a function of coacervate charge 
stoichiometry 
 
To determine the encapsulation of the virus at different charge ratios, turbidity 
was used for the measurement of total complex formation. The turbidity of three different 
concentrations of encapsulated PPV as a function of charge fraction, which is the ratio of 
the polycation, PLys to the polyanion PGlu, is shown in Figure 6.2A. Bimodal curves 
were obtained for 4 and 6 log10 (MTT50/mL) of PPV coacervates. The peaks of the 
turbidity indicated the complex coacervate formation. The second peak of turbidity was 
near the charge fraction of 0.5 for 4 and 6 log10 (MTT50/mL) PPV. The turbidity reading 
increased with an increase of PPV concentration, indicating more complex coacervates 
were formed when increasing the virus concentration. Bimodal curves were observed for 
BVDV coacervates, as shown in Figure 6.2B. Only two concentrations of BVDV 
coacervates were studied due to the initial concentration of enveloped BVDV propagated 
being lower than PPV. Similar turbidity curve shapes were obtained for both viruses, but 
the second peaks of turbidity were shifted to a higher charge fraction 0.6 for 4 and 5 log10 
(MTT50/mL) BVDV. This shift means that more cationic PLys was needed to achieve a 
neutral charge complex coacervate. It indicated the electrostatic nature of complex 
coacervation, and the preference for the system to reach charge neutrality. 
 
Figure 6.1 Optical micrographs of virus encapsulation within coacervate droplets. (A&B&C) PPV 
coacervates, and (D&E&F) BVDV coacervates. (A&D) Brightfield micrograph of  virus coacervate 
droplets, (B&E) fluorescent image of NHS-Rhodamine tagged virus, and (C&F) overlay of the brightfield 




While optical microscopic images and turbidity confirmed the successful 
formation of virus coacervates, it did not provide any quantitative information on how 
much virus was taken up into the coacervates. Therefore, the MTT cell viability assay 
was used to quantify the concentration of infectious virus in each phase. The virus titer as 
a function of coacervate charge stoichiometry is shown in Figure 6.3. When the cationic 
charge fraction increased, PPV and BVDV were extracted into the dense coacervate 
phase, resulting in an obvious increase in the virus titer in the coacervate phase and a 
corresponding decrease of virus titer in the supernatant phase. The maximum amount of 
virus in the coacervate phase corresponded to the second peak in the turbidity 
measurements. At higher cationic charge fractions, the virus particles were excluded from 
the coacervate phase but were back to the initial levels in the supernatant. The viruses 
showed the same trend as BSA, human hemoglobin, and hen egg white lysozyme 
concentrations titration as a function of coacervate charge stoichiometry [37]. 
 
Figure 6.2 Turbidity of encapsulated virus. (A) PPV coacervates, and (B) BVDV coacervates. All data 




From Figure 6.3A-C, the majority of the PPV particles were taken into the 
coacervate phase occurred near the charge ratio 0.5. It is consistent with the second peak 
of PPV coacervates turbidity occurring near the charge fraction of 0.5 in Figure 6.2A. 
Similar to PPV, the MTT results of BVDV also match with the turbidity data. The 
highest level of BVDV encapsulated in the dense phase occurred near the charge ratio of 
0.6, as shown in Figure 6.3D and E, which is also consistent with the second peak of 
BVDV coacervates turbidity occurring near the charge fraction of 0.6 in Figure 6.2B.  
In addition, the partition of viruses into the coacervate phase as a function of 
coacervate charge stoichiometry is calculated and shown in Figure 6.4. A positive ln (K) 
value means the partitioning of viral particles favored the coacervate phase, while a 
negative value means the viral particles stayed in the supernatant phase. When the 
cationic charges fractions increased, PPV and BVDV were partitioned into the dense 
coacervate phase, achieving a maximum point of partitioning. Afterward, the viral 
particles were excluded from the coacervate phase back into the supernatant when the 
charge fractions continue to increase. The maximum partition of the virus into the 
coacervate phase happened at the charge fraction when the second peak in the turbidity 




Figure 6.3 Live virus titration. (A&B&C) Encapsulated PPV, and (D&E) encapsulated BVDV. (A&D) 4 
log10 (MTT50/mL), (B&E) 5 log10 (MTT50/mL), and (C) 6 log10 (MTT50/mL). All data points are the 
average of three separate tests and error bars represent the standard deviation. 
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The coacervates have the maximum capacity to extract PPV from solution near 
the charge ratio 0.5, and to extract BVDV near the charge ratio 0.6. In all cases, the 
highest level of virus encapsulation and partition in the dense coacervate phase occurred 
around the point where the system was net neutral. The shift to higher charge fraction for 
BVDV extraction is likely due to the BVDV having a lower pI than PPV [43]. The pI of 
BVDV is further away from the buffer solution pH of 8.0 than PPV, as shown in Table 
6.1. Therefore, BVDV carries a more net negative charge than PPV, thus needing more 
positively charged polypeptide to form the neutrally charged complex coacervate.  
Virus recovery in the dense coacervate phase was also calculated and shown in SI 
Figure A.3.1. At each peak of the virus titer in the coacervate phase, and each maximum 
virus partition point (Figure 6.3&4), the maximum virus recovery was observed (SI 
Figure A.3.1). PPV coacervates could achieve a 100% encapsulation and recovery from 
the dense phase, whereas BVDV only recovered 50% of the infectious virus. This is 
likely due to enveloped BVDV is less stable than non-enveloped PPV in a high 
concentration of salt solution since the high osmotic pressure by high concentrations of 
salt can cause leakage in the viral envelope membrane [53].  
 
6.3.3 Thermal stability of encapsulated virus vs. free virus 
 
To demonstrate the effect of complex coacervates on the stability of viruses 
against high temperatures, free purified PPV or BVDV were first explored to find a 
critical starting temperature point where the virus could be completely inactivated. A 
temperature of 60°C was selected for the non-enveloped PPV for up to one week due to 
PPV started to lose 1 log of infectivity at 60°C for 1 hour [54]. A temperature of 40°C 
was selected for the enveloped BVDV for up to two days since BVDV lost 50% of 
infectivity at 37°C for 6 hours [55]. 
 
Figure 6.4 Partition coefficient. (A&B&C) Encapsulated PPV, and (D&E) encapsulated BVDV. (A&D) 4 
log10 (MTT50/mL), (B&E) 5 log10 (MTT50/mL), and (C) 6 log10 (MTT50/mL). All data points are the 
average of three separate tests and error bars represent the standard deviation. 
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Free PPV in aqueous solution and encapsulated PPV were incubated at 60°C, 
followed by releasing the encapsulated PPV back to the solution with 2 M NaCl. The 
high salt solution has been shown to disassemble coalesced coacervate [25, 26, 37] due to 
salt interrupting the electrostatic interactions that hold the coacervate together. The 
stability of encapsulated PPV compared with free PPV against heat is shown in Figure 
6.5A. After 1 day at 60°C, encapsulated PPV effectively maintained its viral titer, only 
losing 1.0 ± 0.1 log10 (MTT50/mL). In comparison, free PPV showed a LRV of 2.9 ± 0.3 
log10 (MTT50/mL). Moreover, free PPV was found to be completed inactivated after 7 
days under 60°C, with an LRV of 5.9 ± 0.5 log10(MTT50/mL). In comparison, 
encapsulated PPV only had a titer loss of 2.7 ± 0.1 log10 (MTT50/mL) after 7 days. These 
results demonstrated that complex coacervates offer effective protection for non-
enveloped PPV against thermal degradation.  
 
 
In addition, the lifetime of infectious PPV particles was determined using the 
simplest model for infectivity loss 𝑛𝑛(𝑡𝑡) = 𝑛𝑛(0)𝑒𝑒−𝑐𝑐/𝜏𝜏[13], where t is the length of thermal 
treatment, n(t) is virus titer at t, n(0) is the initial virus titer, τ is the inverse decay rate, 
corresponding to the mean lifetime of an infectious viral particle. This model assumes the 
infectious viral particles degrade from alive to disrupted state at a constant rate, and the 
corresponding fitted data curves of encapsulated and free PPV are shown in SI Figure 
 
Figure 6.5 Thermal stability of free and encapsulated virus. (A) PPV, and (B) BVDV. All data points are 
the average of three separate tests and error bars represent the standard deviation. 
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A.3.2. The lifetime of encapsulated PPV is determined to be 14 days at 60°C, much 
longer than the lifetime of free PPV to be 4 days at 60°C. 
The enhanced thermal stability of encapsulated PPV compared to the free PPV 
could be attributed to the crowding environment, which disfavors viral surface capsid 
proteins unfolding and denaturation, facilitate heat-induced unfolded viral proteins 
refolding back to the native state [56], and inhibit viruses forming insoluble aggregates 
[24]. The small, dense, compact, polymer-rich coacervate phase can provide entropy and 
enthalpy stabilization [24, 42]. The main driving force for viral capsid protein unfolding 
is believed to be the high conformational entropy of the denatured state [57], and the 
flexible unfolded state has a much greater conformational freedom than the compact 
folded state of a viral protein. The limited volume of the crowding environment would 
minimize the degrees of conformational freedom in the unfolded state, and hence 
improves the stabilization of the native state of viral protein due to an entropic 
stabilization [57, 58]. Also, unfolded viral proteins have larger hydration radii and 
occupy more volume compared to the folded state, and the excluded volume effect from 
the crowding environment lacks the space available for the extended denatured proteins, 
thus favors any process like protein folding in which the volume decreases [57-59]. In 
addition, the denaturation enthalpy of protein in polyelectrolyte complex has been shown 
much higher than free proteins [42], indicating that complex coacervation could impart 
thermal stability to viral capsid proteins.  
Furthermore, complex coacervate microdroplet can be considered as a membrane-
free artificial cellular platform for the viruses, served as a type of protocell [60], which is 
spatial compartmentalization rich in biomacromolecules independent of membrane 
(vesicle) formation [61-63]. Thus, the coacervate stabilizes viruses by mimicking the 
viruses inside of a membrane-free cell, which is a highly crowded environment due to the 
presence of macromolecules, such as proteins, nucleic acids, ribosomes and 
carbohydrates [60]. In reality, viruses replicated and folded their capsid proteins inside 
cells; thus, the intracellular environment mediated by the coacervates favors to fold viral 
capsid proteins in their compact native states and keep the structural stability of viral 
particles. Besides, A water content of 68-83 wt% [26, 64] was reported for BSA- 
poly(diallyldimethylammonium chloride), PLys-PGlu, PLys-poly(L-aspartic acid), 
poly(L-histidine)-PGlu, poly (L-ornithine)-PGlu complex coacervates systems; the high 
amounts of water content trapped by coacervate dense phase can also protect the viral 
particles against dehydration by heat evaporation. Such stabilization has also been shown 
to improve the thermal stability of proteins [24, 36, 42].  
Furthermore, the stability of an enveloped virus BVDV against heat was also 
explored, and the result of encapsulated BVDV vs. free BVDV is shown in Figure 6.5B. 
Free BVDV in aqueous solution and encapsulated BVDV were incubated at 40°C, also 
followed by disassembling the encapsulated BVDV back to the solution with salt. 
However, complex coacervates offered no protection for enveloped BVDV against high 
temperature. The data demonstrated that encapsulated BVDV inactivated faster than free 
BVDV. It might be due to BVDV having a lipid bilayer envelope surrounding its viral 
capsid protein. PLys has been shown to penetrate negatively charged lipid bilayers [65], 
and it might interfere with the BVDV envelope, thus decreasing the thermal stability of 
the enveloped BVDV. This might also be the reason for the 50% BVDV recovery in SI 
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Figure A.3.1. In addition, PLys alone showed slight toxicity, as shown in SI Figure 
A.3.3, possibly due to its interaction with the negatively charged cell membrane, which 
resulted in membrane disruption and cell deaths. 
Herein, we have demonstrated that the complex coacervation can be used to 
stabilize a non-enveloped virus PPV thermally, and the encapsulated PPV can keep its 
lifetime at 60°C for up to two weeks. This method could provide a promising platform 
for creating thermally stable non-enveloped live attenuated vaccines. Other positively 




Two viruses, non-enveloped PPV and enveloped BVDV, were explored for their 
ability to be encapsulated into complex coacervates. At a charge ratio close to 0.5 (50% 
positively charged PLys to 50% negatively charged PGlu), all of the PPV particles were 
extracted from the solution and were encapsulated in the coacervate. The majority of the 
BVDV particles were taken into the coacervate phase near a charge ratio of 0.6. The shift 
to higher charge fraction for BVDV extraction is likely due to the BVDV having a lower 
pI than PPV. The pI of BVDV is further away from the buffer solution pH 8.0 than PPV, 
BVDV carried more net negative charges than PPV, thus need more positively charged 
polypeptide PLys to form the neutral charged complex coacervates system. An 
encapsulated non-enveloped PPV was thermally stabilized and retained its lifetime at 
60°C for up to two weeks. Coacervates could help prevent the cold storage problem seen 
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In this dissertation, we demonstrated how we developed a single-particle chemical 
force microscopy (CFM) method to characterize the chemical surface of virus, focusing 
on hydrophobicity and surface charge. CFM can detect the surface chemistry of viral 
capsids at a single-particle level and enable the comparison of the surface chemistry 
between different types of viruses. Our covalent virus immobilization method can retain a 
natural virus state without deformation or disassembly. We chose to covalently attach the 
virus to a gold surface to guarantee that the bond that is broken during CFM 
measurements is the virus-tip interaction and not the virus-surface interaction. Our atomic 
force microscope (AFM) probe functionalizing method of thiol attachment to gold-coated 
probes can be achieved at room temperature and allows the attachment of many chemical 
functional groups of interest. With the immobilized virus and functionalized AFM tips, 
we have studied viral surface chemistry with small amounts of samples using CFM. We 
determined that porcine parvovirus (PPV) is more hydrophobic than bovine viral diarrhea 
virus (BVDV) using a methyl-terminated AFM probe. When charged groups were put on 
the AFM probes, the surface charge of the virus could be measured. Both PPV and 
BVDV carry a negative charge at neutral pH. 
We have used oppositely charged groups modified AFM tips to study viral 
electrostatic surface properties at various pH solutions. The adhesion force as a function 
of pH was a good fit for a sigmoidal curve, which allowed the determination of the 
inflection point as the isoelectric point (pI) of the virus. CFM determined the pI of PPV 
to be 4.8-5.1 and BVDV to be 4.3-4.5. PPV had literature reported pI of 5.0, and BVDV 
did not have literature reported pI. The pI values determined by CFM are in good 
agreement with most of the pI values determined by the bulk measurements of zeta 
potential and aqueous two-phase system (ATPS). Virus particles are much more complex 
systems than surface capsid proteins, and the theoretical calculations did not provide an 
accurate measure of virus surface pI due to effects not taken into accounts, such as amino 
acid modifications and the viral envelope. Therefore, we need to determine the pI of 
viruses experimentally. With a thorough understanding of virus surface chemistry, future 
technologies in areas of bio-sensing, vaccines, gene therapy, and targeted drug delivery 
could be significantly improved by using CFM to characterize the particle surface 
chemistry. 
The biochemical surface properties of viruses were further exploited for ligand-
free, nonspecific virus detection. The detection depends on the interaction of the virus 
with the osmolyte mannitol. The aggregation of virus-coated gold nanoparticles (AuNPs) 
in mannitol can be detected by dynamic light scattering (DLS), and there is a linear 
increase in aggregate size with an increase in PPV concentration on a semi-log plot. This 
indicates the potential of quantitative detection of the virus with this described AuNPs 
aggregation method. The lowest detectable concentration of the virus was analyzed 
statistically to be 106 MTT50/mL, which is lower than standard antibody assays. The non-
specific nature of this assay was tested by detecting the aggregation of BVDV-coated 
AuNPs in mannitol. The lowest detection concentration for BVDV was determined to be 
104 MTT50/mL. The AuNPs aggregation assay has the ability to determine the presence 
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of a virus in up to 500 μM of bovine serum albumin (BSA) quantitatively, used as a 
model contaminant in a protein-rich biological fluid. Also, PPV was detected 
quantitatively after it was swabbed from a dried sample on a petri dish. The developed 
ligand-free AuNPs aggregation method can determine the presence of virus within 24 
hours, which is comparable or faster than current virus detection methods. This general 
virus detection method could be a quick, sensitive, inexpensive, and portable method for 
detecting the presence of viral particles in low resource countries.  
PPV and BVDV were also explored for their ability to be encapsulated into 
complex coacervates. At a charge ratio close to 0.5 (50% positively charged poly (L-
lysine) (PLys) to 50% negatively charged poly (D, L-glutamic acid) (PGlu)), all of the 
PPV particles were extracted from the solution and were encapsulated in the coacervate. 
The majority of the BVDV particles were taken into the coacervate phase near a charge 
ratio of 0.6. The shift to higher charge fraction for BVDV extraction is likely due to the 
BVDV having a lower pI than PPV, measured by the CFM. The pI of BVDV is further 
away from the buffer solution pH 8.0 than PPV, BVDV carried more net negative 
charges than PPV, thus need more positively charged polypeptide PLys to form the 
neutral charged complex coacervates system. An encapsulated non-enveloped PPV was 
thermally stabilized and retained its lifetime at 60°C for up to two weeks. Coacervates 
could help prevent the cold storage problem seen not only in developing countries but is 




7.2 Future work 
 
For virus surface chemistry characterization by CFM, we would like to explore 
more on viral surface hydrophobicity, PPV, BVDV, and symmetric less hydrophobic 
protein control thyroglobulin will be performed in standard PBS buffer, with a 
hydrophobic methyl and a hydrophilic hydroxyl group functionalized AFM probe. To 
perturb the system, the surfactant Triton X-100 will be added to the solution to disrupt 
hydrophobic interaction between the viral surface and SAM–CH3 modified AFM probe. 
In the opposite regard, lysine will be added to the buffer solution to increase the 
hydrophobic interaction [1]. It has been shown that the charging of the lysine side-chain 
amino groups enhanced the hydrophobic interactions between the non-polar domain of 
GA-Lys and the AFM tip [1]. Other hydrophobic interactions modifiers, such as ethanol, 
poly (ethylene glycol) (PEG), and osmolytes, were also interested in adding to the 
solutions.  
  Comparisons of the adhesion of hydrophobic or electrostatic interactions by CFM 
work to the adhesion to corresponding chromatography columns will be explored. A 
space linker, e.g., PEG, is highly suggested to be used rather than the current ten carbon 
lengths to modify the AFM probe, avoiding any non-specific interactions confusing the 
interested specific interactions at zero separations in the force-distance curves [2].  In 
addition, a quaternary amine and sulphonic acid-functionalized AFM probe will be used 
the explore the surface chemistry difference between full and empty adeno-associated 
virus (AAV) capsids in different buffers conditions used in industry chromatography, to 
better understand the separation of empty capsids from full capsids in gene therapy.  
Furthermore, the interparticle interactions of viral particles are also interesting to 
explore, AFM tips will be functionalized with carboxyl terminated bifunctional linker, 
covalently binding with the same virus that will be probed, allowing measurement of the 
self-interaction forces in different solution conditions. To confirm the virus attached to 
the AFM tip, the functionalized tip will be characterized by confocal microscopy of the 
fluorescently labeled virus [3]. Similar experiments will be conducted as done in the virus 
surface study by changing the buffer conditions. The self-interaction will also be varied 
by changing pH, ionic strength, and surfactant to measure changes in the ionic, 
hydrophobic, and hydrogen bonding of the virus with itself. Reducing water molecules 
environments (i.e., high concentrations of salt, 20%-40% ethanol, 4% PEG, and high 
concentrations of osmolytes) will enhance virus self-interaction due to high 
hydrophobicity of the viral surface. 
For virus detection by AuNPs aggregation, we would like to explore additional 
viruses, reducing the time for the assay, and determining the ideal AuNP size and shape. 
Gold nanospheres in 10, 20, and 40 nm for PPV (~20 nm), and gold nanospheres in 25. 
50, and 100 nm for BVDV (~50 nm) will be explored. Additionally, 40×10 nm gold 
nanorods, and 100 nm gold nanostars will also be used to detect the viruses. The goal is 
to develop this assay into an early screening step for a viral infection in blood samples or 
cleanliness of a surface, which could help to control a viral disease outbreak. 
For stabilization of virus by polyelectrolytes dense phase, other combinations of 
synthesized polypeptides, e.g., PLy-PGlu, PLy-poly(L-aspartic acid), poly(L-histidine)-
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PGlu, poly (L-ornithine)-PGlu (different charge patterns, degree of polymerization) will 
be likely to explore. Except for polyelectrolyte mixing ratio (stoichiometry), the effects of 
polyelectrolyte concentrations, solution pH, and different ionic strengths of solutions on 
the phase behavior of virus complex coacervates are also interested in studying. Sugars 
such as trehalose are planned to add into the formulation of enveloped BVDV complex 
coacervates to improve the thermal stability. Other enveloped viruses like HSV, hepatitis 
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Preparation of 20 mM citrate buffer solutions at pH 3.0-6.0 
A total of 2.101 g citric acid monohydrate was dissolved in 500 mL Nanopure 
water at room temperature with gentle stirring for 10 min to make a 0.02 M homogeneous 
citric acid solution. Then a total of 2.941 g sodium citrate tribasic dihydrate was added 
into 500 mL Nanopure water at room temperature with gentle stirring for 10 min to make 
a 0.02 M homogeneous trisodium citrate solution. To prepare 20 mM citrate buffer 
solutions at pH 3.0-6.0, the volume of 0.02 M citric acid solution and 0.02 M trisodium 
citrate solution was mixed as follows in Table S1. The final pH was adjusted with 1 M 
NaOH or HCl, as needed, and measured with a calibrated pH meter. 
 
Table A.1 the citrate buffer at pH 3.0-6.0 recipe 
pH of citrate buffer Volume (mL) 0.02 M citric acid 
Volume (mL) 0.02 M 
trisodium citrate 
3.0 41.0 9.0 
4.0 29.5 20.5 
4.5 23.4 26.5 
5.0 17.5 32.5 
5.5 11.6 38.3 
6.0 5.7 44.2 
 
 
Preparation of 20 mM phosphate buffer solution at pH 7.0  
 
A total of 5.361 g sodium phosphate dibasic heptahydrate was dissolved in 1000 
mL Nanopure water at room temperature with gentle stirring for 10 min to make a 0.02 
M homogeneous solution. Then, a total of 2.7598 g sodium phosphate monobasic 
monohydrate was added into 1000 mL Nanopure water at room temperature with gentle 
stirring for 10 min to make a 0.02 M homogeneous solution. To prepare 20 mM 
phosphate buffer solutions at pH 7.0, 610 ml 0.02 M sodium phosphate dibasic solution, 
and 390 ml 0.02 M sodium phosphate monobasic solution was mixed. The final pH was 






Characterization of BVDV 
 
For TEM characterization, 7 log10 MTT50/ml purified BVDV was adsorbed to a 
plasma etched TEM copper grid (Carbon Type-B, 300 mesh) for 2 minutes and then 
negatively stained with 2% uranyl acetate (Fisher Scientific) for 2 minutes. The 
morphology of the virus samples was imaged with a FEI Titan Themis Scanning 
















Figure A.1.1 TEM images of enveloped BVDV showing the viral envelope. (A) Bright field image, and 







Figure A.1.2 Topographic image and corresponding height analysis of virus and controls in liquid. (A&B) 
Viruses deposited on gold. (A) PPV and (B) BVDV. (C) NHS-EDC background. (D&E) Viruses deposited 
on SAM-COOH and direct addition of virus without addition of NHS/EDC. (D) PPV, (E) BVDV. (F) PPV 








Figure A.1.3 Confirm probe functionalization. (A) Primary amine modified silica NPs with a COOH-
terminated probe, (B) COOH modified surface with a NR4
+
-terminated probe. Adhesion histograms of 
positive control with a COOH-terminated probe or a NR4
+
-terminated probe, recorded in 20 mM phosphate 








Figure A.1.4 Adhesion histograms and representative force-distance curves (retraction part) of BVDV with 
a COOH-terminated probe (A) or a NR4
+-terminated probe (B), recorded in 20 mM citrate or phosphate 







Figure A.1.5 The electrostatic potential map of virus surface. (A) PPV capsid protein VP2, (B) BVDV 
glycoprotein E2, and (C) BVDV glycoprotein E2. (Created in PyMOL) 
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A.2 Virus detection by mannitol-induced gold nanoparticle 
aggregation 
 
The calculation for concentration of control BSA of 10-3 μM based on the same 
area coverage of 108 MTT50/mL virus PPV on AuNPs is shown as follows: 














1 × 106 particles
1 pfu
∗∗




∗ 7 log10 �
pfu
mL
� = 7.8  log10 �
MTT50
mL
�,1 thus107  pfu
mL




∗∗ Infectivity ratio = infectious particles
total particles
= 1,000,000,2  
thus 1 pfu = 1,000,000 particles 
Step 2, coverage area of PPV=APPV = πrPPV2 = π(
dPPV
2




Coverage area of BSA=ABSA = πrBSA2 = π(
dBSA
2
)2 = π(6.78 nm
2
)2 = 11.5π nm2 
Ratio of coverage area PPV/BSA=156π  𝑡𝑡𝑡𝑡
2
11.5π nm2
 = 14 






= 1 nM = 10−3μM 
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Figure A.2.1 Uncoated AuNPs before and after 1 M osmolyte. All data points are the average of three 







Figure A.2.2 UV-Vis absorbance spectra of coated AuNPs before and after 1 M osmolyte. Dashed lines 







Figure A.2.3 Characterization of synthesized and BVDV or thyroglobulin coated AuNPs. (A) UV-Vis 
absorption spectrum, (B) hydrodynamic diameter 
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A.3 Stabilization of viruses through complex coacervation 
 
The recovery of the virus was calculated by Eq.A.3.1. 
𝐿𝐿𝑒𝑒𝑅𝑅𝑅𝑅𝑅𝑅𝑒𝑒𝑅𝑅𝑅𝑅 (%) = 𝐶𝐶c×𝑉𝑉c
𝐶𝐶i ×𝑉𝑉i
× 100                            (A.3.1) 
where, Cc is the virus concentration in the coacervate phase, Vc is the virus 
volume in the coacervate phase, Ci is the initial virus concentration, and Vi is the initial 








Figure A.3.1 Live virus recovery in coacervate. (A&B&C) Encapsulated PPV, and (D&E) Encapsulated 
BVDV. (A&D) 4 log10 (MTT50/mL), (B&E) 5 log10 (MTT50/mL), and (C) 6 log10 (MTT50/mL). All data 







Figure A.3.2 The infectivity loss of free and encapsulated virus. All data points are the average of three 







Figure A.3.3 Cytotoxicity of polypeptides. (A) PK-13 cells, and (B) BT-1 cells. 
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B.10 Figure 2.11 permission 
Figure 2.11 is licensed under the Creative Commons Attribution-Share Alike 3.0 
Unported 
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Creative Commons Attribution (CC BY 4.0) licence. Anyone may reproduce, distribute, 
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commercial purposes), subject to full attribution to the original publication and authors. 
The full terms of this licence may be seen at 
http://creativecommons.org/licences/by/4.0/legalcode. 
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